KOL | Erika RM von MutiusComprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, ... |
Kol melanjutkan untuk Erika RM von Mutius
| Year | |
|---|---|
| 2022 | Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, Munich, Germany; Institute of Asthma and Allergy Prevention (IAP), Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Institute for Asthma and Allergy Prevention, Helmholtz Centre Munich, 85764 Neuherberg, Germany |
| 2021 | Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany |
| 2020 | German Center for Lung Research, CPC-M From the Institute of Asthma and Allergy Prevention, Helmholtz Centre Munich, Munich, and the Asthma and Airway Disease Research Center, University of Arizona, Tucson. |
| 2019 | Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Institute for Asthma and Allergy Prevention, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany Dr von Hauner Children's Hospital, Ludwig Maximilian University German Center for Lung Research (DZL) |
| 2018 | Member of the German Centre for Lung Research, Munich, Germany Direktorin, Institut für Asthma und Allergieprävention Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Ingolstädter Landstraße 1, 85764 Neuherberg |
| 2017 | Children Hospital and Children Polyclinic in the Dr. von Haunersches Children Hospital, Ludwig-Maximilians-University, Lindwurmstr. 4, 80337 Munich, Germany Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL) |
Erika RM von Mutius: Statistik pengaruh
Jalankan laporan
| Concept | World rank |
|---|---|
| respiratory sounds immunity | #1 |
| asthma turkish | #1 |
| rs2738751 | #1 |
| regression approach order | #1 |
| age dust microbiota | #1 |
| helminth parasites exposure | #1 |
| agreement association | #1 |
| protective 6 years | #1 |
| worldwide asthma epidemic | #1 |
| immune responses birth | #1 |
| pollen concentration feeding | #1 |
| milk asthma | #1 |
| oropharyngeal microbiota children | #1 |
| 17q21 polymorphisms ormdl3 | #1 |
| 1133 children | #1 |
| interaction npsr1 polymorphisms | #1 |
| rs11079788 | #1 |
| interquartile range asthma | #1 |
| common inhalants | #1 |
| incident wheezing | #1 |
| 17q21 locus method | #1 |
| living environment children | #1 |
| farm animals asthma | #1 |
| hlx1 polymorphisms | #1 |
| food sensitization egg | #1 |
| increased risk rhinoconjunctivitis | #1 |
| gsdma phytohemagglutinin | #1 |
| order covariates | #1 |
| age increased diversity | #1 |
| pasture cohort lca | #1 |
| wheezing w12 | #1 |
| protection allergic diseases | #1 |
| network differences groups | #1 |
| tregs foxp3 demethylation | #1 |
| cleanliness matter | #1 |
| nct02496468 | #1 |
| gel variations gels | #1 |
| selection bias responders | #1 |
| lower prevalence asthma | #1 |
| age asthma child | #1 |
| microorganisms farms | #1 |
| alliance asthma | #1 |
| maternal atopy tregs | #1 |
| asthma symptoms community | #1 |
| associations pet contact | #1 |
| hyperreaktivität | #1 |
| 26 farms bavaria | #1 |
| solids development | #1 |
| traditional farms | #1 |
| children beta 2agonists | #1 |
| ilcs inception | #1 |
| lca feeding patterns | #1 |
| epidemiologic phenotypes | #1 |
| development allergic illnesses | #1 |
| school children germany | #1 |
| farm dwellings homes | #1 |
| carriers hlx1 | #1 |
| exposure protective | #1 |
| children farmers | #1 |
| wheezing fever | #1 |
| atopic smokers baseline | #1 |
| risk gene asthma | #1 |
| asthma richness | #1 |
| seasonal allergens | #1 |
| functionality network differences | #1 |
| diseases farm | #1 |
| rural children w12 | #1 |
| 6 types cheese | #1 |
| concomitant bhr 95 | #1 |
| data netcomi | #1 |
| th2related genes cytokines | #1 |
| association farm contact | #1 |
| prediction quality snps | #1 |
| spts specific ige | #1 |
| cumulative incidence finland | #1 |
| allergies endotoxin | #1 |
| prognosis early wheeze | #1 |
| life chronic asthma | #1 |
| allergies addition | #1 |
| occupational disinfectants asthma | #1 |
| asthma german | #1 |
| exposure farm | #1 |
| ilcs administration | #1 |
| amish hutterite children | #1 |
| farm milk | #1 |
| asthma genetic effects | #1 |
| followup farm living | #1 |
| isaac phase data | #1 |
| farm lung function | #1 |
| polysaccharides cde | #1 |
| aetiology atopic disease | #1 |
| childhood asthma fever | #1 |
| pets crowding | #1 |
| mite sensitization aor | #1 |
| maternal farming | #1 |
| incidence indoor allergens | #1 |
| male saline solution | #1 |
| lpa ppg stimulation | #1 |
| persistence allergic rhinitis | #1 |
| environments asthma | #1 |
| allergies childhood phase | #1 |
| farm reduced prevalence | #1 |
| interaction rora | #1 |
| 457 iu | #1 |
| analyses provocation time | #1 |
| asthma german children | #1 |
| genetic interaction npsr1 | #1 |
| associations maternal sensitization | #1 |
| study prehireonset | #1 |
| identification immune phenotypes | #1 |
| childhood protective | #1 |
| acrossolar study | #1 |
| immune activation populations | #1 |
| npsr1 rora | #1 |
| gabriel advanced study | #1 |
| tolllike receptor farmers | #1 |
| acrossolar | #1 |
| 048 95 95 | #1 |
| external microbial | #1 |
| treg marker genes | #1 |
| t1432c | #1 |
| offspring atopic mothers | #1 |
| farm milk consumption | #1 |
| sum indicators | #1 |
| data fetal growth | #1 |
| farming environments | #1 |
| asthma bacteria | #1 |
| microbial exposure patterns | #1 |
| 9 bronchodilators | #1 |
| aa nonallergic asthma | #1 |
| initial cohort pattern | #1 |
| rora susceptibility gene | #1 |
| prenatal animal contact | #1 |
| richness farming | #1 |
| bronchial hyperreactivity childhood | #1 |
| cough soot | #1 |
| 95 asthmatic children | #1 |
| 17q21 polymorphisms | #1 |
| menarche hormonal | #1 |
| alpine farms | #1 |
| wheeze active smoking | #1 |
| coupled receptor polymorphisms | #1 |
| swinesheds | #1 |
| mold problems children | #1 |
| 15ans | #1 |
| early development wheeze | #1 |
| feeding cattle cowsheds | #1 |
| allergic sensitization latex | #1 |
| domestic asthma child | #1 |
| study questionnaire responses | #1 |
| histamine challenges age | #1 |
| protective farm environment | #1 |
| atopic sensitization early | #1 |
| peak airborne moulds | #1 |
| 1120 german schoolchildren | #1 |
| kitchen moisture damage | #1 |
| determinants airway responsiveness | #1 |
| pasture study tubes | #1 |
| lps recognition development | #1 |
| farm milk exposure | #1 |
| strongest predictor atopy | #1 |
| followup solar cohort | #1 |
| phytohemagglutinin ormdl3 | #1 |
| farming allergies | #1 |
| children predominant hyperreactivity | #1 |
| asthma allergies | #1 |
| allergies protective pet | #1 |
| mold immune responsiveness | #1 |
| feeding overweight | #1 |
| helminths protective | #1 |
| actinomycetes peak | #1 |
| obstruktive atemwegserkrankungen | #1 |
| reduced risk allergy | #1 |
| kazal type spink5 | #1 |
| fever milk consumption | #1 |
| asthma austria allergic | #1 |
| followup solar iii | #1 |
| personal cleanliness risk | #1 |
| asthma puberty | #1 |
| association farm milk | #1 |
| blood ormdl3 | #1 |
| copd sod3 | #1 |
| usage preventive measures | #1 |
| males pierced ears | #1 |
| features anthroposophic lifestyle | #1 |
| menarche allergic | #1 |
| w12 ddhay fever | #1 |
| tubes rnastabilizing solution | #1 |
| mattress dust association | #1 |
| breastfeeding length | #1 |
| methods solar cohort | #1 |
| antibiotics allergies | #1 |
| 035 iu sige | #1 |
| crobiome data | #1 |
| phenotype health variables | #1 |
| igg4 coexpression | #1 |
| prenatal farm | #1 |
| infant inflammation crp | #1 |
| stepwise protocol bhr | #1 |
| non‐farm children | #1 |
| farm dairy products | #1 |
| phenotypes atopic | #1 |
| 5 years predictor | #1 |
| grass pollen 95 | #1 |
| tenascin neuropeptide receptor | #1 |
| heating children | #1 |
| leur relation | #1 |
| authors grass arabinogalactans | #1 |
| increased atp2a3 fpr2 | #1 |
| phenotypes lca | #1 |
| overweight dresden | #1 |
| food allergy yogurt | #1 |
| neonatal immune mechanisms | #1 |
| immunity newborn mothers | #1 |
| rhinitis predictor | #1 |
| solar study | #1 |
| incident wheezing association | #1 |
| fever atopic dermatitis | #1 |
| review hygiene hypothesis | #1 |
| inhaled steroids dresden | #1 |
| spt atopic dermatitis | #1 |
| cowsheds childrens bedrooms | #1 |
| netcomi network construction | #1 |
| amish hutterite | #1 |
| farmers nonfarmers children | #1 |
| east germany allergic | #1 |
| east germany leipzig | #1 |
| asthmatic children result | #1 |
| children isaac asthma | #1 |
| homes farm dwellings | #1 |
| predictor igg1 galactosylation | #1 |
| occurrence allergy | #1 |
| protective mechanisms asthma | #1 |
| atopy interactions | #1 |
| allergies existing cohort | #1 |
| il13cd4 cells ilcs | #1 |
| clinical examinations challenges | #1 |
| girls mechanism | #1 |
| farmrelated exposures | #1 |
| actinomycetes alpine farms | #1 |
| associations indoor mould | #1 |
| ahr acinetobacter lwoffii | #1 |
| cbmcs ormdl3 | #1 |
| lpastimulation carriers | #1 |
| expiratory volume lca | #1 |
| rnastabilizing solution | #1 |
| lower atopy asthma | #1 |
| 812 children | #1 |
| protective cheese consumption | #1 |
| parents allergies | #1 |
| ilt4 cb | #1 |
| bronchial hyperreactivity age | #1 |
| preschool children predictor | #1 |
| ilcs neonatal mice | #1 |
| exposures pieces | #1 |
| fpr2 clec4e | #1 |
| moderate‐to‐adequate | #1 |
| regular farm animal | #1 |
| hrqol farm children | #1 |
| development allergies | #1 |
| newborn interleukin17 leukocytes | #1 |
| stepwise protocol phase | #1 |
| tnc risk gene | #1 |
| hlx1 snps cbmcs | #1 |
| atopic dermatitis adolescence | #1 |
| farming asthma | #1 |
| egg aor | #1 |
| allergoprotective | #1 |
| farm homes homes | #1 |
| germany prevalence differences | #1 |
| treatment 9 bronchodilators | #1 |
| farm animal exposure | #1 |
| germany dresden | #1 |
| bactoscan | #1 |
| asthma risk lca | #1 |
| derp1lpa | #1 |
| aetiology early years | #1 |
| asthma consumption | #1 |
| living farm | #1 |
| pet contact infancy | #1 |
| atopic dermatitis increase | #1 |
| munich leipzig | #1 |
| children amish farms | #1 |
| 1120 children | #1 |
| leipzig munich | #1 |
| psychosocial characteristics asthma | #1 |
| igg1 galactosylation predictor | #1 |
| cla allergoprotective capacity | #1 |
| transient wheeze age | #1 |
| 20 fall volume | #1 |
| allergies cohort | #1 |
| infections hygiene hypothesis | #1 |
| unhygienic contact | #1 |
| treatment childhood asthma | #1 |
| dzl | #1 |
| atopic embryonic | #1 |
| demethylation foxp3 demethylation | #1 |
| asthma risk class | #1 |
| allergy exposures | #1 |
| lukas2 lca | #1 |
| protective farm asthma | #1 |
| overweight munich | #1 |
| aa clec4e | #1 |
| protection childhood asthma | #1 |
| wheeze asthma questions | #1 |
| crohns disease atopy | #1 |
| skin tests spt | #1 |
| aor interquartile range | #1 |
| children indoor mould | #1 |
| chapter 16 epidemiology | #1 |
| rs7164773 | #1 |
| vehicle traffic asthma | #1 |
| children unification | #1 |
| auc spt | #1 |
| maternal farm | #1 |
| maschildren | #1 |
| failure☆ | #1 |
| studies microbial exposures | #1 |
| farm farm children | #1 |
| protective atopic sensitization | #1 |
| late onset menarche | #1 |
| coding region il4ra | #1 |
| secretion life | #1 |
| provocation time bhr | #1 |
| crp early age | #1 |
| predictive models incidence | #1 |
| complementary food year | #1 |
| children automobiles child | #1 |
| health urbanrural differences | #1 |
| hypopharynx moraxella | #1 |
| infancy jia | #1 |
| indoor bacterial microbiota | #1 |
| 95 hormonal contraceptives | #1 |
| atopy microbial influences | #1 |
| children leipzig | #1 |
| newborn leukocytes surveys | #1 |
| asthma bronchial response | #1 |
| 95 agmr | #1 |
| agents reduced risk | #1 |
| participation rates phase | #1 |
| protective factors strategies | #1 |
| health services exposure | #1 |
| allergies topic surveys | #1 |
| pattern atopic sensitization | #1 |
| environmental microbial | #1 |
| transient wheeze asthma | #1 |
| subsample predominant obstruction | #1 |
| selfreported nickel allergy | #1 |
| microbes epigenetic mechanisms | #1 |
| agriculture asthma | #1 |
| immune responsiveness life | #1 |
| preschool children rhinitis | #1 |
| cord blood offspring | #1 |
| allergic germany | #1 |
| evidence allergy prevention | #1 |
| traditional upbringing | #1 |
| factor school behavior | #1 |
| asthma food sensitization | #1 |
| 3 mm spt | #1 |
| unbalanced meat consumption | #1 |
| wheeze farmers children | #1 |
| isolated cd4cd25hi tregs | #1 |
| exposure farming environment | #1 |
| 45yearold children protection | #1 |
| allergies viral infections | #1 |
| heattreated milk samples | #1 |
| “atopic march | #1 |
| atopic disease bias | #1 |
| gabriel study | #1 |
| aor farm exposures | #1 |
| allergyrisk factors | #1 |
| allergy protective | #1 |
| anti‐asthmatic drugs | #1 |
| tregs cd4cd25hi | #1 |
| igein | #1 |
| gsdma expression secretion | #1 |
| unprocessed farm milk | #1 |
| allergies cohort studies | #1 |
| prevalence atopic sensitisation | #1 |
| tbx21 | #1 |
| pets farm animals | #1 |
| farm cowsheds | #1 |
| aa ifih1 expression | #1 |
| food diversity year | #1 |
| changing gender ratio | #1 |
| tregs maternal atopy | #1 |
| juvenile crohn disease | #1 |
| 95 late introduction | #1 |
| consumption farm milk | #1 |
| incident wheezing women | #1 |
| marked differences prevalence | #1 |
| persistence earlylife exposures | #1 |
| positive sensitization egg | #1 |
| soot benzene | #1 |
| work ilc2s | #1 |
| protective effects asthma | #1 |
| interaction npsr1 protein | #1 |
| 035 iu specificity | #1 |
| single microbial markers | #1 |
| package functionality | #1 |
| groups rural areas | #1 |
| throat microbiota | #1 |
| rhinoconjunctivitis participation | #1 |
| prehireonset | #1 |
| animal sheds barns | #1 |
| recurrent unremitting wheeze | #1 |
| dairy products protective | #1 |
| asthma 105 years | #1 |
| milkassociated cla | #1 |
| atopic dermatitis onset | #1 |
| allergic illnesses | #1 |
| transient wheezing age | #1 |
| tnc npsr1 | #1 |
| bronchial obstruction hyperreactivity | #1 |
| patients treg cells | #1 |
| farmingrelated exposures | #1 |
| 30 amish | #1 |
| current asthma age | #1 |
| atopic embryonic allergic | #1 |
| cattle childrens bedrooms | #1 |
| study rural environment | #1 |
| 6 years subtypes | #1 |
| farm children microorganisms | #1 |
| ilt4 cord blood | #1 |
| peptidoglycan ppg birth | #1 |
| prevalence environmental factors | #1 |
| asthma concomitant bhr | #1 |
| school age early | #1 |
| late introduction egg | #1 |
| children road traffic | #1 |
| maternal farm exposure | #1 |
| infancy case status | #1 |
| bronchial hyperreactivity wheezing | #1 |
| ige seasonal allergens | #1 |
| association atopic sensitization | #1 |
| year environmental exposures | #1 |
| mrna expression tregs | #1 |
| 585883 | #1 |
| current wheeze benzene | #1 |
| children 7 yrs | #1 |
| increased expression ormdl3 | #1 |
| ml1 cohort studies | #1 |
| 28 dust samples | #1 |
| wheezing atopic sensitization | #1 |
| children atopic sensitization | #1 |
| life antibiotic exposure | #1 |
| bacterial signals atopy | #1 |
| accuracy regression approach | #1 |
| yogurt year | #1 |
| current asthma soot | #1 |
| atopic dermatitis farm | #1 |
| managing wheezing | #1 |
| persistence adolescence | #1 |
| normal censored | #1 |
| lukas2 umc | #1 |
| influential factors phenotype | #1 |
| 18 95 incidence | #1 |
| protective allergic diseases | #1 |
| farm exposure asthmatics | #1 |
| prevent allergic diseases | #1 |
| asthma risk pasture | #1 |
| hrqol protective | #1 |
| bhr asthma child | #1 |
| cleanliness dust parameters | #1 |
| dgge asthma | #1 |
| feeding patterns risk | #1 |
| asthma wisc | #1 |
| unprocessed cow | #1 |
| children severe atopy | #1 |
| animal sheds 28 | #1 |
| children alliance asthma | #1 |
| tcells foxp3 | #1 |
| microbial exposure sum | #1 |
| barns samples | #1 |
| ascaris lumbricoides exposure | #1 |
| cowsheds cattle | #1 |
| epidemiological evidence consumption | #1 |
| europe protection | #1 |
| spts agreement | #1 |
| infant genetic polymorphism | #1 |
| 95 grass pollen | #1 |
| wheeze bronchial | #1 |
| aa hcs | #1 |
| higher specificity asthma | #1 |
| 5–13‐year | #1 |
| childhood bronchial hyperreactivity | #1 |
| puberty infant | #1 |
| allergen exposure life | #1 |
| city air pollution | #1 |
| 7 yrs determinants | #1 |
| west germany overweight | #1 |
| antipyretics reduced risk | #1 |
| increased risks rhinoconjunctivitis | #1 |
| health influential factors | #1 |
| kitchen living area | #1 |
| asthma aor | #1 |
| netcomi functionality | #1 |
| ranks performance | #1 |
| allergies year | #1 |
| dresden munich | #1 |
| development preschool wheezing | #1 |
| gasdermin gsdma | #1 |
| 95 allergen | #1 |
| adolescent aging asthma | #1 |
| maternal farming activities | #1 |
| igg1 galactosylation levels | #1 |
| yoghurt asthma risk | #1 |
| childhood gondii seropositivity | #1 |
| south bavarian population | #1 |
| moisture mold exposure | #1 |
| 105 years richness | #1 |
| mite exposure risk | #1 |
| environmental exposure age | #1 |
| association incident rhinoconjunctivitis | #1 |
| score total quantity | #1 |
| expression 17q21 | #1 |
| birth tbx21 | #1 |
| farming environment development | #1 |
| polymorphisms tbx21 | #1 |
| risk mite sensitization | #1 |
| west germany munich | #1 |
| 5 years aor | #1 |
| damage systemic inflammation | #1 |
| consumption asthma | #1 |
| adolescent agriculture dust | #1 |
| quantitative confirmation associations | #1 |
| exposure farm children | #1 |
| animal farms substances | #1 |
| allergic diseases cutoff | #1 |
| phase stratified sample | #1 |
| perinatal influences | #1 |
| farm nonfarm children | #1 |
| asthma diversity | #1 |
| wheeze classes | #1 |
| endotoxin allergy | #1 |
| environmental exposures asthma | #1 |
| diversity protective effects | #1 |
| development childhood asthma | #1 |
| mice atopic sensitization | #1 |
| predominant obstruction | #1 |
| covariates potential confounding | #1 |
| ema protective farm | #1 |
| phenotypes atopic sensitization | #1 |
| pasture study spt | #1 |
| microorganisms animal sheds | #1 |
| children early phenotypes | #1 |
| higher hscrp values | #1 |
| topic puberty rhinitis | #1 |
| germany breast feeding | #1 |
| children amish children | #1 |
| 12 months crowding | #1 |
| work overload work | #1 |
| no2 allergic sensitisation | #1 |
| personal cleanliness | #1 |
| atopy farm | #1 |
| allergic allergic dermatitis | #1 |
| introduction yogurt | #1 |
| pasture lukas2 | #1 |
| dgge health outcomes | #1 |
| genetic association tnc | #1 |
| 624 children | #1 |
| lukas2 birth cohorts | #1 |
| infant adolescent aging | #1 |
| childhood allergy children | #1 |
| asthma symptoms adolescence | #1 |
| infant contact animals | #1 |
| maternal atopy secretion | #1 |
| followup work discontent | #1 |
| bamse npsr1 | #1 |
| study parsifal | #1 |
| validity food questionnaire | #1 |
| 18 months protective | #1 |
| immunity innate infant | #1 |
| “hygiene hypothesis | #1 |
| increased food diversity | #1 |
| asthma dresden | #1 |
| airborne fungi actinomycetes | #1 |
| prenatal animal | #1 |
| egg positive sensitization | #1 |
| life fungi humans | #1 |
| dermatitis symptoms | #1 |
| new onset wheeze | #1 |
| allergic rhinitis childhood | #1 |
| protective diversity | #1 |
| ppg lpa ppg | #1 |
| farm asthma | #1 |
| doctor allergic rhinitis | #1 |
| association haplotype studies | #1 |
| yogurt diversity | #1 |
| farming environment protective | #1 |
| endotoxin levels samples | #1 |
| sensitised children wheeze | #1 |
| lca pasture | #1 |
| unprocessed cows milk | #1 |
| specific exposures cows | #1 |
| 3785 adolescents | #1 |
| kitchen visible mold | #1 |
| west germany allergic | #1 |
| aa increased atp2a3 | #1 |
| foxp3 demethylation tregs | #1 |
| allergies | #1 |
| predictor immune activation | #1 |
| diversity microbial exposure | #1 |
| farm specific exposures | #1 |
| allergic diseases questionnaires | #1 |
| bacterial exposures associations | #1 |
| transmaternal asthma protection | #1 |
| phase isaac programme | #1 |
| rs11071559 | #1 |
| childhood asthma age | #1 |
| unpasteurized cows milk | #1 |
| asthma farm children | #1 |
| ddhay fever children | #1 |
| seasonal rural | #1 |
| arabinogalactan cde | #1 |
| anthropometric data overweight | #1 |
| allergy symptoms childhood | #1 |
| asthmatics hc | #1 |
| il4ra association | #1 |
| tbx21 hlx1 snps | #1 |
| npsr1 interaction | #1 |
| phase international | #1 |
| linens child dust | #1 |
| tbx21 hlx1 | #1 |
| messenger surveys | #1 |
| asthmaprotective farm | #1 |
| wheezing 3rd year | #1 |
| 5–13‐year school children | #1 |
| associations transient sensitization | #1 |
| hyperreactivity expiratory volume | #1 |
| asthma questionnaire responses | #1 |
| regulatory responses protection | #1 |
| asthma arabinogalactan | #1 |
| snps wheeze | #1 |
| tregs age | #1 |
| increased prevalence cough | #1 |
| 12 months doctor | #1 |
| farmers children | #1 |
| grass arabinogalactan | #1 |
| allergoprotective capacity | #1 |
| unremitting wheeze | #1 |
| protective effects diversity | #1 |
| coexpression igg1 | #1 |
| serum ige levels | #1 |
| solar 2nd followup | #1 |
| asthma microbiome analysis | #1 |
| farm exposure asthma | #1 |
| solids relation | #1 |
| asthma symptoms adulthood | #1 |
| protective childhood | #1 |
| samples farm dwellings | #1 |
| muramic acid concentration | #1 |
| potential confounders jobs | #1 |
| children acrossolar cohort | #1 |
| no2 traffic counts | #1 |
| childhood dampness | #1 |
| bronchial hyperreactivity adolescence | #1 |
| development atopic sensitisation | #1 |
| rural allergy endotoxin | #1 |
| environmental exposures protection | #1 |
| single taxa groups | #1 |
| supplementation milk cla | #1 |
| age bacterial endotoxin | #1 |
| preschool wheezing aor | #1 |
| recurrence atopic dermatitis | #1 |
| anthroposophic families validity | #1 |
| tnc asthma | #1 |
| farm studies | #1 |
| grass arabinogalactan mice | #1 |
| farm children bavaria | #1 |
| predominant hyperreactivity subsample | #1 |
| dresden east germany | #1 |
| visible mold homes | #1 |
| early life insight | #1 |
| fever atopic sensitization | #1 |
| barns farm dwellings | #1 |
| farm milk meat | #1 |
| atopic sensitisation fever | #1 |
| network construction netcomi | #1 |
| aa immunity receptors | #1 |
| dampness bronchial hyperreactivity | #1 |
| infant design | #1 |
| otitis fever | #1 |
| asthma west germany | #1 |
| gabriel advanced surveys | #1 |
| lps foxp3 demethylation | #1 |
| allergic rhinitis type | #1 |
| allergic diseases protective | #1 |
| logistic models npsr1 | #1 |
| atopic diseases association | #1 |
| stepwise procedure risk | #1 |
| 911 yrs | #1 |
| bhr fall | #1 |
| 95 asthma | #1 |
| association farm | #1 |
| cutoff 3 mm | #1 |
| 115 iu | #1 |
| edta tubes countries | #1 |
| actinomycetes cowsheds | #1 |
| farming protective farm | #1 |
| farming children | #1 |
| symptoms school age | #1 |
| physiciandiagnosed asthma groups | #1 |
| ormdl3 gsdma expression | #1 |
| cla content plasma | #1 |
| crowding dry cough | #1 |
| hc aa | #1 |
| cde source | #1 |
| newonset allergic rhinitis | #1 |
| consumption allergic | #1 |
| fpr2 aa | #1 |
| cowsheds peak | #1 |
| asthma atopic disease | #1 |
| nickel allergy asthma | #1 |
| methods 2nd followup | #1 |
| loft farm milk | #1 |
| common infections infants | #1 |
| yogurt cows milk | #1 |
| tempo method | #1 |
| humans hypopharynx moraxella | #1 |
| benzene current wheeze | #1 |
| 95 endotoxin exposure | #1 |
| sige sensitizations symptoms | #1 |
| role th2 immunity | #1 |
| work overload followup | #1 |
| current contact asthma | #1 |
| preventive measures counselling | #1 |
| bacterial groups prevalence | #1 |
| provocation time | #1 |
| diversity consumed types | #1 |
| incident wheezing asthma | #1 |
| life protective | #1 |
| prediction farm children | #1 |
| relation late introduction | #1 |
| 95 nonatopic asthma | #1 |
| atopy rural subjects | #1 |
| male poland quality | #1 |
| ormdl3 gasdermin | #1 |
| lca clinical phenotypes | #1 |
| computing microbial associations | #1 |
| associations airwayrelated symptoms | #1 |
| child environmental pollutants | #1 |
| parsifal‐study | #1 |
| menarche allergic rhinitis | #1 |
| tobit regression ranks | #1 |
| analyses isaac phase | #1 |
| farm milk asthma | #1 |
| asthma asthma bacteria | #1 |
| 1 ppg stimulation | #1 |
| lumbricoides farmers children | #1 |
| str bhr | #1 |
| gsdma expression | #1 |
| sige cutoff | #1 |
| exposure gstm1 deficiency | #1 |
| patients neutrophil inflammation | #1 |
| early phenotypes age | #1 |
| otus bacterial diversity | #1 |
| cd4cd25hi tcells | #1 |
| farmers anthroposophic families | #1 |
| childhood asthma allergies | #1 |
| work overload school | #1 |
| microbiome data package | #1 |
| hlx1 polymorphisms influence | #1 |
| environments pasture | #1 |
| jia domestic arthritis | #1 |
| regulatory triggering receptor | #1 |
| allergy prevention studies | #1 |
| allergies respiratory infections | #1 |
| infants karelia | #1 |
| farm childhood asthma | #1 |
| protective effects exposure | #1 |
| allergen exposure associations | #1 |
| hrqol rural farm | #1 |
| immune stimulation life | #1 |
| exposure muramic | #1 |
| bifidobacterium breastfed infants | #1 |
| dairying environment pollen | #1 |
| development asthma | #1 |
| association ilt4 | #1 |
| pasture cohort | #1 |
| protective exposures | #1 |
| asthmatics asthma phenotypes | #1 |
| censored immunological | #1 |
| insight asthma | #1 |
| asthma concomitant asthma | #1 |
| cohorte pasture | #1 |
| igg4 ige expression | #1 |
| wheezerelated latent classes | #1 |
| 168fold | #1 |
| farm exposure igg4 | #1 |
| wheeze sensitisation | #1 |
| gene expression ilt3 | #1 |
| children farm children | #1 |
| airborne moulds actinomycetes | #1 |
| psychosocial characteristics children | #1 |
| association occupational disinfectants | #1 |
| dermatitis depending | #1 |
| microbial exposure endotoxin | #1 |
| innate immunity receptors | #1 |
| environmental differences finland | #1 |
| clec4e aa | #1 |
| solar cohort | #1 |
| otus farming | #1 |
| parasitic infections predictor | #1 |
| comparison microbiome data | #1 |
| harmful workplace exposure | #1 |
| source arabinogalactan | #1 |
| sensitisation early | #1 |
| farming environments asthma | #1 |
| 1314 newborn infants | #1 |
| exposure mattress dust | #1 |
| asthma tregs | #1 |
| domestic cats child | #1 |
| allergies personal cleanliness | #1 |
| microbial exposure asthma | #1 |
| childhood design | #1 |
| 95 atopic eczema | #1 |
| atopic eczema 95 | #1 |
| childrens bedrooms cowsheds | #1 |
| wheezing children wheezing | #1 |
| mold subclinical inflammation | #1 |
| girls allergic rhinitis | #1 |
| risk hutterite children | #1 |
| new microscope | #1 |
| fever atopic | #1 |
| pets associations | #1 |
| risk tcell phenotypes | #1 |
| hypersensitivity infections | #1 |
| farm rural children | #1 |
| model bronchial hyperreactivity | #1 |
| crude measure exposure | #1 |
| allergic rhinitis jia | #1 |
| farm dwellings children | #1 |
| participants solar | #1 |
| girls late onset | #1 |
| rora asthma susceptibility | #1 |
| observing children | #1 |
| protection yogurt | #1 |
| cowshed dust cde | #1 |
| overweight marked differences | #1 |
| moisture damage kitchen | #1 |
| rhinoconjunctivitis sex | #1 |
| antiasthma drugs children | #1 |
| questionnaire responses asthma | #1 |
| 9 10yold children | #1 |
| ddhay fever | #1 |
| parental questionnaires | #1 |
| farm protects | #1 |
| indicators total quantity | #1 |
| atopic sensitization development | #1 |
| groups netcomi | #1 |
| respiratory symptoms childhood | #1 |
| excessive sige production | #1 |
| pierced ears association | #1 |
| advanced surveys | #1 |
| repeated episodes fever | #1 |
| children diabimmune study | #1 |
| muramic acid wheezing | #1 |
| allergyprotective potential | #1 |
| allergic rhinitis puberty | #1 |
| cowsheds farm animals | #1 |
| stimulation 45yearold children | #1 |
| sod3 sod3 snps | #1 |
| farm fever | #1 |
| menarche hormonal contraceptives | #1 |
| tregs life | #1 |
| farm living symptoms | #1 |
| school university life | #1 |
| polymorphisms lps recognition | #1 |
| prehireonset odds ratio | #1 |
| allergies early phenotypes | #1 |
| asthmatics innate leukocytes | #1 |
| wheezing invertedu shape | #1 |
| unifying computational tool | #1 |
| tregs asthmatics | #1 |
| pierced ears asthma | #1 |
| transcription factors hlx1 | #1 |
| maturation gut microbiome | #1 |
| ige levels exposure | #1 |
| farming exposure childhood | #1 |
| agreement spts | #1 |
| fever spt cutoff | #1 |
| atopy allergen specificity | #1 |
| latent classes populations | #1 |
| 95 puberty | #1 |
| paediatric origins | #1 |
| wholeto | #1 |
| cε germline transcript | #1 |
| early age risk | #1 |
| asthma turkish children | #1 |
| children rural allergy | #1 |
| indoor microbiota development | #1 |
| identified polymorphisms asthma | #1 |
| mold problems kitchen | #1 |
| south bavarian | #1 |
| farms farm homes | #1 |
| bacterial exposures | #1 |
| model hyperreactivity | #1 |
| allergies generations | #1 |
| influential factors health | #1 |
| annual concentrations benzene | #1 |
| environmental factors sensitization | #1 |
| adolescents jobs | #1 |
| spink5 kazal type | #1 |
| dust parameters development | #1 |
| abundances 6 otus | #1 |
| alpine farm environments | #1 |
| late introduction solids | #1 |
| fever blood samples | #1 |
| solar iii | #1 |
| association spink5 420lys | #1 |
| sige spt | #1 |
| children preschool conjunctivitis | #1 |
| increased diversity food | #1 |
| hyperreactive children | #1 |
| male parents receptors | #1 |
| multicenter cohort prevalence | #1 |
| gene expression ilt4 | #1 |
| persistence bronchial hyperreactivity | #1 |
| estonia environmental differences | #1 |
| cd4cd25hi isolated cells | #1 |
| animal contact infancy | #1 |
| wheezing male respiratory | #1 |
| jobs asthma risk | #1 |
| npsr1 tnc | #1 |
| domestic child child | #1 |
| shop milk | #1 |
| farming nasal samples | #1 |
| epidemiologic phenotype | #1 |
| stepwise procedure gene | #1 |
| countries pasture study | #1 |
| employment new onset | #1 |
| paper online questionnaires | #1 |
| countries isaac phase | #1 |
| 1 year occurrence | #1 |
| farm indoor | #1 |
| hygiene hypothesis endotoxin | #1 |
| cd4creil13 | #1 |
| farm wheeze phenotypes | #1 |
| followup solar | #1 |
| generations birth cohort | #1 |
| gpra polymorphisms asthma | #1 |
| farm living | #1 |
| lower atopic sensitization | #1 |
| farm fungi humans | #1 |
| npsr1 messenger receptors | #1 |
| farm lifestyles | #1 |
| subtypes atopic dermatitis | #1 |
| pollen dairy farms | #1 |
| asthma indoor exposure | #1 |
| german peers | #1 |
| gpra gene | #1 |
| ddhay fever 95 | #1 |
| netcomi network | #1 |
| farm exposure exposure | #1 |
| fever farm | #1 |
| farm environments farms | #1 |
| factors th1 | #1 |
| rora neuropeptide receptor | #1 |
| farm animals childhood | #1 |
| anthroposophic lifestyle features | #1 |
| insight environmental factors | #1 |
| allergies atopic dermatitis | #1 |
| jobs potential confounders | #1 |
| endotoxin levels stables | #1 |
| farm allergic rhinitis | #1 |
| atopic sensitization | #1 |
| munich dresden | #1 |
| regular farm | #1 |
| immune receptors birth | #1 |
| neonatal mice ahr | #1 |
| diagnosed fever 95 | #1 |
| gene expression ormdl3 | #1 |
| eczema regions | #1 |
| asthma protective | #1 |
| preschool dermatitis questionnaires | #1 |
| allergic rhinitis menarche | #1 |
| antipyretics increased risk | #1 |
| allergic asthmatics asthmatics | #1 |
| endotoxin level production | #1 |
| wheeze farming exposure | #1 |
| igg nglycosylation populations | #1 |
| farms wheeze | #1 |
| th2related genes | #1 |
| atopic sensitization aor | #1 |
| 2nd followup challenges | #1 |
| allergy‐protective effects | #1 |
| th2 th1 gsdma | #1 |
| classical definitions lca | #1 |
| questionnaires childhood | #1 |
| protection hygiene hypothesis | #1 |
| allergic diseases hrqol | #1 |
| pcr sscp method | #1 |
| asthma rhinoconjunctivitis eczema | #1 |
| asthma bacterial diversity | #1 |
| asthma toll | #1 |
| 95 atopic sensitization | #1 |
| protective farming | #1 |
| farm environments asthma | #1 |
| richness asthma | #1 |
| food items year | #1 |
| protective asthma | #1 |
| wheeze farm living | #1 |
| turkish children asthma | #1 |
| 420lys | #1 |
| farm animals cats | #1 |
| analysis step package | #1 |
| adolescent agriculture | #1 |
| protection asthma | #1 |
| 17q21 risk | #1 |
| 13 microbial influences | #1 |
| network construction comparison | #1 |
| epigenetic regulation mechanism | #1 |
| associations hscrp values | #1 |
| h4 acetylation offspring | #1 |
| mrna expression year | #1 |
| occurrence generations | #1 |
| allergen exposure age | #1 |
| life inversely | #1 |
| associations dna fingerprinting | #1 |
| farming environment role | #1 |
| repeated infections life | #1 |
| spink5 420lys | #1 |
| lumbricoides crude measure | #1 |
| sige association | #1 |
| rora snps | #1 |
| boys fever | #1 |
| symptoms gender ratio | #1 |
| germany allergic | #1 |
| atopic sensitization birth | #1 |
| positive sensitization | #1 |
| netcomi | #1 |
| lca male phenotype | #1 |
| bronchial response wheeze | #1 |
| allergic rhinitis predictor | #1 |
| asthma rora | #1 |
| contact farm | #1 |
| life maternal atopy | #1 |
| class pasture | #1 |
| lpastimulation | #1 |
| living area risk | #1 |
| farm children hrqol | #1 |
| asthma interactions | #1 |
| bhr str | #1 |
| atopic dermatitis jobs | #1 |
| allergy cohort methods | #1 |
| foxp3 cd4cd25hi | #1 |
| dampness childhood | #1 |
| environmental allergens variety | #1 |
| wheeze environmental determinants | #1 |
| amish environment | #1 |
| lpastimulation cord blood | #1 |
| stable dust extract | #1 |
| 57 911yearold children | #1 |
| asthmatic farm children | #1 |
| bmi allergic dermatitis | #1 |
| gpra polymorphisms | #1 |
| endotoxin exposure association | #1 |
| adolescence bronchial hyperreactivity | #1 |
| endotoxin allergen exposure | #2 |
| asthma adolescence | #2 |
| agriculture allergens | #2 |
| microbial exposure study | #2 |
| nonfarm homes children | #2 |
| atopic developing countries | #2 |
| interval156 | #2 |
| wheeze 12 | #2 |
| environmental microorganisms children | #2 |
| artemisia olive pollen | #2 |
| protein rhinitis allergic | #2 |
| atopic eczema causation | #2 |
| munich participants | #2 |
| 95 protective factors | #2 |
| rhinitis adolescents | #2 |
| card4 protein rhinitis | #2 |
| farming environment mother | #2 |
| isaac atopic eczema | #2 |
| cd14 maternal exposures | #2 |
| life pvalues | #2 |
| wheeze bronchial hyperresponsiveness | #2 |
| farmers children children | #2 |
| work discontent | #2 |
| asthma control pa | #2 |
| ages current paracetamol | #2 |
| nocturnal asthma severity | #2 |
| pa interrelations | #2 |
| polymorphisms il13 gene | #2 |
| expression innate | #2 |
| arg130gln polymorphism linkage | #2 |
| siblings atopic children | #2 |
| il4 gene | #2 |
| asthma parsifal | #2 |
| tregs demethylation | #2 |
| positive spt sige | #2 |
| microbial agents association | #2 |
| allergen levels socks | #2 |
| subsample children | #2 |
| eczema conjunctivitis eczema | #2 |
| affluent countries | #2 |
| difference endotoxin levels | #2 |
| genetic variation card4 | #2 |
| farm milk pregnancy | #2 |
| lessaffluent countries | #2 |
| adult arm alliance | #2 |
| fev1 fdr fdr | #2 |
| ifnγ levels snps | #2 |
| fieldworkers house dust | #2 |
| consumption unpasteurized milk | #2 |
| snps il4 gene | #2 |
| allergies genetic variation | #2 |
| development atopic diseases | #2 |
| phase prevalence rates | #2 |
| cases objective measurements | #2 |
| olive pollen dander | #2 |
| current interpretation | #2 |
| animal exposure levels | #2 |
| asthma child dermatitis | #2 |
| fieldworkers dust collection | #2 |
| life current symptoms | #2 |
| pha th17 lineage | #2 |
| atopic sensitization 14 | #2 |
| association atopic children | #2 |
| lipid ppg | #2 |
| lower atopy | #2 |
| hc ca2 | #2 |
| study participants fieldworkers | #2 |
| maternal contact protective | #2 |
| new onset wheezing | #2 |
| animal sheds pregnancy | #2 |
| children bronchial obstruction | #2 |
| exposure farmers children | #2 |
| atopy early life | #2 |
| 047 95 gg | #2 |
| igg4 ige levels | #2 |
| test inhalent | #2 |
| lifelong farm exposure | #2 |
| pattern missing values | #2 |
| lessaffluent countries adolescents | #2 |
| fev1 score associations | #2 |
| exposures farm | #2 |
| aa hc | #2 |
| farmers asthma symptoms | #2 |
| asthma meeting | #2 |
| onset male recurrence | #2 |
| bacteriological properties | #2 |
| ga²len harmonization | #2 |
| relation dust endotoxin | #2 |
| followup university | #2 |
| card4 21596 children | #2 |
| card4 association | #2 |
| doctors diagnosed asthma | #2 |
| improvements fdr | #2 |
| processed cow | #2 |
| snps inflammatory diseases | #2 |
| levels alk samples | #2 |
| th17 lineage markers | #2 |
| messenger receptors tenascin | #2 |
| causation environmental associations | #2 |
| rna russia | #2 |
| atopic smokers | #2 |
| association allergic diseases | #2 |
| university baseline | #2 |
| card4 21596 | #2 |
| prediction asthma | #2 |
| premature respiratory | #2 |
| immunoglobulin life | #2 |
| imposed social isolation | #2 |
| serum levels c4ma3 | #2 |
| antit2 biological therapy | #2 |
| farming anthroposophic | #2 |
| participants dresden | #2 |
| dander artemisia | #2 |
| asthma protection | #2 |
| antibiotic asthma risk | #2 |
| fdr clinical response | #2 |
| dendritic cells dust | #2 |
| t2inflammation | #2 |
| allergies farming status | #2 |
| farm animals symptoms | #2 |
| pha farming mothers | #2 |
| school level 95 | #2 |
| halle west germany | #2 |
| 95 047 95 | #2 |
| adult farmers role | #2 |
| time breastfed children | #2 |
| isaac prevalence rates | #2 |
| th2 cytokines ilc2s | #2 |
| eczema symptom prevalence | #2 |
| neu5gc role | #2 |
| living farms | #2 |
| pha maternal farming | #2 |
| nonfarming mothers lipid | #2 |
| protect development | #2 |
| atopic diseases subjects | #2 |
| lipid lpa | #2 |
| eczema lessaffluent countries | #2 |
| farming nonfarming families | #2 |
| dresden higher greenness | #2 |
| probability incidence | #2 |
| alliance ages | #2 |
| amish hutterite homes | #2 |
| order sensitized patients | #2 |
| dust samples levels | #2 |
| parsifal study phenotypes | #2 |
| farming mothers ppg | #2 |
| frequency nocturnal asthma | #2 |
| relapse newonset | #2 |
| germany asthma | #2 |
| bhr west germany | #2 |
| rora asthma | #2 |
| foxp3 demethylation | #2 |
| opposite direction children | #2 |
| asthma symptoms fever | #2 |
| negative volatile organic | #2 |
| microbial exposure risk | #2 |
| sensitization patterns inhalant | #2 |
| allergic asthma degradation | #2 |
| allergies cd14 expression | #2 |
| asthmaassociated | #2 |
| asthma cohort | #2 |
| bronchial challenge children | #2 |
| farm children | #2 |
| bronchial hyperresponsiveness allergic | #2 |
| tregs cord blood | #2 |
| pregnancy specific ige | #2 |
| 17q21 | #2 |
| bm190th | #2 |
| environmental microbial exposure | #2 |
| grass pollen dander | #2 |
| followup ndvi | #2 |
| allergic rhinitis adolescence | #2 |
| farms reference | #2 |
| symptom control pa | #2 |
| environmental microorganisms | #2 |
| highrisk predictors | #2 |
| influences development | #2 |
| th17 markers | #2 |
| fev1 fdr | #2 |
| agmr 95 | #2 |
| beta1 endotoxin | #2 |
| increase worldwide | #2 |
| current symptoms asthmaassociated | #2 |
| 645 children | #2 |
| asthma hygiene hypothesis | #2 |
| geneenvironment interactions asthma | #2 |
| 19th century allergic | #2 |
| il4 il13 pathway | #2 |
| low sensitization rates | #2 |
| paracetamol fever | #2 |
| early immune maturation | #2 |
| neu5gc exposure | #2 |
| association opposite direction | #2 |
| study participants levels | #2 |
| current paracetamol 95 | #2 |
| parent asthma | #2 |
| strachan | #2 |
| fever west germany | #2 |
| cd14 genotypes asthma | #2 |
| allergic tolllike receptor | #2 |
| children bronchial hyperresponsiveness | #2 |
| farming families allergies | #2 |
| interactions asthma | #2 |
| traditional farm | #2 |
| antiidiotypic aspergillosis | #2 |
| role maternal exposures | #2 |
| demethylation foxp3 | #2 |
| polymorphisms card4 | #2 |
| asthma phenotypes negative | #2 |
| phase isaac | #2 |
| specificity lca | #2 |
| increase parent | #2 |
| sod3 transcript | #2 |
| protection allergy | #2 |
| children dresden | #2 |
| exposure environmental microorganisms | #2 |
| cd4 cells offspring | #2 |
| alk samples levels | #2 |
| environmental exposures mother | #2 |
| influence cord | #2 |
| sensitized patients order | #2 |
| tbx21 gene | #2 |
| socks alk samples | #2 |
| asthma crp | #2 |
| life increased risk | #2 |
| newonset asthma symptoms | #2 |
| childhood obesoty | #2 |
| fieldworkers absolute levels | #2 |
| hutterite farm children | #2 |
| children farm | #2 |
| cats eczema | #2 |
| allergic disorders children | #2 |
| individual level bhr | #2 |
| role helminths | #2 |
| early life prevalence | #2 |
| coaacetate | #2 |
| increased risk employment | #2 |
| statistical analysis performance | #2 |
| allele cd14 1721 | #2 |
| immunoglobulin nod1 | #2 |
| human microbiota asthma | #2 |
| farmlike indoor microbiota | #2 |
| microbial influences | #2 |
| frequency nocturnal symptoms | #2 |
| alk samples fieldworkers | #2 |
| ppg pha | #2 |
| improvements fdr score | #2 |
| sputum extracellular | #2 |
| nonfarming families | #2 |
| higher greenness quartile | #2 |
| study design participation | #2 |
| ors affluent countries | #2 |
| gmcsf ifnγ levels | #2 |
| associations lessaffluent countries | #2 |
| nocturnal asthma life | #2 |
| severity spirometric measures | #2 |
| bhr tirana | #2 |
| asthma symptoms children | #2 |
| eczema allergic dermatitis | #2 |
| affluent countries eczema | #2 |
| age asthma cohort | #2 |
| farmers child cross | #2 |
| immune responses function | #2 |
| eczema affluent | #2 |
| quartile work discontent | #2 |
| gels bands | #2 |
| ages strongest associations | #2 |
| wheeze bronchial responsiveness | #2 |
| antiige therapy response | #2 |
| standardized procedure centres | #2 |
| farming exposure | #2 |
| c4ma3 asthma | #2 |
| prenatal farm exposure | #2 |
| 14 260 | #2 |
| highdna | #2 |
| age allergic rhinitis | #2 |
| alk samples | #2 |
| current exposure cats | #2 |
| collected dust indoor | #2 |
| exposure farming | #2 |
| bhr individual level | #2 |
| breathomics asthma | #2 |
| maternal immunity gondii | #2 |
| studies farms | #2 |
| viable listeria spp | #2 |
| positive maternal record | #2 |
| dust endotoxin allele | #2 |
| domestic child dust | #2 |
| healthcare precision medicine | #2 |
| asthma symptoms eczema | #2 |
| alternaria animals animals | #2 |
| children nonfarm homes | #2 |
| bronchial hyperresponsiveness children | #2 |
| bronchitis east germany | #2 |
| symptom control bmi | #2 |
| affluent countries centers | #2 |
| allele specific ige | #2 |
| children affluent countries | #2 |
| exposure life | #2 |
| data maternal weight | #2 |
| atopic dermatitis wheeze | #2 |
| peptidoglycan ppg | #2 |
| higher foxp3 | #2 |
| associations atopy | #2 |
| asthmaassociated aor | #2 |
| indoor bacterial | #2 |
| eczema farmers children | #2 |
| cd4cd25hi foxp3 | #2 |
| histamine challenges | #2 |
| inflammatory diseases allergy | #2 |
| il13 gene linkage | #2 |
| leipzig halle | #2 |
| measles vaccination infection | #2 |
| atopic eczema phenotypes | #2 |
| exposure lifestyle factors | #2 |
| developing allergies | #2 |
| milk cd14 | #2 |
| cd14 1721 association | #2 |
| eczema farm exposures | #2 |
| nonfarm children | #2 |
| multivariate analyses haying | #2 |
| 95 school level | #2 |
| values edna concentrations | #2 |
| childhood symptoms relapse | #2 |
| c4ma3 biomarker | #2 |
| allergic diseases allergies | #2 |
| affluent countries associations | #2 |
| socks dust | #2 |
| amish farms | #2 |
| consumption farm | #2 |
| consumption unprocessed | #2 |
| south bavaria | #2 |
| immunoglobulin analyses children | #2 |
| childhood lca | #2 |
| atopic dermatitis childhood | #2 |
| cd14 1721 | #2 |
| childhood phase | #2 |
| adaptor protein rhinitis | #2 |
| farming families | #2 |
| associations hscrp levels | #2 |
| tirana mumbai | #2 |
| asthma observed | #2 |
| atopic sensitization upregulation | #2 |
| farming environment allergies | #2 |
| excessive edna production | #2 |
| dairying eczema | #2 |
| life rural children | #2 |
| doctors diagnosis aor | #2 |
| bronchial hyperresponsiveness exposure | #2 |
| patients childhood symptoms | #2 |
| severe exacerbations feno | #2 |
| cd14 1721 children | #2 |
| allele card4 21596 | #2 |
| nocturnal symptoms spirometry | #2 |
| eczema isaac phase | #3 |
| cx3cr1 polymorphisms polymorphism | #3 |
| role atopic sensitization | #3 |
| 45yearold children | #3 |
| microbiota farm | #3 |
| auc asthma | #3 |
| sige asthma | #3 |
| vivo expression irf1 | #3 |
| eosinophils matrix metalloproteinase | #3 |
| asthma protection progeny | #3 |
| il15 gene variants | #3 |
| allergic inflammation polymorphisms | #3 |
| life allergic diseases | #3 |
| current asthma rhinoconjunctivitis | #3 |
| 1431c specific ige | #3 |
| 95ci nonatopic asthma | #3 |
| atopic diseases mutations | #3 |
| work work overload | #3 |
| cx3cr1 polymorphisms atopy | #3 |
| atopic mothers | #3 |
| forward initiative | #3 |
| children bronchial hyperreactivity | #3 |
| endotoxin milk | #3 |
| eczema farmers | #3 |
| rhinoconjunctivitis atopic eczema | #3 |
| monocytes lps stimulation | #3 |
| asthma amino acid | #3 |
| paf allergic | #3 |
| il15 associations | #3 |
| protective farm | #3 |
| domestic arthritis | #3 |
| genetic variation crth2 | #3 |
| crude measure | #3 |
| culture techniques study | #3 |
| farm dwellings | #3 |
| bavaria obesity | #3 |
| progeny asthma | #3 |
| rhinoconjunctivitis conjunctivitis | #3 |
| rural dwellings | #3 |
| mmp9 variants mmp9 | #3 |
| duration prevalence | #3 |
| ferme | #3 |
| il5 c746 allergic | #3 |
| paf seasonal allergens | #3 |
| sod3 extracellular matrix | #3 |
| g1258a | #3 |
| severity moisture damage | #3 |
| tlr2 polymorphisms | #3 |
| cd14 association | #3 |
| 1q31 locus | #3 |
| 280met | #3 |
| individual level questionnaires | #3 |
| crosssectional population | #3 |
| locus dennd1b | #3 |
| cowshed dust extract | #3 |
| susceptibility col29a1 expression | #3 |
| questionnaires physical examination | #3 |
| c39134a | #3 |
| farming farm | #3 |
| allergic disequilibrium rhinitis | #3 |
| maternal tlr | #3 |
| c746t | #3 |
| united kingdom albania | #3 |
| il5 c746t | #3 |
| seasonal allergens atopy | #3 |
| bhr haplotypes humans | #3 |
| network construction | #3 |
| affluent countries atopy | #3 |
| biomaterial collection | #3 |
| rural areas europe | #3 |
| sod3 variants | #3 |
| bhr pcdh1 polymorphisms | #3 |
| jobrelated chronic stress | #3 |
| asthma farming environment | #3 |
| adam33 polymorphisms asthma | #3 |
| increased treg cells | #3 |
| organic waste storage | #3 |
| asthma genetic severity | #3 |
| german children munich | #3 |
| european ancestry asthma | #3 |
| substances protection | #3 |
| occurrence rhinitis | #3 |
| prevalence allergies | #3 |
| samples 1q31 locus | #3 |
| mmp9 variants risk | #3 |
| eosinophil pathway genes | #3 |
| allergyprotective | #3 |
| rare tlr2 mutations | #3 |
| stat6 haplotype | #3 |
| endotoxin levels asthma | #3 |
| associations pcdh1 | #3 |
| allergic phenotypes correction | #3 |
| asthma tolllike receptors | #3 |
| farm dust endotoxin | #3 |
| rhinitis increased risk | #3 |
| young adult europe | #3 |
| childhood asthma community | #3 |
| individual level centers | #3 |
| asthma pcdh1 | #3 |
| blood allergen | #3 |
| countries endotoxin levels | #3 |
| hygiene hypothesis | #3 |
| fever aor | #3 |
| asthma atopic sensitization | #3 |
| tlr2 receptor function | #3 |
| amino acid cx3cr1 | #3 |
| atopic asthma effects | #3 |
| tlr2 amino acid | #3 |
| col29a1 polymorphisms | #3 |
| —study | #3 |
| c2892 | #3 |
| col29a1 variants eczema | #3 |
| children farming | #3 |
| eosinophil pathway | #3 |
| 1q31 locus dennd1b | #3 |
| wheeze allergy | #3 |
| prenatal protection asthma | #3 |
| hlx1 gene development | #3 |
| dennd1b chromosome | #3 |
| protection development | #3 |
| eczema col29a1 | #3 |
| perennial allergens paf | #3 |
| food correction | #3 |
| markers fetal growth | #3 |
| growing farm | #3 |
| mmp9 influence development | #3 |
| stat1 gene variations | #3 |
| 3099 children | #3 |
| animal sheds | #3 |
| persistent flexural eczema | #3 |
| eczema strong association | #3 |
| atopic sensitisation | #3 |
| dresden odds ratio | #3 |
| domestic asthma | #3 |
| dcs a20 induction | #3 |
| age 7–10 years | #3 |
| 9 mmp9 mmp9 | #3 |
| ile117thr | #3 |
| environmental dusts | #3 |
| 53152 | #3 |
| asthma snp rs2786098 | #3 |
| protocadherin‐1 | #3 |
| asthma genetic association | #3 |
| stat6 gene regulation | #3 |
| albania antibody specificity | #3 |
| treatment asthma phenotypes | #3 |
| puberty risk factors | #3 |
| population german | #3 |
| role asthma prevalence | #3 |
| phase international study | #3 |
| eczema international study | #3 |
| risk nonatopic asthma | #3 |
| allergy protection | #3 |
| asthma major | #3 |
| rhinoconjunctivitis paf | #3 |
| atopic dermatitis aor | #3 |
| exposure helminths | #3 |
| parent prevalence | #3 |
| conjunctivitis paf | #3 |
| bacterial diversity asthma | #3 |
| effects single snps | #3 |
| characteristics respiratory | #3 |
| pcdh1 asthma | #3 |
| food year | #3 |
| asthma cattle | #3 |
| sensitisation affluent countries | #3 |
| lwoffii f78 | #3 |
| prevalence asthma | #3 |
| children negative spts | #3 |
| female fetus immunity | #3 |
| disequilibrium rhinitis allergic | #3 |
| polymorphisms gm csf | #3 |
| protection contre | #3 |
| today1 | #3 |
| munich polymorphism | #3 |
| t12888c | #3 |
| ppg expression | #3 |
| adam33 snps | #3 |
| f78 | #3 |
| gni measurements | #3 |
| farming status | #3 |
| hlx1 gene variants | #3 |
| asthma bordetella | #3 |
| col29a1 expression eczema | #3 |
| life development | #3 |
| european science foundation | #3 |
| cytokine cluster bhr | #3 |
| experimental asthma progeny | #3 |
| cohort alliance | #3 |
| wheezing neutrophils | #3 |
| cowshed dust | #3 |
| t3085 | #3 |
| hygiene hypothesis development | #3 |
| gni rho | #3 |
| c1407t | #3 |
| responses innate | #3 |
| children african ancestry | #3 |
| populations illness surveys | #3 |
| regular contact | #3 |
| arabinogalactan isolated | #3 |
| dennd1b asthma | #3 |
| allergic phenotype polymorphism | #3 |
| onset asthma child | #3 |
| microorganisms dust | #3 |
| paracetamol risk | #3 |
| endotoxin dust samples | #3 |
| dogs exposure | #3 |
| protein rhinitis | #3 |
| nonatopic asthma 95ci | #3 |
| farm animals farm | #3 |
| col29a1 polymorphisms eczema | #3 |
| paf sensitisation | #3 |
| anthroposophic children | #3 |
| il15 gene asthma | #3 |
| atopic female germany | #3 |
| pcr sscp analysis | #3 |
| farm contact | #3 |
| polymorphisms hlx1 gene | #3 |
| children isaac phase | #3 |
| bdnf polymorphisms asthma | #3 |
| breastfeeding overweight | #3 |
| hlx1 gene | #3 |
| putative functional role | #3 |
| nf kappa polymorphism | #3 |
| asthma identified | #3 |
| farms asthma | #3 |
| col29a1 polymorphisms susceptibility | #3 |
| col29a1 genetic variants | #3 |
| prenatal protection | #3 |
| asthma 1431c | #3 |
| atopy dresden | #3 |
| allergic asthmatics aa | #3 |
| allergic diseases children | #3 |
| asthma endotoxin levels | #3 |
| irf1 interferon expression | #3 |
| il15 il15 associations | #3 |
| 1431c | #3 |
| crth2 influences development | #3 |
| moraxella colonization | #3 |
| blatella | #3 |
| allergy a20 induction | #3 |
| col29a1 eczema | #3 |
| il5 il5 c746 | #3 |
| germany west german | #3 |
| prenatal asthma protection | #3 |
| doctors diagnosis | #3 |
| pcdh1 polymorphisms associations | #3 |
| throat microbiota asthma | #3 |
| 1000 enfants | #3 |
| asthma subphenotypes | #3 |
| role adam33 polymorphisms | #3 |
| isaac polymorphisms | #3 |
| role neu5gc | #3 |
| bias asthma bias | #3 |
| lukas2 birth | #3 |
| overweight germany | #3 |
| asthma symptoms adults | #4 |
| tlr2 mutations | #4 |
| early life basis | #4 |
| environmental dust samples | #4 |
| cheese consumption | #4 |
| asthma snps | #4 |
| lifetime prevalence asthma | #4 |
| asthma atopic diseases | #4 |
| parent odds ratio | #4 |
| heating prevalence | #4 |
| lower risk allergy | #4 |
| genes il4r | #4 |
| occurrence atopic dermatitis | #4 |
| human genetic nod1 | #4 |
| exposure microbial | #4 |
| current asthma bhr | #4 |
| leisure time activity | #4 |
| tolllike receptors receptor | #4 |
| risk atopic dermatitis | #4 |
| asthma phenotype children | #4 |
| development atopic | #4 |
| increase eczema prevalence | #4 |
| atopic dermatitis birth | #4 |
| initial data analysis | #4 |
| anthroposophic families | #4 |
| eczema questionnaires adolescent | #4 |
| col29a1 gene | #4 |
| rare tlr2 | #4 |
| questionnaires eczema | #4 |
| stables farm milk | #4 |
| birthcohort study | #4 |
| cromolyns | #4 |
| a20 induction | #4 |
| stable dust | #4 |
| fever eczema | #4 |
| children mattresses | #4 |
| cd4cd25hi tregs | #4 |
| ige levels associations | #4 |
| environmental factors development | #4 |
| antibiotics antipyretics | #4 |
| endotoxin relation | #4 |
| cx3cr1 polymorphisms | #4 |
| childhood asthma | #4 |
| wheeze ige levels | #4 |
| glu420lys | #4 |
| life childhood | #4 |
| study centers phase | #4 |
| t2high asthma | #4 |
| questionnaires populations | #4 |
| allergic diseases humans | #4 |
| factors wheeze | #4 |
| birth atopic dermatitis | #4 |
| mother role | #4 |
| prevalence random | #4 |
| n2267 | #4 |
| asthma auc | #4 |
| children farms | #4 |
| feeding prevalence | #4 |
| benzene no2 | #4 |
| incident sensitization | #4 |
| particle boluses | #4 |
| alliance cohort | #4 |
| wheeze bhr | #4 |
| secretory receptors allergic | #4 |
| ilc2s human asthma | #4 |
| common sensitizations | #4 |
| cough bronchitis | #4 |
| current symptoms asthma | #4 |
| nonfarming | #4 |
| prenatal asthma | #4 |
| cowsheds | #4 |
| aetiology asthma | #4 |
| east germany bhr | #4 |
| indoor pollen | #4 |
| sas genetics | #4 |
| genetic nod1 | #4 |
| wheezing onset | #4 |
| children munich | #4 |
| asthma current symptoms | #4 |
| asthma medication exposure | #4 |
| predictors visits | #4 |
| parental allergic rhinitis | #4 |
| phase 2 allergies | #4 |
| 5 13 years | #4 |
| doctors diagnosis asthma | #4 |
| agreement spt | #4 |
| asthma 3 | #4 |
| high‐sensitivity c‐reactive protein | #4 |
| permanovas | #4 |
| childhood protect | #4 |
| dietary habits children | #4 |
| cord blood lipid | #4 |
| c746 | #4 |
| licheniformis spores | #4 |
| sounds rhinitis | #4 |
| asthma induction | #4 |
| fever 17 | #4 |
| gabriel advanced | #4 |
| adolescents duration | #4 |
| adult lung disease | #4 |
| participants fieldworkers | #4 |
| early identification atopy | #4 |
| 99th dahlem conference | #4 |
| questionnaires adolescent eczema | #4 |
| pro27ser | #4 |
| crp blood leukocytes | #4 |
| groups taxa | #4 |
| h20like homeobox | #4 |
| spt sige | #4 |
| allergy international study | #4 |
| allergic il5 | #4 |
| dust personal | #4 |
| fetal growth asthma | #4 |
| lukas2 | #4 |
| inhalant patients | #4 |
| 95 gene expression | #4 |
| asthma hygiene | #4 |
| promoter region arg130gln | #4 |
| fatty acids allergic | #4 |
| late phenotype | #4 |
| rs2786098 | #4 |
| allergic ecuador eczema | #4 |
| allergic dermatitis allergic | #4 |
| genotypes cd14 | #4 |
| col29a1 expression | #4 |
| infections early | #4 |
| flexural eczema | #4 |
| il4r tlr4 | #4 |
| cats pregnancy | #4 |
| fever year | #4 |
| microbes asthma | #4 |
| farm environment development | #4 |
| genetic rhinitis allergic | #4 |
| gene expression receptors | #4 |
| risk factor symptoms | #4 |
| candidate genes wheeze | #4 |
| exposure cats | #4 |
| neonatal window | #4 |
| bacillus licheniformis spores | #4 |
| german children bavaria | #4 |
| children maternal overweight | #4 |
| allergies children | #4 |
| occupational allergy risks | #4 |
| asthma symptoms association | #4 |
| microbial compounds | #4 |
| predictor wheezing | #4 |
| eczema flg mutations | #4 |
| minimum battery | #4 |
| immunity receptors | #4 |
| lrti asthma | #4 |
| development atopic sensitization | #4 |
| dogs symptoms | #5 |
| phänotypen | #5 |
| asthma medication 95 | #5 |
| sensitization atopic | #5 |
| atopy flexural eczema | #5 |
| 14452 | #5 |
| cow milk samples | #5 |
| atopic sensitization asthma | #5 |
| participation behaviour | #5 |
| rhinitis increase | #5 |
| tests bronchitis | #5 |
| 26 farms | #5 |
| airway responsiveness age | #5 |
| helsinki alert | #5 |
| tnc nps | #5 |
| rs3771300 | #5 |
| milk odds | #5 |
| adulthood asthma | #5 |
| childhood isaac phase | #5 |
| tbx21 promoter activity | #5 |
| tbx21 gene variants | #5 |
| combination hlx1 variants | #5 |
| subtypes risk | #5 |
| moisture mold problems | #5 |
| disinfectants asthma | #5 |
| risk atopic | #5 |
| children current wheeze | #5 |
| mechanism environmental factors | #5 |
| ornonaffluent | #5 |
| life questionnaires switzerland | #5 |
| allergic diseases exposure | #5 |
| nod1 variation | #5 |
| tbx21 polymorphisms development | #5 |
| ige regulation | #5 |
| 2q14 | #5 |
| children validity | #5 |
| ormdl3 gsdma | #5 |
| processing intensity | #5 |
| rural subjects | #5 |
| puberty menarche | #5 |
| farming mothers | #5 |
| atopic eczema allergic | #5 |
| moulds actinomycetes | #5 |
| young adults methods | #5 |
| il13cd4 | #5 |
| verlaufsformen | #5 |
| genetic variants tbx21 | #5 |
| hlx1 polymorphisms development | #5 |
| lung health disease | #5 |
| asthma child dust | #5 |
| flexural eczema strength | #5 |
| severe atopy | #5 |
| allergen 95 | #5 |
| popular terms | #5 |
| current symptoms rhinoconjunctivitis | #5 |
| genetic asthma | #5 |
| il13cd4 cells | #5 |
| jf1 msf | #5 |
| n1046 | #5 |
| mmp9 influence | #5 |
| communitybased random sample | #5 |
| duration jobs | #5 |
| receptors innate immunity | #5 |
| c2892t | #5 |
| parental reports asthma | #5 |
| hlx1 variants | #5 |
| cowshed | #5 |
| ors atopy | #5 |
| visits predictors | #5 |
| 95 reverse causation | #5 |
| eczema relation | #5 |
| dresden | #5 |
| endotoxin protection | #5 |
| trigger factors asthma | #5 |
| delayed manifestation | #5 |
| atopic dermatitis age | #5 |
| hyperreactivity child | #5 |
| 95 populationattributable risk | #5 |
| taxa groups | #5 |
| pregnancy year | #5 |
| wisconsin infant | #5 |
| ors positive association | #5 |
| nonfarmers children | #5 |
| female germany allergic | #5 |
| atopy airway hyperresponsiveness | #5 |
| milk exposure | #5 |
| asthma endotoxins | #5 |
| neu5gc mice | #5 |
| linkage development | #5 |
| cd14 gene expression | #5 |
| thr280met | #5 |
| consumption 4 years | #5 |
| asthma girls | #5 |
| cats risk factor | #5 |
| allergic rhinitis wheeze | #5 |
| exposure rhinitis | #5 |
| incident wheeze | #5 |
| 2nd followup | #5 |
| cd4cd25hi | #5 |
| pattern sensitization | #5 |
| timing exposures | #5 |
| combination hlx1 polymorphisms | #5 |
| inverse association overweight | #5 |
| allergystudy | #5 |
| west german children | #5 |
| milk consumption age | #5 |
| influence ige | #5 |
| agriculture animals | #5 |
| tbx21 combination | #5 |
| environmental dust | #5 |
| associations wheeze | #5 |
| lowgrade inflammation hscrp | #6 |
| comprehensive questionnaires | #6 |
| 14 genes tripeptidylpeptidases | #6 |
| sscp method | #6 |
| inversely asthma | #6 |
| 5 regions tao | #6 |
| asthma austria | #6 |
| steiner schools | #6 |
| natural atopic dermatitis | #6 |
| parsifal | #6 |
| cold air challenge | #6 |
| children east germany | #6 |
| pierced ears | #6 |
| 7 years association | #6 |
| children positive spt | #6 |
| allergic diseases | #6 |
| rora npsr1 | #6 |
| abschnitten | #6 |
| polymorphisms stat6 gene | #6 |
| systemic inflammation age | #6 |
| deubiquitinating enzyme tao | #6 |
| allergic markers | #6 |
| allergoprotective properties | #6 |
| fever atopy | #6 |
| sounds surveys | #6 |
| distinct underlying mechanisms | #6 |
| nd132656 | #6 |
| central europe asthma | #6 |
| childhood asthma genes | #6 |
| nonaffluent | #6 |
| 11094 | #6 |
| childhood asthma phenotypes | #6 |
| il33 17q12q21 | #6 |
| prevent allergic | #6 |
| bolus dispersion | #6 |
| complete screening | #6 |
| pair deubiquitinating enzyme | #6 |
| childhood aa | #6 |
| no2 current asthma | #6 |
| allergens needed | #6 |
| pair male nod2 | #6 |
| protection allergies | #6 |
| european dairy farms | #6 |
| countries albania | #6 |
| microorganisms samples | #6 |
| dust collection | #6 |
| bavarian preschool children | #6 |
| isaac programme | #6 |
| overweight data | #6 |
| asthma allergic sensitisation | #6 |
| allergy tests children | #6 |
| susceptibility gene asthma | #6 |
| longitudinal populations | #6 |
| primary preventive strategies | #6 |
| responders frequency | #6 |
| rhinoconjunctivitis atopic | #6 |
| sensitisation exposure | #6 |
| food allergy 95 | #6 |
| children farming environment | #6 |
| tlr1 tlr10 | #6 |
| 16q12 region | #6 |
| eating environmental | #6 |
| 17q12q21 earlier onset | #6 |
| asthma authors | #6 |
| onset disease germany | #6 |
| yearly interviews | #6 |
| atemwegserkrankungen | #6 |
| german nationality | #6 |
| fever wheezing | #6 |
| central europe interactions | #6 |
| oropharyngeal microbiota | #6 |
| hypertonic skin tests | #6 |
| tripeptidylpeptidases subunit p40 | #6 |
| lifestyle factors symptoms | #6 |
| study rarer snps | #6 |
| allergic epistasis | #6 |
| devenues | #6 |
| asthma context | #6 |
| tests asthma | #6 |
| new locus time | #6 |
| allergic immunologic receptors | #6 |
| lung barrier | #6 |
| dogs environmental exposure | #6 |
| strategies disease | #6 |
| 939 children | #6 |
| data 7 years | #6 |
| interactions farm exposures | #6 |
| genetic variants 17q12q21 | #6 |
| current contact | #6 |
| progression asthma | #6 |
| rhinoconjunctivitis eczema | #6 |
| asthma genotypes | #6 |
| genetic variants time | #6 |
| dipeptidyl peptidases tripeptidylpeptidases | #6 |
| asthma transition | #6 |
| farm nonfarm | #6 |
| hypersensitivity male | #7 |
| questionnaires allergic | #7 |
| children breast | #7 |
| chemokine cx3cl1 cx3cr1 | #7 |
| 15245 | #7 |
| childhoodonset disease | #7 |
| stat1 gene | #7 |
| birth cohorts report | #7 |
| european science | #7 |
| breastfeeding prevalence | #7 |
| genetic predisposition role | #7 |
| 95 endotoxin | #7 |
| asthma fever | #7 |
| interleukin4 sequence analysis | #7 |
| diversity introduction | #7 |
| aerosol bolus dispersion | #7 |
| child dust | #7 |
| invading microorganism | #7 |
| symptoms adulthood | #7 |
| indoor moisture | #7 |
| strategies asthma | #7 |
| 5 harmonization | #7 |
| amish children | #7 |
| environmental exposure endotoxin | #7 |
| immunologic receptors allergic | #7 |
| birth function | #7 |
| farm exposure | #7 |
| children international study | #7 |
| atopic dermatitis association | #7 |
| asthma school age | #7 |
| preanalytix | #7 |
| pasture study | #7 |
| foxp3 blood | #7 |
| lymphoid cells asthma | #7 |
| children regular contact | #7 |
| biomarker immune activation | #7 |
| asthma environmental factors | #7 |
| perennial allergen | #7 |
| fever atopic asthma | #7 |
| school age asthma | #7 |
| log2fold | #7 |
| allergic atopic embryonic | #7 |
| levels farm | #7 |
| farm homes | #7 |
| fetal development allergic | #7 |
| atopic europe | #7 |
| grass rphl | #7 |
| questionnaires phase | #7 |
| cells dust | #7 |
| farm life | #7 |
| influence neonatal | #7 |
| inhalant age | #7 |
| association cord blood | #7 |
| wheeze atopy | #7 |
| reference exposure | #7 |
| steiner school children | #7 |
| large centres | #7 |
| centers increase | #7 |
| polymorphisms il4 gene | #7 |
| steiner school | #7 |
| pasture birth | #7 |
| rhinitis early childhood | #7 |
| exposure farms | #7 |
| lower risk asthma | #7 |
| juvenile inflammatory | #7 |
| adult farmers | #7 |
| exposure neu5gc | #7 |
| secretory receptors | #7 |
| murine offspring | #7 |
| fieldworkers | #7 |
| environmental factors children | #7 |
| inverse association consumption | #7 |
| nonfarm homes | #7 |
| hutterite children | #7 |
| wheeze 12 months | #7 |
| infectious diseases phenotype | #7 |
| highrisk occupations | #7 |
| children prognosis | #7 |
| endotoxin allergen | #7 |
| viral infections development | #7 |
| lung sod3 | #7 |
| childrens bedrooms | #7 |
| pregnancy atopic dermatitis | #7 |
| level variety | #7 |
| seasonal sensitivity allergic | #7 |
| allergy antibiotics | #7 |
| paracetamol year | #7 |
| hypertonic sensitivity | #7 |
| pbmcs asthmatics | #7 |
| functional phenotypes | #7 |
| bhr current asthma | #7 |
| infantis populations | #7 |
| isaac eczema | #7 |
| p4×10−9 | #8 |
| hlx1 | #8 |
| c4ma3 | #8 |
| il15 snps | #8 |
| antibiotics year | #8 |
| p11×10−8 | #8 |
| association wheeze | #8 |
| asthmaprotective | #8 |
| agmr | #8 |
| lipid peptidoglycan | #8 |
| finlande | #8 |
| p7×10−14 | #8 |
| amino acid asthma | #8 |
| gabriela | #8 |
| inhalant europe | #8 |
| gabriela study | #8 |
| sensitization mite | #8 |
| crohns disease polymorphisms | #8 |
| fever atopic sensitisation | #8 |
| study rural | #8 |
| 3113 children | #8 |
| p3×10−9 | #8 |
| repeats sequence homology | #8 |
| influence cytokine | #8 |
| age 911 years | #8 |
| children anthroposophic families | #8 |
| proteins dendritic cells | #8 |
| asthma bias | #8 |
| 824 children | #8 |
| immunity gene expression | #8 |
| allergy study | #8 |
| austrian schoolchildren | #8 |
| asthma child conjunctivitis | #8 |
| asthma maternal smoking | #8 |
| il13 variants | #8 |
| childhoodonset disease elevation | #8 |
| allergy epidemiology | #8 |
| amish child | #8 |
| th2 cells ilc2s | #8 |
| indoor microbiota | #8 |
| chromosome 2q14 | #8 |
| asthma physiciandiagnosed asthma | #8 |
| age positive spts | #8 |
| asthma analyses | #8 |
| hrqol questions | #8 |
| exposure dogs | #8 |
| bronchial histamine challenge | #8 |
| sensitization patterns | #8 |
| invertedu shape | #8 |
| asthma atopic sensitisation | #8 |
| airwayrelated symptoms | #8 |
| dogs risk factor | #8 |
| children anthroposophic | #8 |
| chromosome childhoodonset disease | #8 |
| childhood asthma atopy | #8 |
| asthma 08 | #8 |
| current asthma data | #8 |
| mice children | #8 |
| early age exposure | #8 |
| rs8076131 | #8 |
| asthma birth weight | #8 |
| highthroughput sequencing data | #8 |
| factor analysis factor | #8 |
| surveyed children | #8 |
| igg1 galactosylation | #8 |
| eczema asthma child | #8 |
| diet year | #8 |
| atopic sensitization prevalence | #8 |
| genetic risk asthma | #8 |
| children reference | #8 |
| diversity year | #8 |
| international variations | #8 |
| university work | #8 |
| 95 food allergy | #8 |
| ppg stimulation | #8 |
| cows milk age | #8 |
| association food diversity | #8 |
| allergies childhood | #8 |
| 17q12q21 | #8 |
| unprocessed milk | #9 |
| ribosomal 16s risk | #9 |
| asthma child child | #9 |
| role human asthma | #9 |
| levels allergens | #9 |
| microbial exposure | #9 |
| regular exposure | #9 |
| clinical response score | #9 |
| relation environment | #9 |
| microbial substances | #9 |
| fcer1a susceptibility locus | #9 |
| asthma risk | #9 |
| relation asthma | #9 |
| exposure farming environments | #9 |
| allergic seasonal risk | #9 |
| animals supplementation | #9 |
| polymorphisms development | #9 |
| tbx21 promoter | #9 |
| farming environment | #9 |
| asthma child | #9 |
| ige levels gwas | #9 |
| asthma allergy symptoms | #9 |
| 1314 children | #9 |
| association stat6 variation | #9 |
| 1 npsr1 | #9 |
| kazal type | #9 |
| subspecies bifidobacterium | #9 |
| factors sensitization | #9 |
| asthma symptoms baseline | #9 |
| asthma early life | #9 |
| bronchial hyper‐responsiveness | #9 |
| allergic phenotypes | #9 |
| asthma antibiotics | #9 |
| dennd1b | #9 |
| col29a1 variants | #9 |
| teenagers asthma | #9 |
| allergic inflammation patients | #9 |
| chromosome ige levels | #9 |
| ecuador eczema | #9 |
| random subsample | #9 |
| life female germany | #9 |
| n7498 | #9 |
| conjunctivitis cross | #9 |
| igg4 ige | #9 |
| study asthma | #9 |
| asthma infant | #9 |
| association wheezing | #9 |
| 1314yrolds | #9 |
| atopic sensitization children | #9 |
| drug development strategies | #9 |
| germany munich | #9 |
| rural farm | #9 |
| positive spts | #9 |
| allergic preschool conjunctivitis | #9 |
| 5 european | #9 |
| autriche | #9 |
| regulatory th17 cells | #9 |
| rad50 gene chromosome | #9 |
| partial nonresponders | #9 |
| ausprägungen | #9 |
| life prenatal exposure | #9 |
| gwas approaches | #9 |
| low levels hscrp | #9 |
| young german | #9 |
| cytokines environmental | #9 |
| asthma respiratory conditions | #9 |
| 105 years age | #9 |
| prevalence atopic | #9 |
| life ahr | #9 |
| symptoms 12 months | #9 |
| npsr1 snps | #9 |
| eczema weight | #9 |
| cord blood cytokines | #9 |
| skinprick | #9 |
| longitudinal follow‐up | #9 |
| airway hyperresponsiveness children | #10 |
| consumption raw | #10 |
| adult cases controls | #10 |
| prevalence differences | #10 |
| ilt3 ilt4 | #10 |
| mattress dust | #10 |
| n1138 | #10 |
| endotoxin muramic acid | #10 |
| latex children | #10 |
| centers prevalence rates | #10 |
| new zealand bhr | #10 |
| farm children children | #10 |
| ratio asthma | #10 |
| life allergen | #10 |
| international study asthma | #10 |
| atopic dermatitis 95 | #10 |
| blood samples tubes | #10 |
| mechanisms oral tolerance | #10 |
| hormonal factors role | #10 |
| bdnf gene variants | #10 |
| asthma chromosome | #10 |
| 45 saline | #10 |
| bias exposure | #10 |
| mothers contact | #10 |
| humans hypersensitivity | #10 |
| gabriel advanced studies | #10 |
| ige levels asthma | #10 |
| early life immunity | #10 |
| young german adults | #10 |
| study occupational | #10 |
| infection allergic | #10 |
| leipzig east germany | #10 |
| genetic probability receptors | #10 |
| predictors health utilization | #10 |
| association atopic | #10 |
| substances development | #10 |
| bhr prevalence | #10 |
| reservoir method | #10 |
| house dust endotoxin | #10 |
| asthma nocturnal | #10 |
| indoor heating | #10 |
| receptors immunity | #10 |
| production cord blood | #10 |
| context eczema | #10 |
| urban rural area | #10 |
| new onset rhinitis | #10 |
| farm exposures asthma | #10 |
| countries centres | #10 |
| missing values paper | #10 |
| 1992–2001 | #10 |
| phase protocol | #10 |
| association new onset | #10 |
| interrelations risk factors | #10 |
| rural school children | #10 |
| lebensbedingungen | #11 |
| subsequent development asthma | #11 |
| association respiratory health | #11 |
| ige measurements | #11 |
| reduced risk asthma | #11 |
| allergic disease children | #11 |
| newborn male polymorphism | #11 |
| allergy risks | #11 |
| symptoms allergic rhinoconjunctivitis | #11 |
| microbiome lung | #11 |
| wheeze aor | #11 |
| tuberculosis notification rates | #11 |
| factors agriculture | #11 |
| parsifal study | #11 |
| health outcomes countries | #11 |
| protective development | #11 |
| allergic asthma conjunctivitis | #11 |
| early life development | #11 |
| occupational disinfectants | #11 |
| genotyped polymorphisms | #11 |
| npsr1 polymorphisms | #11 |
| transient wheezing | #11 |
| german schoolchildren | #11 |
| blood foxp3 | #11 |
| school beginners | #11 |
| active smoking association | #11 |
| wheeze year | #11 |
| farm exposures | #11 |
| farm buildings | #11 |
| fetal ige | #11 |
| asthma lower | #11 |
| samples persons | #11 |
| atopic dust | #11 |
| children rural | #11 |
| tbx21 polymorphisms | #11 |
| overweight body mass | #11 |
| atopy | #11 |
| asthma risk participants | #11 |
| children school entry | #11 |
| persistent uncontrolled asthma | #11 |
| pregnancy early life | #11 |
| asthma bacterial | #11 |
| cytokines allergic inflammation | #11 |
| german multicentre | #12 |
| healthy children asthma | #12 |
| asthmatic cohort | #12 |
| children exposed children | #12 |
| age 105 years | #12 |
| dermatitis phenotypes | #12 |
| ige grass | #12 |
| child environmental | #12 |
| infection analyses | #12 |
| young adults school | #12 |
| 95 nox | #12 |
| cattle child | #12 |
| children low levels | #12 |
| asthma epidemic | #12 |
| asthma parent | #12 |
| bhr wheeze | #12 |
| birth cohorts asthma | #12 |
| skin prick testing | #12 |
| hypersensitivity immunity | #12 |
| increase prevalence | #12 |
| current paracetamol | #12 |
| damage mold | #12 |
| farm | #12 |
| pet contact | #12 |
| backgroundasthma | #12 |
| male respiratory | #12 |
| association moisture | #12 |
| sensitization birth | #12 |
| transient wheeze | #12 |
| mattress dust samples | #12 |
| children background | #12 |
| female humans hypersensitivity | #12 |
| standard deviation skewness | #12 |
| polymorphisms bdnf gene | #12 |
| doctor asthma | #12 |
| management childhood asthma | #12 |
| stepwise protocol | #12 |
| east germany munich | #12 |
| polymorphism asthma | #12 |
| rural environments | #12 |
| exposure asthma symptoms | #12 |
| fever exposure | #12 |
| participants allergic rhinitis | #12 |
| asthma disease humans | #12 |
| symptoms atopic | #12 |
| munich west germany | #12 |
| asthma candidate gene | #12 |
| multicentre allergy | #12 |
| overweight breast | #12 |
| validated questions | #12 |
| incident asthma 95 | #12 |
| 7 years data | #12 |
| early priming | #12 |
| rural schoolchildren | #13 |
| asthma outcomes patients | #13 |
| asthma rhinoconjunctivitis | #13 |
| farming exposures | #13 |
| allergic sensitisation children | #13 |
| rhinitis allergens | #13 |
| childhood allergy | #13 |
| asthma bronchial | #13 |
| subjects jobs | #13 |
| asthma nocturnal symptoms | #13 |
| hygiene hypersensitivity | #13 |
| npsr1 | #13 |
| childhood isaac | #13 |
| ibd sle | #13 |
| eastern western germany | #13 |
| cord adult blood | #13 |
| wheezing ages | #13 |
| th1cells | #13 |
| asthma snp | #13 |
| farm animal contact | #13 |
| farm dust | #13 |
| spt specific ige | #13 |
| polymorphisms influence | #13 |
| groups phenotype | #13 |
| children raised | #13 |
| northern indiana | #13 |
| children inhaled steroids | #13 |
| local immunity | #13 |
| children polymorphisms | #13 |
| developing microbiota | #13 |
| n349 | #13 |
| antibiotic exposure pregnancy | #13 |
| nod1 gene | #13 |
| atopic eczema symptoms | #13 |
| expression ormdl3 | #13 |
| asthma mental health | #13 |
| switzerland children | #13 |
| dresden germany | #13 |
| occupational exposure disinfectants | #13 |
| sx1 | #13 |
| asthma community | #13 |
| asthma1 | #14 |
| il15 gene | #14 |
| delayed introduction solids | #14 |
| standardised questionnaires | #14 |
| burden prevalence | #14 |
| asthma step | #14 |
| maternal sensitization | #14 |
| air challenge | #14 |
| symptoms rhinoconjunctivitis | #14 |
| respiratory atopic | #14 |
| asthma bronchial hyperresponsiveness | #14 |
| farm rural | #14 |
| cross environmental exposure | #14 |
| diseases atopic | #14 |
| fx5 | #14 |
| exacerbations fev1 | #14 |
| 7 polymorphisms | #14 |
| increased risk age | #14 |
| nonaffluent countries | #14 |
| diabimmune study | #14 |
| mrna expression vivo | #14 |
| changing gender | #14 |
| allergic sensitization age | #14 |
| farming lifestyle | #14 |
| positive spts age | #14 |
| role lung microbiome | #14 |
| atopic environmental | #14 |
| upper respiratory symptoms | #14 |
| 10‐year‐old children | #14 |
| th2 commitment | #14 |
| preventive development | #14 |
| incidence rhinitis | #14 |
| innate infant | #14 |
| introduction complementary food | #14 |
| rhinitis conjunctivitis | #14 |
| german children | #14 |
| 3099 | #14 |
| detailed questionnaires | #14 |
| late introduction | #14 |
| polymorphisms ormdl3 | #14 |
| breast feeding children | #14 |
| untypical | #14 |
| asthma allergy | #15 |
| children allele | #15 |
| factors bronchial | #15 |
| puberty rhinitis | #15 |
| allele evidence | #15 |
| bronchial responsiveness children | #15 |
| rhinitis puberty | #15 |
| mold problems | #15 |
| children early | #15 |
| association asthma symptoms | #15 |
| dogs children | #15 |
| epidemiological studies exposure | #15 |
| allele2 | #15 |
| ω3 polyunsaturated | #15 |
| diabimmune | #15 |
| bronchial hyperreactivity | #15 |
| pregnancy protective | #15 |
| sensitization indoor allergens | #15 |
| respective tlrs | #15 |
| ahr male mice | #15 |
| street residence | #15 |
| nocturnal symptoms | #15 |
| allergy risk | #15 |
| skin prick tests | #15 |
| 17q21 locus | #15 |
| immunity asthma | #15 |
| contact farm animals | #15 |
| unpasteurized | #15 |
| 7 year | #16 |
| nonatopic asthma children | #16 |
| newborn phenotype | #16 |
| microbial environment | #16 |
| wheeze trajectories | #16 |
| hutterite | #16 |
| exposure atopic | #16 |
| diseases allergy | #16 |
| sas institute | #16 |
| 80 chromosomes | #16 |
| burden childhood asthma | #16 |
| asthma farm | #16 |
| childhood asthma asthma | #16 |
| polymorphisms atopy | #16 |
| association atopy | #16 |
| chronic asthma children | #16 |
| protocadherin1 | #16 |
| asthma asthma risk | #16 |
| endotoxin house | #16 |
| multi‐centre study | #16 |
| n1133 | #16 |
| microbial exposures | #16 |
| lung microbiome health | #16 |
| 9 11 | #16 |
| clinical response measures | #16 |
| seasonal surveys questionnaires | #16 |
| allergic diseases childhood | #16 |
| bacteria respiratory tract | #16 |
| increased food | #16 |
| rhinoconjunctivitis | #17 |
| factors atopic | #17 |
| function school | #17 |
| humans preschool haemophilus | #17 |
| animals domestic | #17 |
| allergic asthma aa | #17 |
| pregnancy gene expression | #17 |
| asthma biomarkers humans | #17 |
| atopy childhood | #17 |
| persistent sensitization | #17 |
| asthma associations | #17 |
| eczema exposure | #17 |
| age 7 years | #17 |
| asthma 95 | #17 |
| asthma environment | #17 |
| asthma immune responses | #17 |
| respiratory health children | #17 |
| munich germany | #17 |
| single microbial | #17 |
| dust extract | #17 |
| aerosol bolus | #17 |
| munich | #17 |
| variants increase | #17 |
| epidemiologic dermatitis | #17 |
| ga2len skin | #17 |
| bavarian | #17 |
| child allergic | #17 |
| neuropeptide receptor npsr1 | #17 |
| levels microbial | #17 |
| pregnancy 6 years | #18 |
| cbmcs | #18 |
| increase childhood | #18 |
| childrens mattresses | #18 |
| female humans asthma | #18 |
| trajectories asthma | #18 |
| atopy rhinitis | #18 |
| edna concentrations | #18 |
| asthma phenotyping | #18 |
| current wheezers | #18 |
| eczema 95 | #18 |
| mef75 | #18 |
| maternallyacquired mice mice | #18 |
| children german | #18 |
| german populations | #18 |
| polymorphism genetic receptors | #18 |
| protective microbiota | #18 |
| col29a1 | #18 |
| ormdl3 gene | #18 |
| maternal contact | #18 |
| preschool dna ribosomal | #18 |
| immune adaptation | #18 |
| type employment | #18 |
| cb production | #18 |
| wheeze | #18 |
| meat children | #18 |
| asthma 6 years | #18 |
| asthma exposure | #18 |
| anthroposophic lifestyle | #18 |
| 7 yrs | #18 |
| underlying responses | #18 |
| phenotypes children | #18 |
| measles infection | #18 |
| newonset symptoms | #19 |
| sounds risk | #19 |
| higher levels endotoxin | #19 |
| disease atopic | #19 |
| arg130gln | #19 |
| life asthma risk | #19 |
| birth 13 years | #19 |
| german center | #19 |
| rural children | #19 |
| asthma | #19 |
| receptors innate | #19 |
| life exposures | #19 |
| seasonal risk | #19 |
| cary | #19 |
| life diversity | #19 |
| symptoms asthma | #19 |
| developing asthma | #19 |
| asthma allergy development | #19 |
| hscrp age | #19 |
| children current | #19 |
| microbial association networks | #19 |
| ilt4 | #19 |
| 3 years life | #19 |
| tcell phenotypes | #19 |
| farming activities | #19 |
| crp levels age | #19 |
| poor symptom control | #19 |
| susceptibility human | #19 |
| child crosssectional studies | #19 |
| atopic dermatitis studies | #19 |
| linkage disequilibrium polymorphisms | #19 |
| asthma report | #19 |
| asthma bronchiale | #19 |
| atopy phenotypes | #19 |
| innate mice models | #19 |
| viable bacterial counts | #19 |
| receptors innate immune | #19 |
| expression treg | #19 |
| regulatory tolllike receptor | #19 |
| mice sod3 | #20 |
| isaac | #20 |
| gene expression measurements | #20 |
| specific ige food | #20 |
| symptoms wheeze | #20 |
| unhygienic | #20 |
| atopy snps | #20 |
| school university | #20 |
| life farm | #20 |
| 6 haplotype | #20 |
| westernized countries | #20 |
| adults childhood | #20 |
| unboiled | #20 |
| haplotype studies | #20 |
| asthma nonatopic asthma | #20 |
| gender ratio | #20 |
| asthma trajectories | #20 |
| npsr1 nps | #20 |
| allergic disease prevalence | #20 |
| dermatitis early | #20 |
| persistent uncontrolled | #20 |
| dust female humans | #20 |
| breast feeding risk | #20 |
| disease germany | #20 |
| children living | #20 |
| infant colonization | #20 |
| farm environments | #20 |
| animal exposure | #20 |
| pvalues patients | #20 |
| inbred balb spores | #20 |
| stables | #20 |
| pregnancy production | #21 |
| tripeptidylpeptidases | #21 |
| n1062 | #21 |
| studies eczema | #21 |
| network differences | #21 |
| eczema atopy | #21 |
| environmental microbiome | #21 |
| c589t | #21 |
| atopic asthma children | #21 |
| patients degradation | #21 |
| ige igg4 | #21 |
| farm environment | #21 |
| environment lifestyle | #21 |
| childhood background | #21 |
| hypersensitivity infant | #21 |
| plasma erythrocyte membranes | #21 |
| children east | #21 |
| tlr2 receptor | #21 |
| germany humans germany | #21 |
| bifidobacterium colonization | #21 |
| children inhaled | #21 |
| unremitting | #21 |
| bhr 95 | #21 |
| pseudocroup | #21 |
| markers early | #21 |
| rora | #21 |
| development allergic diseases | #21 |
| prevalence rates symptoms | #21 |
| asthma review | #21 |
| current asthma wheeze | #21 |
| turkish children | #21 |
| gstm1 deficiency | #21 |
| lps risk | #22 |
| gabriel | #22 |
| 95 prenatal exposure | #22 |
| alleles asthma | #22 |
| neonatal immune responses | #22 |
| npsr1 gene | #22 |
| samples dust | #22 |
| crth2 th2 cells | #22 |
| objective sought | #22 |
| childhood atopy | #22 |
| food diversity | #22 |
| chromosome asthma | #22 |
| highschool | #22 |
| lower prevalences | #22 |
| β1→3glucans | #22 |
| immune maturation | #22 |
| muramic acid | #22 |
| endotoxin house dust | #22 |
| effective airway | #22 |
| r753q | #22 |
| isaac childhood | #22 |
| exposure germany | #22 |
| feeding obesity | #22 |
| respiratory diseases children | #22 |
| asthmatic phenotypes | #22 |
| allergic rhinitis 95 | #22 |
| living germany | #22 |
| seasonal risk factors | #22 |
| 17q21 asthma | #22 |
| fecal microbiota children | #23 |
| farm childhood | #23 |
| children adulthood | #23 |
| symptoms atopic eczema | #23 |
| traffic counts | #23 |
| hillerød | #23 |
| microbiota respiratory | #23 |
| child cross | #23 |
| 7 prevalence | #23 |
| rapid alternative | #23 |
| nonlinear relations | #23 |
| association atopic asthma | #23 |
| bronchial challenge tests | #23 |
| single taxa | #23 |
| asthma agents | #23 |
| new onset | #23 |
| asthma cats | #23 |
| gross national | #23 |
| nonfarm | #23 |
| breast feeding asthma | #23 |
| isaac phase | #23 |
| asthma 12 months | #23 |
| southern bavaria | #23 |
| childhood allergies | #23 |
| bronchitis child | #24 |
| tobit regression | #24 |
| gene expression immunity | #24 |
| wheeze symptoms | #24 |
| phenotypes childhood | #24 |
| dust endotoxin | #24 |
| west german | #24 |
| current symptoms | #24 |
| haying | #24 |
| asthma cross | #24 |
| allergic dermatitis | #24 |
| doctor diagnosed | #24 |
| 2fold risk | #24 |
| exposure road traffic | #24 |
| asthma 5 years | #24 |
| eczema susceptibility | #24 |
| children indoor | #24 |
| differences asthma prevalence | #24 |
| asthma age | #24 |
| allergic respiratory symptoms | #24 |
| countrys | #24 |
| asthma bhr | #24 |
| contact livestock | #24 |
| asthma prevention | #24 |
| asthma aa | #24 |
| 4 phenotypes | #24 |
| asthma early | #24 |
| exposure paracetamol | #25 |
| 2 12 months | #25 |
| prevention asthma | #25 |
| environmental determinants | #25 |
| expression ige | #25 |
| risk atopic diseases | #25 |
| igg1 ige | #25 |
| farm animals | #25 |
| car traffic | #25 |
| methods association | #25 |
| cytokines children | #25 |
| sensitization early | #25 |
| 5030 | #25 |
| il13 pathway | #25 |
| antibiotic year | #25 |
| sputum eosinophils feno | #26 |
| microbiota asthma | #26 |
| child conjunctivitis | #26 |
| farms humans | #26 |
| environmental asthma | #26 |
| allergen sensitisation | #26 |
| 3rd year | #26 |
| written questionnaire | #26 |
| increased treg | #26 |
| 5 european countries | #26 |
| early phenotypes | #26 |
| fev1 bhr | #26 |
| clinical phenotypes children | #26 |
| asthma syndrome | #26 |
| card4 | #26 |
| early atopic | #26 |
| levels mite | #26 |
| risk allergic sensitization | #26 |
| risk factors probability | #26 |
| trendwise | #26 |
| wheezing childhood | #26 |
| blood samples children | #26 |
| prevalence atopic eczema | #27 |
| asthma environmental | #27 |
| specific ige levels | #27 |
| single snps | #27 |
| muramic | #27 |
| wheeze childhood | #27 |
| allergens europe | #27 |
| npsr1 asthma | #27 |
| children parental asthma | #27 |
| visible mould | #27 |
| consumption raw milk | #27 |
| children asthma symptoms | #27 |
| ilt3 | #27 |
| asthmatic participants | #27 |
| asthma childhood | #27 |
| association childhood asthma | #27 |
| 9 11 years | #27 |
| prevention allergic diseases | #27 |
| childhood origins | #27 |
| respiratory infections year | #27 |
| 035 iu | #27 |
| prevalence fever | #27 |
| asthma child cross | #27 |
| factors year | #27 |
| analysis lca | #28 |
| host factors infection | #28 |
| 10 years data | #28 |
| immune phenotypes | #28 |
| atopic phenotypes | #28 |
| east germany | #28 |
| higher hrqol | #28 |
| gene asthma | #28 |
| early identification children | #28 |
| ige therapy | #28 |
| levels sensitization | #28 |
| dust children | #28 |
| weekly diaries | #28 |
| feno fev1 | #28 |
| childhood asthma risk | #28 |
| recurrence persistence | #28 |
| pregnancy increase | #28 |
| il13 polymorphisms | #28 |
| adult agriculture | #29 |
| vivo age | #29 |
| pediatric asthma patients | #29 |
| primary prevention asthma | #29 |
| centers prevalence | #29 |
| early years life | #29 |
| farming | #29 |
| acinetobacter lwoffii | #29 |
| pblc | #29 |
| dust indoor | #29 |
| anthroposophy | #29 |
| women males | #29 |
| bioair | #29 |
| mite sensitization | #29 |
| polymorphisms il13 | #29 |
| polymorphisms identified | #29 |
| preschool environmental | #29 |
| questionnaires urban | #29 |
| enhanced expression genes | #29 |
| rad50 gene | #29 |
| dismutase 3 | #30 |
| asthma childhood asthma | #30 |
| viral infections asthma | #30 |
| biodiversity child | #30 |
| boys asthma | #30 |
| incidence recurrence | #30 |
| effective ways | #30 |
| affluent | #30 |
| il10 snps | #30 |
| centres countries | #31 |
| ribosomal preschool dna | #31 |
| probability persistence | #31 |
| enhancer marks | #31 |
| asthma atopic | #31 |
| persons european ancestry | #31 |
| traditional farming | #31 |
| atopy children | #31 |
| bronchial obstruction | #31 |
| moisture damage | #31 |
| questionnaires asthma | #31 |
| il10 polymorphisms | #31 |
| childhood infectious | #31 |
| atopic food | #31 |
| card4 nod1 | #31 |
| children diagnosed asthma | #31 |
| association paracetamol | #32 |
| prick tests | #32 |
| doctordiagnosed | #32 |
| living environments | #32 |
| obese children age | #32 |
| européens | #32 |
| symptoms childhood | #32 |
| african ancestry asthma | #32 |
| microbial components | #32 |
| susceptibility asthma | #32 |
| atopic diseases | #32 |
| germany leipzig | #32 |
| studies dermatitis | #32 |
| asthma odds ratio | #32 |
| epidemiology asthma | #32 |
| gata3 gene | #32 |
| rural regions | #32 |
| r2447x | #32 |
| transferase deficiency | #32 |
| preschool day | #32 |
| cohorts asthma | #32 |
| microbial environments | #32 |
| disease childhood | #32 |
| linked polymorphisms | #32 |
| infants countries | #32 |
| huge burden | #32 |
| allergic diseases age | #32 |
| eczema prevalence | #33 |
| multiancestry association | #33 |
| immune cell enhancer | #33 |
| allergic genetic epigenesis | #33 |
| multiancestry association study | #33 |
| asthma associations loci | #33 |
| bhr fev1 | #33 |
| imputation data | #33 |
| genetic epigenesis allergic | #33 |
| specificity skin tests | #33 |
| year life | #34 |
| asthma risk children | #34 |
| mite allergen exposure | #34 |
| new onset symptoms | #34 |
| clec4e | #34 |
| participants childhood | #34 |
| studies dust | #34 |
| development atopy | #34 |
| participants questionnaire | #34 |
| health utilization children | #34 |
| fascinating | #34 |
| tests surveys | #34 |
| pregnancy maternal health | #34 |
| bacterial farms | #34 |
| asthma atopic eczema | #34 |
| endotoxins environmental | #34 |
| curve asthma | #34 |
| infant contact | #34 |
| dust microbiota | #34 |
| bradykinin receptor gene | #34 |
| indoor mould | #34 |
| pattern frequency | #34 |
| feno lung function | #35 |
| anthroposophic | #35 |
| 95 atopic dermatitis | #35 |
| children cross | #35 |
| germany haplotypes | #35 |
| western lifestyle | #35 |
| prick testing | #35 |
| risk asthma | #35 |
| asthma asthma phenotypes | #35 |
| diseases rhinitis | #35 |
| asthma conjunctivitis | #35 |
| tagging polymorphisms | #35 |
| preschool fatty acids | #35 |
| wingedhelix | #35 |
| farms female | #35 |
| analysis steps | #35 |
| urbanrural differences | #35 |
| raw cows milk | #35 |
| western germany | #35 |
| nonatopic mothers | #35 |
| endotoxin levels | #35 |
| prevalence childhood asthma | #36 |
| exposure genetic | #36 |
| 16s rrna data | #36 |
| asthma dendritic cells | #36 |
| chapter 1 epidemiology | #36 |
| skin test reactivity | #36 |
| maternal vitamin intake | #36 |
| maternal exposures | #36 |
| 1 stimulation | #36 |
| tolerance biomarkers | #36 |
| leipzig | #36 |
| earlylife exposures | #37 |
| allemagne | #37 |
| nasal samples | #37 |
| 8263 | #37 |
| case status | #37 |
| lifestyle environment | #37 |
| ril33 | #37 |
| incidence persistence | #37 |
| asthma candidate | #37 |
| native milk | #37 |
| foxp3 levels | #38 |
| endotoxin asthma | #38 |
| mouse model asthma | #38 |
| asthma cough | #38 |
| asthma allergens | #38 |
| eczema environmental | #38 |
| atopy prevalence | #38 |
| allergy birth | #38 |
| amish | #38 |
| recurrence risk factors | #38 |
| reverse causation | #38 |
| wisc | #38 |
| nps npsr1 | #38 |
| life increased | #38 |
| development allergic | #38 |
| maximum expiratory flow | #38 |
| dust asthma | #38 |
| innate immunity genes | #38 |
| itchy | #38 |
| association ndvi | #38 |
| ormdl3 expression | #38 |
| protect children | #39 |
| igg nglycosylation | #39 |
| levels house | #39 |
| ige switching | #39 |
| seasonal perennial | #39 |
| genetic rhinitis | #39 |
| haploview | #39 |
| polymorphisms asthma | #39 |
| wheezing phenotypes | #39 |
| adulthood risk factors | #39 |
| allergic symptoms children | #39 |
| traffic asthma | #39 |
| diversity environmental | #39 |
| maternal health pregnancy | #39 |
| degradation patients | #39 |
| c589 | #39 |
| transcription 6 | #40 |
| animal farms | #40 |
| children bronchial | #40 |
| isolated polysaccharides | #40 |
| antibiotics development | #40 |
| eczema | #40 |
| crosssectional studies | #40 |
| biodiversity health | #40 |
| preschool conjunctivitis | #40 |
| 4606 | #40 |
| symptoms allergic | #40 |
| mite exposure | #40 |
| small airway dysfunction | #41 |
| farm residence | #41 |
| risk factors health | #41 |
| german cities | #41 |
| stress young | #41 |
| allergic child | #41 |
| effects asthma | #41 |
| eczema phenotypes | #41 |
| allergens age | #41 |
| treg cells patients | #41 |
| discotheques | #41 |
| asthma wheeze | #41 |
| 95 antibiotics | #42 |
| polymorphism single nucleotide | #42 |
| food questionnaire | #42 |
| bronchiale | #42 |
| international patterns | #42 |
| dust female | #42 |
| microbiome data | #42 |
| onset year | #42 |
| pcdh1 | #42 |
| subspecies infantis | #43 |
| dermatitis food | #43 |
| treg th17 cells | #43 |
| time asthma | #43 |
| asthma food | #43 |
| increased regulatory | #43 |
| worldwide variations | #43 |
| asthma onset | #43 |
| sensitized subjects | #43 |
| atopic diseases asthma | #44 |
| wide variations | #44 |
| prevalence symptoms | #44 |
| cells cord | #44 |
| followup physical activity | #44 |
| gsdma | #44 |
| early childhood infections | #44 |
| asthma food allergy | #44 |
| developing countries children | #44 |
| asthma cystic fibrosis | #44 |
| atp2a3 | #44 |
| sequential switching | #44 |
| diseases childhood | #44 |
| facklamia | #44 |
| work overload | #44 |
| 97th | #44 |
| national institute allergy | #44 |
| microbiome asthma | #44 |
| increased risk symptoms | #44 |
| phenotype respiratory | #45 |
| birth 12 months | #45 |
| bamse | #45 |
| animals pregnancy | #45 |
| questionnaire responses | #45 |
| sensitization inhalant | #45 |
| antiasthma drugs | #45 |
| dust endotoxins | #45 |
| biodiversity hypothesis | #45 |
| severe atopic eczema | #45 |
| 7445 | #45 |
| fever 95 | #45 |
| exposure early life | #45 |
| traffic exposure | #45 |
| prevalence bhr | #46 |
| control physical | #46 |
| farm animal | #46 |
| improvement reduction | #46 |
| asthma gwas | #46 |
| adolescence differences | #46 |
| evidence gene | #46 |
| humans hygiene | #46 |
| atopic diseases children | #46 |
| prevalence current wheeze | #46 |
| asthma cluster | #46 |
| prevalence diseases | #46 |
| receptor tolllike receptors | #46 |
| spt reactivity | #46 |
| factors asthma | #47 |
| children atopic disease | #47 |
| efraim | #47 |
| international study | #47 |
| 95 eczema | #47 |
| franche | #47 |
| germany east | #47 |
| wheeze phenotypes | #47 |
| tirana | #47 |
| analysis step | #47 |
| prevalence rhinoconjunctivitis | #47 |
| airways diseases | #48 |
| perennial allergens | #48 |
| lung function spirometry | #48 |
| doctordiagnosed asthma | #48 |
| polymorphisms il4 | #48 |
| wheeze age | #48 |
| asthma risk loci | #48 |
| asthma adjusted | #48 |
| fungal flora | #48 |
| asthma biological | #48 |
| halle | #48 |
| cluster children | #48 |
| parental interviews | #48 |
| breath volatile | #48 |
| frequent wheeze | #48 |
| prevalences asthma | #48 |
| milk farm | #49 |
| risk factors incidence | #49 |
| chromosome susceptibility | #49 |
| children female humans | #49 |
| n228 | #49 |
| children paracetamol | #49 |
| fcer1a | #49 |
| pcrsscp | #50 |
| physiciandiagnosed | #50 |
| diversity food | #50 |
| longum subsp infantis | #50 |
| bacterial markers | #50 |
| background atopic | #50 |
| beta13glucans | #50 |
| unpasteurized milk | #50 |
| exposures asthma | #50 |
| association allergic | #51 |
| microbial burden | #51 |
| lwoffii | #51 |
| conjugated mice mice | #51 |
| children cities | #51 |
| maintenant | #51 |
| asthma dust | #51 |
| allergy symptoms | #51 |
| common chronic disease | #51 |
| association atopic dermatitis | #51 |
| identified polymorphisms | #51 |
| populationattributable risk | #51 |
| country prevalence | #51 |
| asthma maternal | #51 |
| igg1 igg4 | #51 |
| epidemiologischen | #52 |
| specific protective | #52 |
| 9357 | #52 |
| prevalence wheeze | #52 |
| geneenvironment interactions | #52 |
| ige sige | #52 |
| eczema childhood | #52 |
| bmi asthma | #52 |
| itchy rash | #52 |
| wheeze cough | #52 |
| gpra | #52 |
| sensitization children | #52 |
| doctor diagnosis | #52 |
| infant study | #52 |
| milk consumption | #52 |
| indoor endotoxin | #52 |
| age wheezing | #52 |
| atopic eczema children | #53 |
| children current asthma | #53 |
| ige children | #53 |
| early life exposure | #53 |
| outdoor pollution | #53 |
| life exposure | #53 |
| il13 gene | #53 |
| 2q32 | #53 |
| adam33 asthma | #53 |
| cross sectional studies | #54 |
| female germany life | #54 |
| animals asthma | #54 |
| prevalence wheezing | #54 |
| nonmicrobial | #54 |
| male prevalence | #54 |
| estonian children | #54 |
| asthma odds | #54 |
| prevalence association | #55 |
| cough wheeze | #55 |
| stepwise procedure | #55 |
| bacterial microbiota | #55 |
| year asthma | #55 |
| samples farm | #55 |
| maternal ige | #56 |
| cd14 tolllike receptor | #56 |
| adult asthma patients | #56 |
| immunoglobulin interleukin13 | #56 |
| visible mold | #56 |
| atopy development | #56 |
| tuberculosis notification | #56 |
| strong protective | #56 |
| alex study | #56 |
| asthma atopy | #56 |
| random samples | #56 |
| atopy wheeze | #57 |
| mef50 | #57 |
| member 1 polymorphism | #57 |
| pollutant exposure | #57 |
| adam33 polymorphisms | #57 |
| life atopic dermatitis | #57 |
| eczema flg | #57 |
| diseases methods | #57 |
| asthma allergic rhinoconjunctivitis | #57 |
| mononuclear lipid | #57 |
| derp1 | #57 |
| 3785 | #57 |
| prevention allergic | #57 |
| stat6 gene | #58 |
| total serum | #58 |
| eczema female | #58 |
| hypersensitivity immunoglobulin | #58 |
| early asthma | #58 |
| specificity asthma | #58 |
| reported parents | #58 |
| diseases children | #58 |
| th17 lineage | #59 |
| finland estonia | #59 |
| 6 years age | #59 |
| farm families | #59 |
| 1q31 | #59 |
| asthma morbidity children | #59 |
| german participants | #59 |
| milk cla | #59 |
| rna yield | #60 |
| iedap | #60 |
| beta 2agonists | #60 |
| allergic surveys | #60 |
| preschool wheezing | #60 |
| predictors incidence | #60 |
| birth school age | #60 |
| development childhood | #60 |
| exposure asthma | #61 |
| implicated genes | #61 |
| seasonal skin tests | #61 |
| atopy eczema | #61 |
| breastfed children | #61 |
| species colonization | #61 |
| asthma birth | #62 |
| childhoodonset asthma | #62 |
| immunoglobulin infant | #62 |
| estonia finland | #62 |
| respiratory sounds | #62 |
| large german | #62 |
| life immune | #62 |
| development airway hyperresponsiveness | #62 |
| persistence asthma | #62 |
| indoor allergen exposure | #63 |
| endotoxin level | #63 |
| total quantity | #63 |
| asthma breast | #63 |
| hyperreactivity bronchial | #63 |
| children role | #63 |
| dermatitis risk | #63 |
| atopic | #63 |
| cystic fibrosis abpa | #63 |
| exposure assessed | #63 |
| children regions | #63 |
| dust parameters | #64 |
| newborn lymphocyte | #64 |
| no2 benzene | #64 |
| helminth ascariasis ascaris | #64 |
| children centers | #64 |
| differential networks | #64 |
| allergenspecific ige | #64 |
| animal contact | #65 |
| childhood allergic diseases | #65 |
| healthy controls children | #65 |
| risk wheezing | #65 |
| sensitization allergic | #66 |
| prevalence current asthma | #66 |
| immunological data | #66 |
| umc | #66 |
| dust extracts | #66 |
| atopic symptoms | #66 |
| ga²len | #66 |
| living area | #66 |
| allergic rhinitis age | #66 |
| preschool haemophilus humans | #66 |
| 2 questionnaires | #67 |
| ige expression | #67 |
| biomarkers predictors | #67 |
| pa obesity | #67 |
| maternal atopy | #67 |
| respiratory allergies | #67 |
| mère | #68 |
| antibiotic sales | #68 |
| weight boys | #68 |
| early wheeze | #68 |
| ige allergens | #69 |
| hypersensitivity immunization | #70 |
| atopic disease children | #70 |
| gene gene interaction | #70 |
| allergic disorders | #70 |
| suisse | #70 |
| asthma complex | #70 |
| sod3 | #70 |
| small airway function | #71 |
| atopic rhinitis | #71 |
| occurrence progression | #71 |
| allergic sensitization children | #71 |
| unprocessed | #71 |
| barns | #71 |
| prenatal vitamin | #71 |
| tlr2 tlr1 | #71 |
| breathomics | #71 |
| factor asthma | #72 |
| association occupational exposure | #72 |
| 158 95 | #72 |
| molecular fingerprinting | #72 |
| persistent asthma children | #72 |
| infantis | #72 |
| children wheeze | #72 |
| european ancestry association | #73 |
| sounds respiratory | #73 |
| ormdl3 | #73 |
| onset allergic | #73 |
| gni | #73 |
| exposure europe | #74 |
| severe eczema | #74 |
| food allergy asthma | #74 |
| health services children | #74 |
| west humans | #74 |
| risk wheeze | #74 |
| rfel | #75 |
| standardized procedure | #75 |
| children hrqol | #75 |
| asthma genome | #75 |
| maternal immunity | #75 |
| chromosome 17q21 | #75 |
| total serum ige | #75 |
| asthmatic mothers | #75 |
| asthma case | #76 |
| rural differences | #76 |
| symptoms eczema | #76 |
| microbial molecules | #76 |
| eczema children | #76 |
| food inhalant | #76 |
| allergy childhood | #76 |
| wheezing | #76 |
| sexspecific association | #77 |
| asthma healthy | #77 |
| diversity microbial | #77 |
| 9 mmp9 | #77 |
| hyperresponsiveness bhr | #77 |
| blood cytokines | #78 |
| childhood | #78 |
| turkish origin | #78 |
| wheezing illnesses | #78 |
| edta tubes | #78 |
| sensitisation children | #78 |
| mothers asthma | #78 |
| findings prevalence | #78 |
| rhinitis atopic | #78 |
| years odds | #78 |
| 6399 | #78 |
| interactions snps | #79 |
| seasonal asthma | #79 |
| neuropeptide receptor | #79 |
| genes innate immunity | #79 |
| milk yoghurt | #79 |
| 95 protection | #79 |
| dander | #80 |
| ige skin | #80 |
| cats child | #80 |
| prevalence respiratory | #81 |
| microbial agents | #81 |
| symptoms 12 | #81 |
| lower prevalence | #81 |
| development atopic dermatitis | #81 |
| forkhead box protein | #81 |
| childhood wheeze | #81 |
| introduction solids | #82 |
| laryngitis | #82 |
| 13 14 | #82 |
| age 45 | #82 |
| children european | #82 |
| ribosomal pcr | #82 |
| age prevalence | #82 |
| bacterial viral infections | #82 |
| concentrations so2 | #82 |
| total fat content | #83 |
| current wheezing | #83 |
| reporter genetic predisposition | #83 |
| study pcr | #83 |
| children siblings | #83 |
| hypersensitivity risk | #83 |
| gut commensals | #83 |
| cleanliness | #83 |
| study population patients | #83 |
| microbial stimulation | #83 |
| oligoarticular juvenile | #84 |
| specific exposures | #84 |
| tests child | #84 |
| control pa | #84 |
| new asthma | #84 |
| 4732 | #84 |
| single nucleotide rna | #85 |
| α1 antitrypsin | #85 |
| bronchial responsiveness | #85 |
| atopy risk | #85 |
| européenne | #85 |
| n134 | #85 |
| arabinogalactan | #86 |
| truck traffic | #86 |
| children feeding | #86 |
| hyper responsiveness | #86 |
| ige levels | #86 |
| bifidobacterium species | #86 |
| wheeze prevalence | #86 |
| infant inflammation | #86 |
| comté | #86 |
| visits asthma | #87 |
| age asthma | #87 |
| genes asthma | #87 |
| exposure associations | #87 |
| analysis respiratory | #87 |
| influential factors | #87 |
| 95 fever | #87 |
| tolllike receptors tlrs | #88 |
| rhinitis risk | #88 |
| allergy tests | #88 |
| asthma polymorphisms | #88 |
| pollution allergens | #88 |
| exposure tobacco smoke | #88 |
| asthma children | #89 |
| rphl | #89 |
| aged 6 | #89 |
| bronchial hyper | #89 |
| asthma phenotypes | #89 |
| allergic seasonal surveys | #90 |
| current exposure | #90 |
| children area | #90 |
| critical time window | #90 |
| filaggrin mutations | #91 |
| development eczema | #91 |
| newborn limit | #91 |
| joint workshop | #91 |
| newborn leukocytes | #91 |
| asthma school | #91 |
| mononuclear polymorphism | #92 |
| sensitisation | #92 |
| preschool haemophilus | #93 |
| experimental asthma | #93 |
| south germany | #93 |
| low levels exposure | #93 |
| allergic rhinitis symptoms | #93 |
| rs2305480 | #93 |
| geführt | #93 |
| previous studies association | #93 |
| east west germany | #93 |
| zpbp2 | #94 |
| tregulatory cells | #94 |
| pertussis infection | #94 |
| fed children | #95 |
| expression toll | #95 |
| eczema symptoms | #95 |
| university life | #95 |
| asthma loci | #95 |
| nickel allergy | #95 |
| asthma common | #95 |
| greater consumption | #95 |
| 16q12 | #95 |
| international variation | #95 |
| expression th1 | #96 |
| lps recognition | #96 |
| dysbalance | #96 |
| trigger factors | #96 |
| cumulative prevalence | #96 |
| dust environmental | #96 |
| allergic sensitisation | #96 |
| nonfarmers | #96 |
| airway dysfunction | #96 |
| anaphylaxie | #96 |
| onset wheeze | #96 |
| indoor factors | #97 |
| 95 overweight | #97 |
| inhalant allergens | #97 |
| schoolchildren aged | #97 |
| city air | #97 |
| regulatory treg | #97 |
| seasonal sensitivity | #98 |
| children germany | #98 |
| tlr1 tlr2 | #98 |
| factors school | #98 |
| age 3 years | #98 |
| childhood adulthood | #98 |
| background asthma | #98 |
| years aor | #99 |
| comprehensive questionnaire | #99 |
| rural school | #99 |
| seasonal surveys | #99 |
| earlyonset asthma | #99 |
| asthma inflammation | #99 |
| children atopic | #99 |
| current wheeze | #99 |
| eastern germany | #99 |
| childhood atopic dermatitis | #100 |
| preschool crosssectional studies | #100 |
| isaac questionnaire | #100 |
| mef25 | #101 |
| expression measurements | #101 |
| genetic factors susceptibility | #101 |
| summarised | #101 |
| weight girls | #101 |
| raw cow | #101 |
| ige concentrations | #102 |
| tenascin tnc | #102 |
| factors wheezing | #102 |
| retinoid acid | #102 |
| risk factors persistence | #102 |
| effects respiratory | #102 |
| years early | #103 |
| sensitization eczema | #103 |
| irf1 gene | #103 |
| 4264 | #103 |
| children increased risk | #103 |
| hdm exposure | #103 |
| exposure milk | #104 |
| sensitization childhood | #104 |
| children relation | #104 |
| hutterites | #105 |
| arabinogalactans | #105 |
| pollen concentration | #105 |
| high‐sensitivity | #105 |
| hyperreactivity | #105 |
| animal dander | #106 |
| physiciandiagnosed asthma | #106 |
| wheezing disorders | #106 |
| questionnaires switzerland | #106 |
| children contact | #106 |
| prevalence atopy | #106 |
| blood ige | #106 |
| underlying factor | #107 |
| detailed questionnaire | #107 |
| puberty age | #107 |
| socs4 | #107 |
| fever episodes | #108 |
| overweight 95 | #108 |
| breast feeding | #108 |
| inverse associations | #108 |
| asthma wheezing | #109 |
| air pollution children | #109 |
| moulds | #109 |
| complex syndrome | #109 |
| publication air pollution | #109 |
| allergic perennial rhinitis | #109 |
| healthy children children | #109 |
| p≤003 | #110 |
| genotype germany | #110 |
| atopic eczema humans | #110 |
| female germany | #110 |
| rs7216389 | #110 |
| folgenden | #110 |
| parental questionnaire | #111 |
| il4ra | #111 |
| female histones | #112 |
| milk samples | #112 |
| tbox transcription factor | #112 |
| environmental study | #112 |
| olive pollen | #112 |
| 1314 | #112 |
| flg variants | #113 |
| risk allergic | #113 |
| experimental allergic asthma | #113 |
| allergic | #113 |
| phenotypes asthma | #113 |
| indoor asthma | #113 |
| allergic disease | #114 |
| challenge data | #114 |
| mould exposure | #114 |
| parent reported | #114 |
| occupational allergy | #114 |
| tests bronchial | #114 |
| asthma sensitization | #114 |
| cord blood ige | #115 |
| cough children | #115 |
| notification rates | #115 |
| foxp3 locus | #115 |
| increased diversity | #115 |
| igg4 responses | #115 |
| regulatory th17 | #116 |
| exclusive breast feeding | #116 |
| immune responsiveness | #116 |
| aged 9 | #116 |
| children underwent | #117 |
| glutathione transferase gst | #117 |
| psychosocial characteristics | #117 |
| germany humans | #118 |
| indoor microbial | #118 |
| living rural | #118 |
| skinprick tests | #118 |
| reference children | #118 |
| allergic sensitization | #118 |
| ratio prevalence | #118 |
| west germany | #118 |
| delayed introduction | #119 |
| children wheezing | #119 |
| ancestry asthma | #119 |
| switching immunoglobulin | #119 |
| skin prick | #119 |
| association chromosome | #120 |
| environment children | #120 |
| levels endotoxin | #120 |
| fibrolysis | #120 |
| childhood risk factors | #120 |
| vitamin supplementation pregnancy | #121 |
| allergens asthma | #121 |
| dampness | #121 |
| symptom control | #121 |
| factors rural | #121 |
| common aeroallergens | #121 |
| lung function measurements | #121 |
| aliments | #121 |
| 300 people | #122 |
| preventive potential | #122 |
| tlr10 | #122 |
| life early | #122 |
| urban traffic | #123 |
| hayfever | #123 |
| frequency pattern | #123 |
| germany prevalence | #124 |
| atopic manifestations | #124 |
| passive smoke exposure | #124 |
| active asthma | #124 |
| severe eosinophilic asthma | #124 |
| immunologic tolllike receptor | #125 |
| il18r1 | #125 |
| potted plants | #125 |
| common inhalant | #125 |
| sensitization development | #126 |
| prevalence allergic diseases | #126 |
| eczema patients | #126 |
| asthma background | #126 |
| paediatric studies | #126 |
| effects prevalence | #126 |
| exposure pets | #126 |
| 3 infections | #126 |
| await | #126 |
| caspase recruitment domain | #127 |
| test reactivity | #127 |
| prävalenz | #127 |
| adaptive cells | #127 |
| exposure endotoxin | #127 |
| allergens child | #127 |
| parent questionnaire | #127 |
| 95 ors | #127 |
| environmental allergens | #127 |
| bdnf polymorphisms | #128 |
| bdnf gene | #129 |
| microbial markers | #129 |
| receptors male | #129 |
| medall | #130 |
| protein allergy | #131 |
| respiratory symptoms children | #131 |
| common allergens | #131 |
| hypersensitivity respiratory | #131 |
| asthma objective | #131 |
| severe eosinophilic | #131 |
| factors allergens | #131 |
| test study | #131 |
| sensitization allergens | #131 |
| male occupational | #132 |
| immunoglobulin inflammation | #132 |
| diseases asthma | #132 |
| expression receptors | #132 |
| effects development | #132 |
| asthma adolescent | #132 |
| bavaria | #133 |
| understanding natural | #133 |
| age 7 | #133 |
| pollen prevalence | #133 |
| early age | #133 |
| dpp10 | #134 |
| allergy | #134 |
| 7 years age | #134 |
| childhood risk | #135 |
| 95 ages | #135 |
| prevalence rhinitis | #135 |
| body composition bmi | #135 |
| crth2 | #135 |
| eczema risk | #136 |
| allergic phenotype | #136 |
| bronchial response | #136 |
| asthma young | #136 |
| 60 iu | #136 |
| ms4a2 | #137 |
| exposure children | #137 |
| snps asthma | #137 |
| ga2len | #137 |
| 6 7 | #137 |
| actinomycetes | #137 |
| mechanisms asthma | #137 |
| régions | #138 |
| snps interactions | #138 |
| sensitized children | #138 |
| mattress | #138 |
| pollutants allergens | #138 |
| asthma development | #138 |
| reduced prevalence | #138 |
| asthma atopic dermatitis | #138 |
| serum ige | #139 |
| sebacate | #139 |
| listeria spp | #139 |
| pollution asthma | #139 |
| milk animals | #139 |
| 3 14 | #139 |
| allergen levels | #139 |
| exposure symptoms | #140 |
| duration type | #140 |
| microbiota children | #140 |
| pasture | #140 |
| largest reduction | #140 |
| tregs foxp3 | #140 |
| age 6 years | #141 |
| exposure indoor | #141 |
| asthma genes | #141 |
| cla content | #142 |
| questionnaires illness surveys | #142 |
| factors difference | #142 |
| susceptibility children | #142 |
| indoor allergens | #142 |
| asthma bronchitis | #142 |
| n183 | #142 |
| unifrac | #143 |
| pregnancy early | #143 |
| asthma defined | #144 |
| inconclusive | #144 |
| pet exposure | #144 |
| exposure year | #144 |
| replication association | #144 |
| snps chromosome | #144 |
| incident asthma | #144 |
| children allergy | #145 |
| onset menarche | #145 |
| dermatitis asthma | #145 |
| expositions | #145 |
| prematurely born children | #146 |
| lower airways | #146 |
| airway mechanics | #146 |
| allergy testing | #146 |
| health outcomes children | #146 |
| interleukin13 interleukin4 | #146 |
| prevalence skin | #146 |
| original article | #147 |
| study centers | #147 |
| biomarkers child | #147 |
| feno patients | #148 |
| children 6 | #148 |
| association early | #148 |
| germany west | #148 |
| atopic outcomes | #149 |
| indoor allergen | #149 |
| early immune | #149 |
| perennial rhinitis allergic | #150 |
| pregnancy respiratory | #150 |
| fall fev1 | #150 |
| prevalence childhood | #151 |
| 105 years | #151 |
| profound differences | #151 |
| confer protection | #151 |
| wheeze children | #151 |
| wheezing children | #151 |
| consumption dairy products | #152 |
| established asthma | #152 |
| immunomodulatory molecules | #152 |
| bhr | #152 |
| exposure increased | #152 |
| distribution asthma | #152 |
| environmental exposure | #152 |
| children review | #152 |
| common respiratory | #153 |
| asthma dermatitis | #153 |
| tagging single | #153 |
| function measurements | #153 |
| wheeze asthma | #153 |
| hens egg | #153 |
| cd28null | #154 |
| hormonal factors | #154 |
| tests sex factors | #155 |
| onset association | #155 |
| bronchial challenge | #155 |
| neighboring countries | #155 |
| atopic children | #156 |
| association asthma | #156 |
| neu5gc | #157 |
| absolute levels | #157 |
| development allergy | #157 |
| positive spt | #157 |
| severity frequency | #157 |
| gene 3 | #157 |
| bacterial lysates | #158 |
| paediatric asthma | #158 |
| asthma females | #158 |
| early environmental | #158 |
| lower diversity | #158 |
| children asthma | #159 |
| patients controlled asthma | #159 |
| developing immune | #159 |
| prevention allergy | #159 |
| reported prevalence | #160 |
| microbiome diversity | #160 |
| children rhinitis | #160 |
| spts | #160 |
| allergic seasonal | #160 |
| german adults | #160 |
| children homes | #160 |
| wheeze rhinitis | #161 |
| preventive measure | #161 |
| atopy asthma | #161 |
| newborn longitudinal | #161 |
| asthma presence | #161 |
| female humans allergic | #162 |
| parental asthma | #162 |
| children lower | #162 |
| immune pathways | #162 |
| exposure prevalence | #163 |
| environmental associations | #163 |
| perennial rhinitis | #163 |
| specific ige | #163 |
| kindl | #164 |
| sensitised | #164 |
| sscp | #164 |
| children sensitized | #165 |
| asthma ige | #165 |
| atopic dermatitis | #165 |
| atopic eczema | #165 |
| ige asthma | #166 |
| 5q31 | #166 |
| infant respiratory | #166 |
| illness surveys questionnaires | #166 |
| epidemiologie | #166 |
| feeding child | #166 |
| studies exposure | #167 |
| air pollutant concentrations | #167 |
| preadolescent children | #167 |
| disease life | #167 |
| adolescent allergens | #167 |
| preschool cross | #167 |
| years lung | #168 |
| year children | #168 |
| current asthma | #168 |
| workplace young | #169 |
| 2688 | #169 |
| regulatory treg cells | #169 |
| stratification patients | #169 |
| airway size | #169 |
| chronic inflammatory disease | #170 |
| adolescent analysis | #171 |
| inhalant | #171 |
| aged 13 | #171 |
| nucleotide rna | #171 |
| sensitization pollen | #171 |
| prevalence current | #172 |
| endotoxins female | #172 |
| sheds | #172 |
| studien | #172 |
| ifnγ levels | #172 |
| skin prick test | #172 |
| nucleotide pregnancy | #172 |
| risk score model | #173 |
| unifying concept | #173 |
| risk atopy | #174 |
| antipyretics | #174 |
| patients nocturnal | #175 |
| female humans questionnaires | #175 |
| small airway | #175 |
| mice asthma | #175 |
| sensitization common | #176 |
| serine protease inhibitor | #176 |
| school level | #176 |
| repeated infections | #176 |
| asthma attack | #176 |
| sensitization pattern | #177 |
| life respiratory function | #177 |
| situ hybridization infant | #177 |
| wheezers | #177 |
| 9p24 | #178 |
| childhood infections | #178 |
| aa patients | #178 |
| genetic severity | #178 |
| sensitization asthma | #178 |
| traffic characteristics | #179 |
| standardized methodology | #179 |
| sputum neutrophils | #179 |
| childhood adolescence | #179 |
| w12 | #179 |
| objective measurements | #179 |
| studies environmental | #179 |
| nocturnal asthma | #179 |
| socks | #180 |
| breastfed infant | #180 |
| asthma genetic | #180 |
| lung function testing | #181 |
| environmental predictors | #181 |
| mattresses | #181 |
| bacterial count | #181 |
| children environmental | #181 |
| vitamin asthma | #182 |
| dust levels | #182 |
| dermatitis children | #182 |
| differences hrqol | #182 |
| immunemediated diseases | #182 |
| mögliche | #183 |
| children levels | #183 |
| tlr signaling | #183 |
| german population | #183 |
| exposure humans | #183 |
| environmental microbiology | #183 |
| vocational training | #183 |
| school district | #185 |
| life prevalence | #185 |
| incidence allergic | #185 |
| work asthma | #186 |
| protein child | #187 |
| development allergic disease | #188 |
| environmental exposures | #188 |
| childhood early adulthood | #188 |
| asthma body | #188 |
| qpcrs | #188 |
| selfselection | #188 |
| tests children | #188 |
| tlr genes | #189 |
| jf1 | #189 |
| inversely | #190 |
| wheezing age | #190 |
| association antibiotic | #190 |
| bacterial groups | #190 |
| muscle mass patients | #190 |
| mother pregnancy | #190 |
| type duration | #190 |
| early wheezing | #190 |
| dry cough | #191 |
| atopic dermatitis children | #191 |
| cd14 gene | #191 |
| blood gene | #191 |
| adjusted irr | #192 |
| pyroglyphidae | #192 |
| longum subsp | #192 |
| milk serum | #193 |
| cε | #193 |
| adam33 | #193 |
| model allergic | #193 |
| eosinophilic asthma | #195 |
| estonian | #195 |
| prevalence severity | #195 |
| caspase recruitment | #196 |
| germany switzerland | #197 |
| enthusiasm | #197 |
| review asthma | #197 |
| earlylife | #198 |
| questionnaire data | #198 |
| representative population | #199 |
| decreased prevalence | #199 |
| rhinitis eczema | #199 |
| upper lower airways | #200 |
| bacteria role | #202 |
| allergy infectious diseases | #202 |
| complex interplay | #202 |
| paediatrician | #203 |
| patients europe | #203 |
| bronchial hyperresponsiveness bhr | #203 |
| phenotyped | #204 |
| difference prevalence | #204 |
| patients aa | #204 |
| dermatitis atopic | #205 |
| 13 years age | #205 |
| amebocyte | #205 |
| new locus | #205 |
| 3034 | #206 |
| allergen specific | #206 |
| factors atopy | #207 |
| asthma respiratory symptoms | #207 |
| asthma methods | #207 |
| diagnosed asthma | #208 |
| studies germany | #208 |
| allergic asthmatics | #208 |
| karelia | #208 |
| male phenotype | #208 |
| glycolylneuraminic acid | #209 |
| studies cytokines | #209 |
| higher diversity | #209 |
| innate adaptive immunity | #209 |
| prevalence obesity | #209 |
| sensitization age | #209 |
| col4a3 | #209 |
| newborn logistic | #209 |
| symptoms children | #210 |
| bronchial provocation | #210 |
| core microbiome | #210 |
| bhr asthma | #210 |
| epithelial barrier function | #210 |
| influence development | #211 |
| low prevalence | #211 |
| exposure sensitization | #211 |
| cats dogs | #211 |
| tlr4 cd14 | #212 |
| asthma animals | #212 |
| birth 6 | #212 |
| asthma allergic | #212 |
| atopic dermatitis asthma | #212 |
| methodssubjects | #212 |
| patients uncontrolled asthma | #213 |
| distinct clusters | #213 |
| exposure allergens | #213 |
| 1872 | #213 |
| cohort methods | #213 |
| workplace exposure | #214 |
| prevalence allergic | #214 |
| asthma allergic diseases | #214 |
| reverse causality | #214 |
| 00035 | #214 |
| rural environment | #214 |
| expression cd14 | #214 |
| life allergic | #215 |
| obesity overweight | #216 |
| mast cell chymase | #216 |
| regulatory responses | #216 |
| il2rb | #218 |
| atopic female | #218 |
| geneticist | #219 |
| child dna | #219 |
| microbial products | #219 |
| causation | #219 |
| disinfectants | #219 |
| variants asthma | #220 |
| pierced | #220 |
| steiner | #220 |
| allergy development | #220 |
| schistosoma schistosomiasis | #221 |
| homogenised | #221 |
| method participants | #221 |
| 90 children | #222 |
| sensitization rates | #222 |
| increased asthma | #222 |
| symptoms baseline | #223 |
| environmental epidemiology | #223 |
| groups asthma | #224 |
| german study | #225 |
| sibship size | #225 |
| alpha1 antitrypsin | #226 |
| sensitization allergen | #226 |
| conjunctivitis allergic | #226 |
| german | #226 |
| school age | #227 |
| provocative concentration | #227 |
| lung health | #228 |
| 95 obesity | #228 |
| test spt | #228 |
| allergic diseases asthma | #228 |
| data asthma | #228 |
| specific stimulation | #228 |
| road traffic | #229 |
| tuberculosis prevalence | #229 |
| healthy worker | #229 |
| wheezing asthma | #229 |
| understanding asthma | #229 |
| umwelt | #230 |
| asthma allergic rhinitis | #230 |
| cord blood cells | #230 |
| asthma phenotype | #230 |
| butyryl | #230 |
| allergy prevention | #231 |
| cord blood cb | #231 |
| subgroup children | #232 |
| health variables | #232 |
| nonallergic asthma | #232 |
| 20 fall | #232 |
| living conditions | #232 |
| discontent | #232 |
| prevalence overweight | #233 |
| innate leukocytes | #233 |
| lively | #233 |
| hyperreactive | #234 |
| complementary food | #234 |
| dermatophagoides pteronyssinus | #234 |
| n144 | #235 |
| fourth grade | #235 |
| exposure pregnancy | #236 |
| resequenced | #236 |
| levels asthma | #236 |
| specific allergen | #236 |
| finland france | #238 |
| puberty girls | #238 |
| incidence asthma | #239 |
| strategies prevention | #239 |
| neutrophilic asthma | #240 |
| preschool cytokines | #241 |
| regulatory th1 | #242 |
| age exposure | #243 |
| immune development | #243 |
| th2 immunity | #243 |
| adaptor protein polymorphism | #245 |
| receptor 1 | #245 |
| adjusted odds ratio | #245 |
| muropeptides | #246 |
| fungal dna ribosomal | #246 |
| role development | #247 |
| prick test | #247 |
| nasal microbiota | #247 |
| fever asthma | #247 |
| children analysis | #248 |
| patients healthcare | #248 |
| class analysis | #249 |
| factors allergic | #249 |
| baseline incidence | #249 |
| therapy severe | #250 |
| clinical science | #250 |
| tlr2 gene | #251 |
| biological therapy | #251 |
| communism | #252 |
| china factors | #253 |
| contact animals | #253 |
| cold air | #253 |
| asthma symptoms | #253 |
| hormonal influences | #254 |
| atopic disease | #255 |
| lowgrade inflammation | #255 |
| preschool dermatitis | #256 |
| low pa | #256 |
| h4 acetylation | #256 |
| body mass children | #257 |
| human asthma | #257 |
| adolescent asthma | #257 |
| 454pyrosequencing | #257 |
| association expression | #258 |
| niaid | #258 |
| epidemiological studies | #259 |
| airborne fungi | #259 |
| prediction quality | #259 |
| life symptoms | #260 |
| exposure early | #260 |
| age 6 | #260 |
| 2051 | #260 |
| life asthma | #260 |
| rhinitis allergic | #260 |
| westernization | #261 |
| early life | #261 |
| discriminate | #261 |
| eczema atopic | #261 |
| interferon expression | #262 |
| utilization health services | #262 |
| spink5 | #262 |
| protein 15 | #263 |
| alpha1antitrypsin | #263 |
| development immune | #263 |
| milk pregnancy | #263 |
| physician diagnosed | #263 |
| children associations | #264 |
| latex sensitization | #265 |
| exposure traffic | #265 |
| indoor exposures | #265 |
| tightly linked | #265 |
| nox concentrations | #266 |
| increase asthma | #266 |
| settled dust | #267 |
| age 13 years | #267 |
| early work | #267 |
| pollen sensitization | #268 |
| prick | #269 |
| fever children | #269 |
| rhinitis | #269 |
| allergen extracts | #270 |
| symptom prevalence | #270 |
| hypersensitivity immune | #270 |
| conditions asthma | #271 |
| relation body mass | #272 |
| child chromosomes | #272 |
| dipeptidyl peptidases | #273 |
| study centres | #273 |
| objective markers | #274 |
| asthma control patients | #274 |
| inflammatory properties | #275 |
| exposure female | #276 |
| host microbiome | #276 |
| dust samples | #277 |
| extracellular polysaccharides | #277 |
| future asthma | #277 |
| male microbiota | #277 |
| increased exposure | #278 |
| study birth | #279 |
| remedy | #280 |
| tests allergens | #280 |
| hire | #280 |
| questionnaires adolescent | #281 |
| 6 years | #282 |
| adolescent animals | #282 |
| child dermatitis | #282 |
| allergies asthma | #282 |
| collection methods | #284 |
| randomeffects | #284 |
| impulse oscillometry | #284 |
| 17 children | #285 |
| population burden | #285 |
| allergic symptoms | #286 |
| differences asthma | #287 |
| tests respiratory | #287 |
| cells ilc2s | #287 |
| geometric ratio | #288 |
| gg 95 | #288 |
| epidemiological surveys | #289 |
| hdms | #289 |
| pollution air | #289 |
| role asthma | #290 |
| risk factors children | #290 |
| data normalization | #290 |
| asthma increased | #291 |
| allergic manifestations | #291 |
| eczema food | #292 |
| asthma factors | #292 |
| answered | #293 |
| indoor exposure | #293 |
| recruitment domain | #293 |
| allergic perennial | #293 |
| environnement | #293 |
| exposure environmental | #293 |
| cohort participants | #293 |
| longitudinal cohort study | #293 |
| asthma data | #294 |
| cbmc | #294 |
| mucosal surfaces | #296 |
| pollution respiratory | #297 |
| smoke pollution | #297 |
| bifidobacterium | #298 |
| global synthesis | #298 |
| exposure benzene | #299 |
| exposure allergic | #299 |
| paxgene | #299 |
| obesity asthma | #299 |
| nonatopic | #299 |
| unification | #299 |
| infancy development | #300 |
| risk allergy | #303 |
| asthma drugs | #306 |
| lumbricoides | #307 |
| reported association | #307 |
| analysis phase | #307 |
| antigens dermatophagoides | #308 |
| severe exacerbations | #308 |
| 2623 | #309 |
| messenger tlymphocytes | #309 |
| neonatal immune | #309 |
| mucosal microbiota | #309 |
| ige sensitization | #309 |
| exposure childhood | #309 |
| factors early | #311 |
| controlled asthma | #311 |
| atopic march | #312 |
| birth cohort studies | #312 |
| midexpiratory | #312 |
| asthma inflammatory | #313 |
| allergy age | #313 |
| signal transducer activator | #314 |
| skin examination | #314 |
| jusqu | #315 |
| variance animals antigens | #315 |
| bacillus spores | #315 |
| genotyping data | #315 |
| independent study | #316 |
| 2 toll | #316 |
| older siblings | #317 |
| pregnancy expression | #318 |
| adjustment covariates | #318 |
| child comorbidity | #318 |
| compared children | #319 |
| bmi united states | #320 |
| fpr2 | #320 |
| il5 il13 | #320 |
| chronic airway inflammation | #321 |
| mfi20 | #321 |
| moisturizer | #323 |
| children birth | #324 |
| ige responses | #325 |
| maximal expiratory | #325 |
| airway hyperresponsiveness ahr | #326 |
| stratified sample | #326 |
| 2 yrs | #326 |
| ichthyosis vulgaris | #327 |
| flg mutations | #327 |
| selfadministered questionnaire | #328 |
| recurrent wheeze | #328 |
| active smoking | #328 |
| bedrooms | #328 |
| extracellular dna | #329 |
| male milk | #330 |
| glycolylneuraminic | #330 |
| pollutant levels | #331 |
| demethylation | #331 |
| dermatophagoides asthma | #331 |
| reference equations | #331 |
| floor dust | #331 |
| accuracy analysis | #331 |
| streptococcaceae | #333 |
| asthma biomarkers | #333 |
| onset asthma | #333 |
| reduced lung function | #334 |
| development sensitization | #334 |
| upper respiratory | #334 |
| children controls | #335 |
| asthma china | #336 |
| boluses | #336 |
| prevalence surveys | #337 |
| 1st year | #337 |
| predictive risk factors | #337 |
| risk current | #337 |
| childhood atopic | #338 |
| 3113 | #338 |
| respiratory outcomes | #339 |
| risk eczema | #339 |
| asthma parents | #340 |
| medical advice | #340 |
| humans prevalence | #341 |
| exposure development | #341 |
| adultonset asthma | #341 |
| filaggrin gene | #342 |
| kitchen | #342 |
| persistent wheeze | #342 |
| nonatopic asthma | #343 |
| age introduction | #343 |
| age 9 | #344 |
| breast fed | #345 |
| hypersensitivity | #346 |
| stat6 transcription | #346 |
| 90th | #348 |
| childhood onset | #349 |
| prevalence | #350 |
| increasing prevalence | #350 |
| rates asthma | #350 |
| exposed children | #350 |
| factors surveys | #351 |
| th1 th2 cells | #353 |
| activator transcription | #354 |
| repeated episodes | #356 |
| freeways | #358 |
| purposepatients | #359 |
| genetic interaction | #359 |
| kazal | #360 |
| subsequent asthma | #360 |
| regression approach | #360 |
| children cohort | #361 |
| strength association | #361 |
| asthma disease | #361 |
| eurotium | #361 |
| cord blood | #363 |
| age 3 | #363 |
| expression asthma | #363 |
| allergic outcomes | #364 |
| food sensitization | #364 |
| farming practices | #364 |
| austria germany | #365 |
| annual concentrations | #365 |
| chronic inflammatory disorders | #366 |
| children reported | #366 |
| lactadherin | #368 |
| atopic status | #369 |
| adolescent air | #370 |
| single snp | #370 |
| earlylife exposure | #370 |
| expression tlr2 | #370 |
| austria switzerland | #371 |
| testing procedures | #371 |
| 1159 | #371 |
| conclusionwe | #371 |
| time activity | #373 |
| east west | #373 |
| obesity prevalence | #373 |
| paragraphs | #374 |
| 22 countries | #374 |
| asthmatic symptoms | #374 |
| performance accuracy | #374 |
| asthma current | #374 |
| smoking asthma | #375 |
| foxp3 tregs | #375 |
| asthma cases | #376 |
| upper respiratory tract | #376 |
| cows milk | #377 |
| associations exposure | #377 |
| positional cloning | #377 |
| statistical approaches | #377 |
| mite allergens | #379 |
| parental reports | #379 |
| population studies | #379 |
| dietary strategies | #381 |
| pieces | #382 |
| inverse association | #383 |
| preschool cohort studies | #384 |
| measles vaccination | #384 |
| unifying | #384 |
| normal lung function | #385 |
| bronchial | #386 |
| impaired lung function | #386 |
| chronic asthma | #386 |
| latex | #386 |
| alliance | #388 |
| gene environment | #389 |
| allergie | #390 |
| haplotype analyses | #391 |
| critical window | #391 |
| potential association | #391 |
| immunological analysis | #391 |
| 11 year | #392 |
| cde | #393 |
| 14 year | #394 |
| risk sensitization | #394 |
| mmp9 gene | #394 |
| early feeding | #394 |
| polymorphism gene | #395 |
| linear regressions | #395 |
| increased risk asthma | #395 |
| immunological mechanisms | #396 |
| th2 th1 | #398 |
| respiratory health | #399 |
| salmeterol xinafoate | #399 |
| study polymorphisms | #399 |
| receptor cx3cr1 | #400 |
| antiviral responses | #401 |
| regions countries | #402 |
| 2033 | #402 |
| receptor polymorphisms | #402 |
| analysis asthma | #403 |
| exposure animals | #403 |
| length time | #403 |
| plea | #404 |
| timothy grass | #405 |
| allergens | #405 |
| study agreement | #405 |
| production ifngamma | #406 |
| allergen exposure | #406 |
| cells asthma | #406 |
| childhood allergic | #407 |
| mugwort | #407 |
| 071 | #407 |
| geneenvironment interaction | #409 |
| data cohort | #409 |
| mold exposure | #410 |
| common occurrence | #411 |
| living room | #411 |
| endotoxin exposure | #411 |
| gene variations | #413 |
| blood rna | #413 |
| blood cb | #413 |
| ige synthesis | #414 |
| germany | #415 |
| facemasks | #416 |
| mite allergen | #416 |
| childhood exposure | #416 |
| house dust | #417 |
| bronchial hyperresponsiveness | #418 |
| illness asthma | #418 |
| 7 years | #418 |
| extended haplotypes | #419 |
| population sample | #420 |
| alimentary | #420 |
| age 2 years | #420 |
| halfwidth | #421 |
| prenatal factors | #421 |
| confers protection | #424 |
| tnc | #424 |
| cytokine secretion | #426 |
| asthma eczema | #427 |
| parasitic infections | #427 |
| asthma treatment | #428 |
| duration breastfeeding | #429 |
| childhood eczema | #429 |
| tlr1 | #430 |
| childrens hospitals | #430 |
| allergic conditions | #431 |
| clinical examinations | #432 |
| 441 | #433 |
| risk overweight | #433 |
| respiratory allergic | #434 |
| specific sensitization | #434 |
| age odds ratio | #438 |
| tobit | #438 |
| decrements | #438 |
| allergy diagnosis | #438 |
| conundrum | #440 |
| annual prevalence | #441 |
| asthma gene | #441 |
| population asthma | #442 |
| fecal microbiota | #443 |
| inception | #443 |
| male odds | #443 |
| chronic inflammatory diseases | #443 |
| persisting | #444 |
| asthma effects | #444 |
| cell phenotypes | #444 |
| increase bmi | #445 |
| observed differences | #445 |
| asthma respiratory | #446 |
| specific serum | #446 |
| exposure respiratory | #448 |
| allergic rhinoconjunctivitis | #449 |
| ethnic origin | #449 |
| allergy food | #450 |
| 033 | #450 |
| adult asthmatics | #451 |
| associations asthma | #452 |
| n149 | #452 |
| including asthma | #455 |
| school entry | #456 |
| dermatophagoides farinae | #457 |
| pregnancy increased risk | #457 |
| germany health | #458 |
| allergic risk | #460 |
| provocation tests | #460 |
| mice role | #460 |
| external environment | #460 |
| airway hyper | #462 |
| westernized | #463 |
| asthma higher | #464 |
| rural health | #464 |
| asthma control test | #465 |
| environmental factors | #466 |
| postal questionnaire | #467 |
| opposite effects | #467 |
| cells innate | #467 |
| alex | #468 |
| immunocap | #468 |
| severity asthma | #468 |
| so2 concentrations | #469 |
| clinical asthma | #470 |
| nod1 signaling | #470 |
| early identification | #470 |
| asthma rhinitis | #471 |
| emphasised | #471 |
| exposure | #471 |
| microbial counts | #471 |
| birth cohorts | #473 |
| antibiotics children | #473 |
| fodder | #473 |
| 1133 | #474 |
| yrs | #474 |
| cross sectional survey | #476 |
| champ | #476 |
| exposure antibiotics | #477 |
| early exposure | #481 |
| risk severity | #482 |
| childhood environment | #483 |
| total immunoglobulin | #484 |
| asthma association | #484 |
| subphenotypes | #485 |
| immunity genes | #486 |
| children | #486 |
| atopic disorders | #486 |
| phenotypes | #487 |
| prospective birth cohort | #487 |
| exposure data | #489 |
| potential confounding | #489 |
| genes environment | #490 |
| studies rhinitis | #490 |
| multicenter cohort | #491 |
| snp association | #494 |
| polymorphisms association | #495 |
| uncontrolled asthma | #495 |
| lifestyles | #496 |
| age 10 | #496 |
| housing animal | #497 |
| southern germany | #497 |
| children jia | #497 |
| phenotype polymorphism | #498 |
| asthma severe | #498 |
| individual level | #498 |
| respiratory hypersensitivity | #500 |
| omega6 fatty acids | #500 |
| birth age | #501 |
| asthma susceptibility | #503 |
| lung function children | #503 |
| sensitizations | #504 |
| white children | #505 |
| diet diversity | #505 |
| tests specific | #505 |
| methods studies | #505 |
| ranks | #508 |
| allergy children | #508 |
| childhood respiratory | #509 |
| prevalence rates | #509 |
| rna samples | #509 |
| housing humans | #510 |
| perennial | #511 |
| stimulation lps | #511 |
| il15 | #513 |
| age 10 years | #514 |
| europe female | #514 |
| children exposed | #515 |
| asthma prevalence | #515 |
| infections asthma | #516 |
| cities china | #516 |
| levels children | #516 |
| receptor tlr | #516 |
| asthma bronchiolitis | #516 |
| cd4cd25high | #517 |
| dpps | #518 |
| th2 immune | #519 |
| atopic conditions | #519 |
| haplotype association | #520 |
| neutrophils eosinophils | #522 |
| eczema asthma | #522 |
| p0041 | #523 |
| age 1 year | #523 |
| polymorphisms snps | #523 |
| risk factors asthma | #523 |
| children maternal | #523 |
| time window | #524 |
| rural areas | #524 |
| adolescence age | #525 |
| maternal vitamin | #525 |
| trans fatty acids | #526 |
| baseline participants | #528 |
| bmi increased risk | #528 |
| obesity body mass | #528 |
| allergens animals | #529 |
| blood humans | #529 |
| c‐reactive protein | #529 |
| 117 95 | #529 |
| persistent asthma | #530 |
| edifice | #530 |
| obesity smoking | #531 |
| environmental bacteria | #531 |
| protect | #532 |
| samples children | #532 |
| oral tolerance | #533 |
| allergic airway inflammation | #534 |
| children methods | #535 |
| immune stimulation | #536 |
| topic rhinitis | #537 |
| il4r | #538 |
| blood eosinophil counts | #539 |
| industrialised | #540 |
| adolescence early adulthood | #541 |
| human microbiota | #541 |
| airway symptoms | #542 |
| immunological markers | #543 |
| rubella virus | #543 |
| lipopolysaccharide receptors | #543 |
| pregnancy asthma | #543 |
| cypress | #544 |
| pathomechanisms | #545 |
| regulatory cell | #546 |
| antitrypsin alpha | #547 |
| 17q12 | #547 |
| greenness | #548 |
| floorcoverings | #549 |
| oligoarticular | #549 |
| hypersensitivity humans | #550 |
| isotype switching | #553 |
| epidemic proportions | #553 |
| association children | #553 |
| lung microbiome | #554 |
| multidisciplinary study | #554 |
| children parental | #555 |
| mental health patients | #555 |
| asthma status | #556 |
| overweight prevalence | #556 |
| aqlq | #558 |
| allergic rhinitis asthma | #558 |
| 1129 | #559 |
| letzten | #560 |
| blood eosinophils | #560 |
| activity body | #561 |
| reduced exposure | #564 |
| 2 immunity | #566 |
| inhaled steroids | #566 |
| hormonal contraceptives | #566 |
| 077 | #567 |
| immune regulatory | #569 |
| exposure matrix | #570 |
| tripeptidyl | #570 |
| initial observations | #570 |
| asthma symptom | #571 |
| health urban | #571 |
| levels total | #575 |
| affluence | #575 |
| hcs patients | #575 |
| diseases prevalence | #575 |
| creactive protein levels | #579 |
| atopic asthma | #579 |
| followups | #580 |
| oro | #580 |
| age controls | #581 |
| association obesity | #581 |
| asthma population | #582 |
| fdr | #582 |
| flanking regions | #582 |
| uht | #584 |
| asthma severity | #584 |
| tlr6 | #584 |
| function asthma | #585 |
| bacterial microbiome | #588 |
| gsdmb | #589 |
| n63 | #590 |
| longum | #590 |
| skin test | #591 |
| 1 antitrypsin | #592 |
| holiday | #593 |
| endotoxin concentrations | #593 |
| il1rl1 | #596 |
| factors respiratory | #596 |
| gasdermin | #596 |
| model asthma | #597 |
| zeigen | #598 |
| pathogenesis asthma | #598 |
| total specific | #598 |
| advising | #598 |
| genetic environmental | #600 |
| galactosylation | #600 |
| active immunity | #601 |
| factors humans | #602 |
| 048 | #603 |
| pregnancy maternal | #603 |
| hladqa1 | #604 |
| statistical analyses | #604 |
| humans human | #604 |
| microbes | #606 |
| sensitization | #606 |
| agents asthma | #606 |
| microbiome studies | #607 |
| ige production | #608 |
| allergic rhinitis | #610 |
| 2 inflammation | #610 |
| infant feeding practices | #611 |
| regulatory molecules | #612 |
| 11–13 | #612 |
| work life | #612 |
| bolus | #612 |
| pollen allergens | #616 |
| chronic stress | #619 |
| albania | #619 |
| aged allergens | #619 |
| urban populations | #620 |
| body plethysmography | #621 |
| arthropod proteins | #621 |
| life age | #621 |
| deep phenotyping | #622 |
| unstimulated | #623 |
| radioallergosorbent | #623 |
| functional features | #625 |
| 779 | #627 |
| endotoxin | #627 |
| data prevalence | #627 |
| protective properties | #629 |
| crosssectional | #629 |
| smoking surveys | #632 |
| school children | #632 |
| models asthma | #633 |
| exacerbating | #635 |
| feeding patterns | #635 |
| settled | #635 |
| child asthma | #636 |
| children atopic dermatitis | #637 |
| standardized questionnaire | #637 |
| lifetime prevalence | #638 |
| igg glycosylation | #639 |
| european children | #639 |
| factors urban | #639 |
| clustering approach | #641 |
| grass pollen | #642 |
| innate immunity | #642 |
| humans microbiota | #643 |
| years increased | #645 |
| symptoms | #646 |
| innate lung | #647 |
| pollen concentrations | #648 |
| participation rates | #650 |
| life children | #650 |
| pets | #650 |
| kindern | #650 |
| health rural | #650 |
| glucocorticoid induced | #652 |
| helsinki | #653 |
| dermatitis allergic | #654 |
| comprehensive analysis | #654 |
| prospective studies association | #656 |
| 16 countries | #658 |
| common chronic | #659 |
| latent classes | #662 |
| age 1 | #662 |
| conclusion data | #663 |
| cd14 expression | #664 |
| di2ethylhexyl | #665 |
| abpa | #665 |
| hygiene | #665 |
| pvalues | #666 |
| hypertonic saline | #667 |
| chemokine cx3cl1 | #668 |
| adult lung | #669 |
| standardized questionnaires | #670 |
| birth cohort | #671 |
| susceptibility locus | #672 |
| central european | #672 |
| cellules | #673 |
| études | #674 |
| jobs | #676 |
| ilc2s | #677 |
| age 45 years | #679 |
| common infections | #680 |
| random sample | #681 |
| dairy farm | #681 |
| female forced | #681 |
| protective | #681 |
| egg allergy | #682 |
| cohorte | #683 |
| dietary habits | #685 |
| recurrent wheezing | #685 |
| childhood experiences | #686 |
| factors air | #688 |
| european community | #692 |
| major gene | #693 |
| doctor | #693 |
| turkish | #694 |
| factors skin | #695 |
| physical examination | #699 |
| rhinitis symptoms | #702 |
| sensitization food | #703 |
| risk obesity | #703 |
| microbial flora | #703 |
| hypersensitivity inflammation | #703 |
| tao | #707 |
| 459 | #708 |
| dramatic increase | #708 |
| microbial interactions | #708 |
| perpetuation | #709 |
| immune activation | #709 |
| immunologic tlymphocytes | #712 |
| population surveys | #712 |
| children time | #713 |
| pregnancy children | #718 |
| bacterial spores | #720 |
| mediated diseases | #721 |
| allergy asthma | #722 |
| ratio aor | #724 |
| sensitized patients | #727 |
| function children | #727 |
| 95 males | #734 |
| alias | #734 |
| il4 il13 | #738 |
| population adolescent | #741 |
| linkage chromosome | #741 |
| nonasthmatic | #742 |
| fractional exhaled | #742 |
| farms | #743 |
| treg cell | #745 |
| type 5 | #748 |
| traffic air | #748 |
| ifih1 | #749 |
| children low | #753 |
| earlier study | #754 |
| total lung | #755 |
| h20 | #758 |
| environment interactions | #758 |
| aeroallergens | #759 |
| moderate levels | #764 |
| indoor dust | #766 |
| edn1 | #768 |
| air trapping | #768 |
| hscrp levels | #769 |
| pulmonary function tests | #769 |
| allergists | #769 |
| hyperresponsiveness | #770 |
| blood leukocytes | #770 |
| pattern recognition receptors | #770 |
| asthma adults | #771 |
| strabismus surgery | #772 |
| term impact | #773 |
| nucleotide receptors | #773 |
| incidence longitudinal | #773 |
| volume humans | #777 |
| rhinitis children | #781 |
| new associations | #784 |
| studies asthma | #784 |
| factors incidence | #785 |
| children allergic | #785 |
| factors tobacco | #788 |
| nonallergic | #788 |
| shortness breath | #789 |
| asthma therapy | #791 |
| gis | #793 |
| male metaanalysis | #793 |
| children health | #794 |
| βdiversity | #795 |
| airway hyperresponsiveness | #795 |
| distinct trajectories | #796 |
| natural habitat | #796 |
| pc20 | #798 |
| personalization | #798 |
| card15 | #799 |
| protective effects | #799 |
| 45 years | #800 |
| pair 1 chromosomes | #801 |
| confer | #802 |
| allergen | #805 |
| age 4 years | #806 |
| infant food | #807 |
| dairy farms | #808 |
| exposure age | #810 |
| bifidobacterium longum | #810 |
| tenascin | #810 |
| pteronyssinus | #811 |
| subclinical inflammation | #811 |
| peak flow | #813 |
| bacillus licheniformis | #813 |
| boiled | #814 |
| initial data | #814 |
| onset age | #815 |
| foe | #816 |
| foxp3 | #817 |
| brevibacterium | #818 |
| positive skin | #819 |
| 0053 | #820 |
| food infant | #821 |
| skin tests | #822 |
| breastfeeding duration | #822 |
| spt | #827 |
| trier | #830 |
| studies respiratory | #830 |
| prevention strategies | #831 |
| asthma health | #832 |
| rad50 | #833 |
| current analysis | #833 |
| promoter polymorphisms | #834 |
| snps haplotypes | #835 |
| farinae | #835 |
| igg4 | #835 |
| regularly | #835 |
| adolescent age | #837 |
| exhaled breath | #838 |
| cx3cr1 | #838 |
| public health problem | #839 |
| toll receptors | #839 |
| asthma bronchi | #839 |
| parental smoking | #839 |
| subsequent development | #840 |
| cladosporium | #841 |
| chronification | #844 |
| fetal blood | #845 |
| modifies | #845 |
| potted | #849 |
| innate | #849 |
| maternal exposure | #850 |
| bacterial endotoxin | #850 |
| allergen sensitization | #852 |
| inspections | #854 |
| 17q | #855 |
| provocation | #856 |
| infant health | #856 |
| infant infant | #858 |
| repeatedly | #861 |
| age 5 | #861 |
| paracetamol | #862 |
| asthma lung | #864 |
| questionnaires young adult | #864 |
| receptors tlrs | #864 |
| volatile organic | #865 |
| birth cohort study | #866 |
| airway eosinophilia | #866 |
| ige | #866 |
| cumulative incidence | #874 |
| outdoor air pollution | #874 |
| latent class analysis | #875 |
| dermatitis | #878 |
| hmos | #878 |
| microbiome humans | #879 |
| 1940 | #880 |
| 057 | #880 |
| 12q | #884 |
| ifngamma tnfalpha | #886 |
| 856 | #888 |
| brink | #888 |
| oscillometry | #890 |
| european populations | #891 |
| bacterial counts | #892 |
| subsample | #895 |
| exposure study | #895 |
| esl | #896 |
| asthma incidence | #896 |
| impact asthma | #900 |
| immunoglobulin ige | #902 |
| inflammation airway | #902 |
| breastfed | #904 |
| respiration disorders | #905 |
| allergen induced | #907 |
| shortness | #908 |
| adult asthma | #908 |
| children overweight | #910 |
| microbiome composition | #910 |
| microbiota development | #912 |
| complex disease | #917 |
| cow milk | #917 |
| immunity innate | #919 |
| peripheral blood samples | #920 |
| 710 | #920 |
| methods cross | #920 |
| estonia | #923 |
| prospective birth | #927 |
| sounds | #928 |
| sectional population | #928 |
| ilcs | #929 |
| biomérieux | #929 |
| participants baseline | #932 |
| 026 | #939 |
| lactococcus lactis | #939 |
| potential confounders | #940 |
| 13 years | #940 |
| dermatophagoides | #940 |
| floors | #942 |
| life style | #944 |
| microbiome host | #949 |
| 055 | #950 |
| environmental effects | #952 |
| identification genes | #952 |
| 454 pyrosequencing | #953 |
| 1120 | #954 |
| asthma exercise | #954 |
| polymorphisms | #954 |
| solids | #954 |
| genotyped | #954 |
| human life | #955 |
| infections child | #957 |
| fever | #959 |
| children countries | #959 |
| rhinitis asthma | #961 |
| domestic | #961 |
| exposures | #961 |
| nasal secretions | #964 |
| disease asthma | #964 |
| immunoglobulin male | #965 |
| cytokines female | #965 |
| obesity children | #966 |
| innsbruck | #970 |
| readings | #971 |
| fev | #973 |
| immunization immunoglobulin | #973 |
| onset child child | #974 |
| teenagers | #975 |
| gondii infection | #976 |
| orphan receptor | #976 |
| bmi physical activity | #977 |
| nucleotide promoter | #978 |
| respiratory conditions | #979 |
| xinafoate | #981 |
| 682 | #981 |
| receptor gene | #981 |
| yearly | #982 |
| 1333 | #983 |
| small effects | #984 |
| child cohort | #986 |
| adolescents asthma | #987 |
| 12 months age | #990 |
| c3h hej | #991 |
| pasteurization | #991 |
| 068 | #991 |
| function development | #992 |
| asthma humans | #992 |
| hercules | #992 |
| sectional | #994 |
| design methods | #994 |
| immunoglobulin class | #995 |
| diagnosis asthma | #998 |
| respiratory symptoms | #1001 |
| bradykinin receptors | #1003 |
| yoghurt | #1005 |
| rural population | #1006 |
| maternally | #1006 |
| ppg | #1006 |
| linens | #1009 |
| preventive measures | #1010 |
| pt15 | #1012 |
| asthma outcomes | #1014 |
| timeframe | #1016 |
| 039 | #1017 |
| phytohemagglutinin | #1017 |
| association physical activity | #1018 |
| median levels | #1019 |
| strongest associations | #1020 |
| asthma medication | #1021 |
| western countries | #1022 |
| sought | #1024 |
| raw milk | #1027 |
| asthma adult | #1029 |
| outcome variables | #1030 |
| upper airways | #1031 |
| 096 | #1033 |
| genomewide association | #1033 |
| asthmatic children | #1035 |
| veillonella | #1037 |
| cell child | #1038 |
| dairying | #1039 |
| breastmilk | #1039 |
| nod1 | #1042 |
| disease children | #1046 |
| milieu | #1046 |
| missing values | #1047 |
| exposure conditions | #1048 |
| controls age | #1051 |
| severe allergic | #1057 |
| il5 | #1058 |
| infant gut | #1059 |
| hobbies | #1059 |
| metalloprotease | #1060 |
| pregnancy prospective | #1062 |
| class switching | #1064 |
| signaling adaptor | #1065 |
| predictor | #1066 |
| rural | #1066 |
| 8 12 | #1068 |
| skin sensitization | #1068 |
| gnp | #1069 |
| moraxella | #1070 |
| central europe | #1070 |
| margarine | #1070 |
| prevalence prospective | #1071 |
| expression humans | #1072 |
| interrelation | #1075 |
| cross sectional study | #1077 |
| large population | #1077 |
| west east | #1079 |
| box transcription | #1079 |
| trflp | #1080 |
| factors child | #1081 |
| risk development | #1081 |
| life respiratory | #1082 |
| cells tregs | #1083 |
| allergic airway | #1083 |
| study areas | #1083 |
| sufferers | #1086 |
| children prevalence | #1086 |
| maternal asthma | #1089 |
| lca | #1090 |
| gene expression data | #1090 |
| exposure delayed | #1091 |
| longduration | #1094 |
| disintegrin | #1095 |
| proteins polymorphism | #1096 |
| nationality | #1096 |
| 930 | #1097 |
| supplementary data | #1098 |
| overweight bmi | #1101 |
| enfants | #1103 |
| forkhead | #1103 |
| conjunctivitis | #1104 |
| studies evidence | #1104 |
| adolescence adulthood | #1105 |
| cd14 | #1106 |
| 248 | #1116 |
| weight risk | #1116 |
| risk gene | #1117 |
| characteristically | #1117 |
| associations observed | #1118 |
| meat consumption | #1119 |
| prevalences | #1122 |
| association exposure | #1123 |
| intermediate phenotypes | #1125 |
| newonset | #1126 |
| il12b | #1127 |
| sscp analysis | #1127 |
| lung function decline | #1127 |
| based clustering | #1128 |
| endotoxins | #1130 |
| taxonomies | #1130 |
| age birth | #1132 |
| expiratory flow | #1132 |
| 859 | #1134 |
| based birth | #1136 |
| log2 | #1144 |
| pet ownership | #1144 |
| gondii | #1145 |
| allergic asthma | #1145 |
| patients severe asthma | #1146 |
| pediatric asthma | #1146 |
| 837 | #1152 |
| skewness | #1152 |
| humans respiratory | #1153 |
| regions china | #1154 |
| environmental tobacco | #1154 |
| dust mite | #1156 |
| disease cohort | #1156 |
| 862 | #1158 |
| deciphering | #1159 |
| countries prevalence | #1160 |
| epidemiological evidence | #1164 |
| anti ige | #1165 |
| 027 | #1165 |
| rarer | #1168 |
| preschool cohort | #1169 |
| inbred balb receptors | #1172 |
| crowding | #1173 |
| genomewide | #1176 |
| receptors ige | #1178 |
| farmers | #1179 |
| phase behaviour | #1180 |
| croup | #1183 |
| contre | #1184 |
| serum immunoglobulin | #1184 |
| food allergens | #1186 |
| asthma bronchodilator | #1189 |
| new paradigm | #1189 |
| levels measured | #1190 |
| exhaled | #1194 |
| respiratory tract | #1196 |
| censored | #1197 |
| children association | #1200 |
| management children | #1206 |
| rorc | #1207 |
| bacterial taxa | #1208 |
| sedentary lifestyle | #1211 |
| fungi humans | #1211 |
| risk childhood | #1214 |
| flg | #1215 |
| regulatory cells tregs | #1216 |
| risk children | #1218 |
| food hypersensitivity | #1218 |
| orphan | #1219 |
| bradykinin | #1220 |
| eosinophilic inflammation | #1221 |
| day life | #1223 |
| factor activity | #1225 |
| 047 | #1229 |
| male pregnancy | #1233 |
| balb ovalbumin | #1234 |
| gene variants | #1236 |
| age menarche | #1236 |
| th1 th2 | #1236 |
| adult allergens | #1240 |
| european population | #1241 |
| small children | #1243 |
| antitrypsin | #1243 |
| ulm | #1247 |
| protective factors | #1250 |
| objective aim | #1251 |
| early years | #1252 |
| pertussis | #1252 |
| airway hyperreactivity | #1253 |
| peripheral blood leukocytes | #1253 |
| food items | #1253 |
| questionnaires | #1256 |
| shop | #1256 |
| debated | #1257 |
| lung function | #1260 |
| telephone interviews | #1260 |
| mite | #1262 |
| studies gene | #1263 |
| disease case | #1264 |
| yogurt | #1267 |
| temperature humidity | #1268 |
| overweight children | #1274 |
| occupational exposures | #1277 |
| fev1 forced | #1281 |
| pollution indoor | #1281 |
| children exposure | #1282 |
| infections risk | #1284 |
| shannon | #1284 |
| diseases occupational | #1289 |
| immunomodulating | #1289 |
| pollution exposure | #1292 |
| potential risk factors | #1293 |
| 182 | #1295 |
| body sites | #1296 |
| tests risk | #1299 |
| age baseline | #1301 |
| gme | #1302 |
| topic polymorphism | #1303 |
| explain | #1303 |
| venipuncture | #1306 |
| endotypes | #1309 |
| factor development | #1312 |
| lymphocytes regulatory | #1312 |
| th1 cytokines | #1314 |
| industrially | #1314 |
| 038 | #1318 |
| sought determine | #1320 |
| harmonization | #1322 |
| cell numbers | #1322 |
| epidemiological survey | #1322 |
| objective investigate | #1327 |
| cleaning | #1329 |
| neuraminic | #1329 |
| lrti | #1330 |
| concerted | #1330 |
| zusammenfassung | #1331 |
| prevalence rural | #1331 |
| respiratory allergy | #1332 |
| gambia | #1332 |
| sponsorship | #1335 |
| induced sputum | #1335 |
| loft | #1337 |
| passive smoking | #1340 |
| 897 | #1342 |
| mass breast | #1343 |
| multiple testing | #1346 |
| puberty | #1347 |
| airway function | #1349 |
| th2 cells | #1351 |
| oxide feno | #1353 |
| expired | #1353 |
| irf1 | #1353 |
| atopic humans | #1354 |
| toxoplasma gondii | #1355 |
| 267 | #1357 |
| 16 18 | #1358 |
| reduction risk | #1358 |
| science foundation | #1359 |
| asthmatics | #1359 |
| 2 innate | #1360 |
| lung microbiota | #1363 |
| france germany | #1366 |
| 279 | #1366 |
| maternal immune | #1367 |
| asthma female | #1369 |
| innate lymphoid | #1374 |
| whey proteins | #1378 |
| preventive strategies | #1381 |
| austria | #1382 |
| common forms | #1383 |
| total ige | #1383 |
| lactococcus | #1386 |
| studies lung | #1387 |
| management asthma | #1388 |
| disagreement | #1389 |
| environmental | #1389 |
| childhood adult | #1390 |
| early intervention | #1395 |
| milk proteins | #1403 |
| severe atopic | #1404 |
| q21 | #1404 |
| risk developing | #1404 |
| fef25 | #1406 |
| airway inflammation | #1407 |
| air samples | #1410 |
| indoor | #1412 |
| dust exposure | #1415 |
| baseline followup | #1417 |
| sige | #1417 |
| bronchodilators | #1418 |
| immune mechanisms | #1418 |
| microbial | #1419 |
| il13 | #1421 |
| hapmap | #1421 |
| longitudinal cohort | #1422 |
| bronchitis | #1422 |
| male multivariate | #1427 |
| pair 17 | #1429 |
| pulmonary eosinophilia | #1429 |
| timepoint | #1433 |
| asthmatic | #1433 |
| chronic inflammatory | #1435 |
| exhaled nitric | #1440 |
| irak4 | #1442 |
| induced airway | #1443 |
| inflammatory pathways | #1444 |
| centres | #1444 |
| overweight | #1445 |
| studies europe | #1445 |
| age 5 years | #1446 |
| bronchodilator response | #1448 |
| airway responses | #1451 |
| factors prevalence | #1454 |
| asthma clinical | #1460 |
| agricultural workers | #1460 |
| infancy | #1461 |
| unique opportunity | #1461 |
| immunizations | #1463 |
| 706 | #1464 |
| barcelona | #1464 |
| a20 | #1466 |
| hand eczema | #1468 |
| association polymorphism | #1468 |
| surveys questionnaires | #1470 |
| recognition receptors | #1470 |
| asthma compared | #1472 |
| immunity | #1473 |
| operating characteristics | #1474 |
| leur | #1474 |
| adolescence | #1475 |
| nod2 signaling | #1476 |
| 362 | #1477 |
| 1 levels | #1478 |
| innate immune responses | #1478 |
| meeting | #1479 |
| dgge | #1480 |
| otitis | #1482 |
| paediatricians | #1490 |
| immunologic mechanisms | #1493 |
| strongest predictor | #1494 |
| peptidases | #1494 |
| populationbased cohort | #1504 |
| ionomycin | #1505 |
| flexural | #1505 |
| tlr2 | #1506 |
| birch pollen | #1507 |
| structured interviews | #1508 |
| tlr2 tlr4 | #1509 |
| igg1 | #1511 |
| understood | #1512 |
| sulphur dioxide | #1514 |
| bacterial composition | #1514 |
| ergosterol | #1515 |
| moderate asthma | #1517 |
| epidemiological data | #1517 |
| living environment | #1517 |
| pasteurized | #1518 |
| latent class | #1520 |
| child welfare | #1521 |
| rôle | #1524 |
| pollution levels | #1524 |
| 153 | #1527 |
| hladq | #1527 |
| respiratory tract infections | #1530 |
| differences prevalence | #1533 |
| jia | #1536 |
| underlying mechanisms | #1536 |
| dust | #1542 |
| 245 | #1551 |
| factors development | #1552 |
| wisconsin | #1555 |
| birthday | #1558 |
| previous 12 months | #1558 |
| children aged | #1564 |
| children increased | #1566 |
| antibiotic exposure | #1567 |
| austrian | #1573 |
| born children | #1578 |
| china female humans | #1579 |
| children risk | #1584 |
| licheniformis | #1584 |
| current studies | #1588 |
| treatment asthma | #1595 |
| trans fatty | #1596 |
| explained | #1596 |
| breastfed infants | #1598 |
| study populations | #1599 |
| tract diseases | #1602 |
| development progression | #1603 |
| 775 | #1603 |
| air microbiology | #1604 |
| regulatory | #1605 |
| disease process | #1607 |
| ascariasis | #1610 |
| male prospective | #1611 |
| erythrocyte membranes | #1612 |
| neuropeptide | #1612 |
| cells1 | #1613 |
| peak expiratory | #1613 |
| familial aggregation | #1617 |
| candidate gene | #1622 |
| ige antibodies | #1624 |
| cells th2 | #1624 |
| early gene | #1626 |
| short communication | #1627 |
| precision medicine | #1627 |
| tolerogenic | #1628 |
| questionnaires young | #1632 |
| studies recurrence | #1634 |
| tcell responses | #1635 |
| newborn infants | #1641 |
| gata3 | #1641 |
| th2 cytokines | #1644 |
| th2 | #1645 |
| nutritional factors | #1647 |
| topic surveys | #1653 |
| style male | #1653 |
| population based study | #1653 |
| card | #1655 |
| microbial diversity | #1656 |
| traffic volume | #1656 |
| 034 | #1656 |
| smoke exposure | #1657 |
| cells transcription | #1661 |
| northern europe | #1661 |
| expiratory volume | #1664 |
| respiratory | #1666 |
| opportunity | #1667 |
| linear discriminant analysis | #1671 |
| followup study | #1677 |
| asthmatic agents | #1678 |
| cheese | #1688 |
| epidemiologic evidence | #1688 |
| employment | #1692 |
| microbiome | #1693 |
| innate immune | #1694 |
| obesity risk | #1694 |
| early introduction | #1694 |
| gitr | #1696 |
| health‐related quality | #1697 |
| aux | #1701 |
| th2 th17 | #1702 |
| gene interaction | #1704 |
| phenotyping | #1704 |
| adulthood | #1706 |
| 476 | #1710 |
| fungal diversity | #1712 |
| provocative | #1716 |
| singlenucleotide polymorphisms | #1717 |
| house dust mite | #1718 |
| mere | #1718 |
| 029 | #1723 |
| life hrqol | #1730 |
| airflow obstruction | #1732 |
| gabon | #1733 |
| asthma control | #1733 |
| genotyping | #1734 |
| anti asthmatic | #1735 |
| innate adaptive | #1739 |
| factors breast | #1742 |
| cytokine genes | #1746 |
| factors children | #1746 |
| 5 7 | #1748 |
| inverse relationship | #1749 |
| helminth parasites | #1749 |
| preschool clinical trials | #1751 |
| inconsistencies | #1753 |
| molds | #1754 |
| masks | #1756 |
| male polymorphism | #1756 |
| gstm1 gstt1 | #1760 |
| fivefold | #1760 |
| chronic airway | #1761 |
| refugees | #1761 |
| bacterial diversity | #1764 |
| susceptibility gene | #1767 |
| street | #1768 |
| environmental tobacco smoke | #1769 |
| association body mass | #1772 |
| cells airway | #1778 |
| soot | #1778 |
| helminth infections | #1779 |
| occupational exposure | #1782 |
| cd4cd25 | #1782 |
| peptidoglycan | #1782 |
| allergic reaction | #1788 |
| exposure assessment | #1789 |
| nucleotide polymorphisms | #1799 |
| generations | #1800 |
| 054 | #1801 |
| key feature | #1801 |
| helminths | #1801 |
| rubella | #1807 |
| life factors | #1809 |
| single nucleotide receptors | #1812 |
| treg cells | #1812 |
| feno | #1817 |
| censoring | #1821 |
| protein 3 | #1821 |
| factors health | #1822 |
| dna fingerprinting | #1823 |
| breastfeeding | #1825 |
| signal transducer | #1828 |
| asthma morbidity | #1828 |
| respiratory illnesses | #1831 |
| 112 | #1831 |
| leisure time | #1834 |
| generational | #1837 |
| vocational | #1838 |
| foxp3 expression | #1841 |
| regulatory cells | #1843 |
| il4 | #1843 |
| heterogeneous disease | #1843 |
| fetal growth | #1845 |
| otus | #1845 |
| forkhead transcription | #1849 |
| sampling methods | #1854 |
| causally | #1855 |
| idiopathic arthritis | #1857 |
| 95 risk factors | #1859 |
| disease incidence | #1878 |
| hypertonic | #1879 |
| friend | #1884 |
| diseases lung | #1886 |
| unraveling | #1886 |
| interleukin33 | #1891 |
| predispose | #1892 |
| age 4 | #1893 |
| aor | #1894 |
| age 2 | #1895 |
| life | #1898 |
| microbe | #1899 |
| lung male | #1900 |
| interleukin5 | #1901 |
| population level | #1901 |
| hrqol | #1903 |
| occupational stress | #1904 |
| jedoch | #1908 |
| brought | #1909 |
| vital capacity | #1909 |
| predictive models | #1914 |
| feeding practices | #1917 |
| coeliac disease | #1918 |
| confounded | #1924 |
| weight breast | #1929 |
| basics | #1932 |
| experimental models | #1932 |
| p0012 | #1933 |
| helminthiasis | #1934 |
| pregnancy prevalence | #1936 |
| child humans | #1938 |
| barrier function | #1941 |
| european commission | #1944 |
| aetiology | #1945 |
| juvenile idiopathic | #1946 |
| percentiles | #1946 |
| cell markers | #1949 |
| galactans | #1951 |
| moisture | #1959 |
| raised | #1959 |
| asthmatic subjects | #1960 |
| blood eosinophil | #1960 |
| invading | #1960 |
| immune mediated | #1960 |
| child female | #1966 |
| lps stimulation | #1966 |
| regulatory region | #1973 |
| 658 | #1975 |
| phenomena infant | #1977 |
| dwellings | #1985 |
| children severe | #1991 |
| dollar | #1994 |
| natural environments | #1997 |
| helper type | #1998 |
| studie | #1999 |
| agriculture | #2000 |
| descriptions | #2000 |
| 041 | #2004 |
| respiratory viral | #2010 |
| infectious agents | #2011 |
| richness | #2012 |
| physical activity pa | #2014 |
| lower frequencies | #2015 |
| life risk | #2018 |
| postnatal exposure | #2019 |
| regulation genetic | #2020 |
| diary | #2020 |
| children data | #2020 |
| physician diagnosis | #2021 |
| bedding | #2024 |
| underline | #2025 |
| relate | #2026 |
| age | #2027 |
| 939 | #2030 |
| chymase | #2038 |
| bovine milk | #2038 |
| ige mediated | #2040 |
| outdoor air | #2041 |
| subsamples | #2046 |
| mass child | #2047 |
| conflicting | #2056 |
| cx3c | #2057 |
| 858 | #2059 |
| schoolage children | #2063 |
| peanuts | #2068 |
| association snps | #2070 |
| standardize | #2072 |
| asthma diagnosis | #2073 |
| bronchial epithelial cells | #2075 |
| early childhood | #2075 |
| polarizing | #2076 |
| discrepant | #2080 |
| asthma quality | #2086 |
| women association | #2087 |
| gastrointestinal microbiome | #2095 |
| confounders | #2097 |
| clinical phenotypes | #2098 |
| abstracts | #2098 |
| dusts | #2099 |
| environment interaction | #2100 |
| symptoms age | #2101 |
| male maternal | #2103 |
| 19th century | #2103 |
| disequilibrium | #2104 |
| tregs | #2109 |
| bacterial colonization | #2111 |
| reduced levels | #2111 |
| dairy products | #2114 |
| permutation | #2116 |
| alternata | #2118 |
| prevalence children | #2118 |
| children higher | #2121 |
| 5q | #2125 |
| child preschool | #2128 |
| protection | #2128 |
| glucans | #2132 |
| year | #2133 |
| th2 cell | #2134 |
| common disease | #2139 |
| mild asthma | #2141 |
| dietary interventions | #2142 |
| animals child | #2145 |
| exhalation | #2145 |
| indoors | #2149 |
| sibling | #2153 |
| offspring mothers | #2154 |
| epigenetic regulation | #2155 |
| immune modulation | #2157 |
| schoolchildren | #2157 |
| ionization time | #2158 |
| studies food | #2161 |
| interleukin4 | #2163 |
| blood samples | #2166 |
| food allergy | #2173 |
| blood sampling | #2175 |
| west | #2178 |
| stat6 | #2178 |
| consumption | #2180 |
| spirometry | #2181 |
| forced expiratory | #2184 |
| utero exposure | #2186 |
| industrialized | #2190 |
| children age | #2192 |
| subsequent risk | #2193 |
| respiratory infections | #2196 |
| topic united states | #2207 |
| occupational diseases | #2208 |
| actinomycetales | #2210 |
| acinetobacter | #2212 |
| 146 | #2213 |
| communicable | #2213 |
| lung epithelial cells | #2215 |
| indoor outdoor | #2215 |
| onset disease | #2220 |
| early development | #2220 |
| female finland | #2221 |
| lung mice | #2229 |
| guardians | #2231 |
| preschool | #2232 |
| 079 | #2234 |
| 18 months | #2236 |
| 12th | #2242 |
| diesel exhaust | #2242 |
| childhood overweight | #2245 |
| th17 cell | #2246 |
| spirometric | #2247 |
| bacteria fungi | #2247 |
| immune regulation | #2248 |
| preventive | #2249 |
| whooping | #2249 |
| bacterial load | #2251 |
| functional relevance | #2252 |
| bmi risk | #2257 |
| christianity | #2258 |
| specific immunoglobulin | #2259 |
| 108 | #2259 |
| patients responders | #2267 |
| résultats | #2268 |
| environmental influences | #2271 |
| decanoic | #2274 |
| consistently | #2277 |
| preventative | #2280 |
| commensals | #2282 |
| cla | #2282 |
| 031 | #2286 |
| objective measures | #2287 |
| association childhood | #2292 |
| foxp3 cells | #2293 |
| avenues | #2296 |
| gene interactions | #2299 |
| 11 years | #2301 |
| asthma study | #2312 |
| normal children | #2318 |
| receptor 2 | #2322 |
| box protein | #2325 |
| 0042 | #2326 |
| limulus | #2329 |
| 056 | #2334 |
| studies children | #2336 |
| 064 | #2338 |
| methodsthe | #2338 |
| variation genotype | #2341 |
| ascaris | #2349 |
| omega3 fatty acids | #2352 |
| 922 | #2353 |
| prrs | #2353 |
| spss | #2354 |
| 035 | #2358 |
| treg | #2361 |
| strongest | #2364 |
| adaptive immune response | #2366 |
| regular | #2368 |
| throat | #2371 |
| microbial composition | #2376 |
| viral respiratory | #2377 |
| populationbased cohort study | #2379 |
| diseases respiratory | #2380 |
| expiratory | #2386 |
| immunologically | #2386 |
| breath | #2395 |
| genetic variation | #2396 |
| human immune | #2397 |
| urban environments | #2401 |
| blood institute | #2402 |
| diaries | #2405 |
| bronchodilator agents | #2405 |
| models male | #2413 |
| cord | #2416 |
| adequately | #2417 |
| ripk1 | #2419 |
| 7000 | #2422 |
| finnish | #2423 |
| gstt1 | #2428 |
| pathway genes | #2430 |
| early adulthood | #2435 |
| african ancestry | #2443 |
| partly | #2445 |
| toll receptor | #2457 |
| attributable | #2459 |
| motor vehicles | #2461 |
| questionnaires sweden | #2462 |
| luciferase reporter | #2464 |
| vitamin intake | #2468 |
| disease review | #2468 |
| enhancer elements | #2474 |
| genetic ancestry | #2477 |
| crosssectional survey | #2479 |
| 095 | #2496 |
| peers | #2497 |
| case control study | #2498 |
| questionnaire | #2500 |
| children adolescent | #2508 |
| cytokines humans | #2508 |
| forkhead box | #2509 |
| tolllike receptors | #2512 |
| tolllike receptor | #2525 |
| airway responsiveness | #2525 |
| interleukin13 | #2525 |
| 239 | #2527 |
| style | #2528 |
| common cold | #2528 |
| artemisia | #2530 |
| uncontrolled | #2540 |
| forced expiratory volume | #2541 |
| young adulthood | #2552 |
| inverse | #2553 |
| switzerland | #2553 |
| modify | #2556 |
| european countries | #2564 |
| pregnancy prenatal | #2568 |
| 060 | #2569 |
| siblings | #2572 |
| th2 response | #2576 |
| activator | #2584 |
| suggested | #2584 |
| myristate | #2585 |
| sectional survey | #2586 |
| disease development | #2586 |
| human microbiome | #2588 |
| 030 | #2590 |
| ω3 | #2590 |
| air pollutant | #2602 |
| immunoglobulin levels | #2603 |
| damp | #2605 |
| large sample | #2608 |
| health children | #2616 |
| viral infections | #2623 |
| humans immunoglobulin | #2624 |
| 241 | #2625 |
| mold | #2626 |
| adverse health effects | #2628 |
| polymorphism | #2633 |
| chronic respiratory diseases | #2637 |
| prenatal exposure | #2638 |
| illness surveys | #2638 |
| translate | #2640 |
| molecular patterns | #2641 |
| imputation | #2641 |
| 141 | #2643 |
| cb | #2643 |
| early | #2646 |
| evenness | #2647 |
| life illness | #2651 |
| stockholm | #2652 |
| exhaled nitric oxide | #2657 |
| virus diseases | #2657 |
| groups children | #2665 |
| 739 | #2668 |
| urban rural | #2672 |
| il4 il5 | #2673 |
| confounder | #2678 |
| gene expression levels | #2678 |
| girls boys | #2684 |
| urgently | #2684 |
| categorised | #2687 |
| onwards | #2687 |
| positive association | #2689 |
| 0048 | #2696 |
| 061 | #2699 |
| host factors | #2699 |
| effects prenatal | #2700 |
| 793 | #2703 |
| 063 | #2712 |
| leukocytes mononuclear | #2717 |
| prenatally | #2721 |
| il23r | #2721 |
| respiratory function | #2731 |
| progression disease | #2732 |
| interaction genetic | #2738 |
| worldwide | #2739 |
| risk allele | #2739 |
| reaction polymorphism | #2739 |
| contacted | #2742 |
| 95 children | #2754 |
| preschool chromosomes | #2755 |
| complete data | #2756 |
| female fetal | #2760 |
| modern | #2764 |
| milk | #2766 |
| effects air | #2770 |
| species level | #2770 |
| potential benefits | #2771 |
| rhinovirus | #2775 |
| urban health | #2778 |
| centile | #2786 |
| messenger receptors | #2787 |
| gstm1 | #2787 |
| questionnaire study | #2796 |
| prematurely | #2800 |
| emergency department visits | #2801 |
| 893 | #2802 |
| prospective longitudinal | #2809 |
| functional variants | #2810 |
| personalized treatment | #2812 |
| 812 | #2815 |
| detailed | #2816 |
| package | #2826 |
| stat1 | #2827 |
| standardized | #2829 |
| nocturnal | #2831 |
| toll | #2843 |
| dietary factors | #2848 |
| asthma patients | #2853 |
| alternaria | #2854 |
| infant formula | #2856 |
| children mothers | #2861 |
| antibiotic treatment | #2871 |
| tobacco smoke | #2878 |
| deubiquitinating | #2878 |
| lci | #2886 |
| living | #2887 |
| respondent | #2888 |
| human bronchial | #2894 |
| persistence | #2899 |
| east | #2902 |
| complement receptors | #2906 |
| male parents | #2911 |
| intrapulmonary | #2914 |
| life span | #2915 |
| 3 mm | #2916 |
| epidemiologic methods | #2917 |
| 645 | #2919 |
| 913 | #2923 |
| transitioning | #2925 |
| male gender | #2928 |
| virtually | #2928 |
| il33 | #2940 |
| listeria | #2942 |
| matrix assisted | #2944 |
| antibiotic | #2947 |
| clinical manifestation | #2956 |
| pollen | #2957 |
| visiting | #2958 |
| reduced risk | #2961 |
| written | #2965 |
| notification | #2966 |
| 074 | #2968 |
| asthma management | #2969 |
| birth | #2974 |
| study prevalence | #2975 |
| mould | #2979 |
| 073 | #2982 |
| 8th | #2983 |
| patients asthma | #2985 |
| 804 | #2985 |
| primary prevention | #2989 |
| 2 months | #2990 |
| year age | #2996 |
| critical period | #2996 |
| forced vital | #3004 |
| 293 | #3010 |
| allergic inflammation | #3011 |
| genetic receptor | #3013 |
| tlr5 | #3022 |
| forced | #3024 |
| confounding factors | #3040 |
| methodological issues | #3047 |
| polymorphism single | #3050 |
| fungal dna | #3054 |
| frequency genetic | #3059 |
| 3 years | #3060 |
| epigenetic mechanisms | #3065 |
| doubt | #3065 |
| tlrs | #3068 |
| dna extraction | #3069 |
| findings studies | #3069 |
| snps genes | #3071 |
| vaccinations | #3079 |
| economic development | #3082 |
| preschool children | #3087 |
| adaptive immune responses | #3087 |
| rural area | #3089 |
| rapid increase | #3089 |
| viewpoints | #3090 |
| overweight obesity | #3093 |
| 066 | #3096 |
| genetic variations | #3098 |
| homes | #3099 |
| analysed | #3103 |
| malditof | #3106 |
| invited | #3110 |
| delayed effects | #3119 |
| environment | #3123 |
| 0036 | #3125 |
| europe humans | #3126 |
| inhalation exposure | #3126 |
| menarche | #3129 |
| hdm | #3131 |
| 12 months | #3141 |
| filaggrin | #3142 |
| cow | #3143 |
| preschool dna | #3154 |
| vital | #3157 |
| pha | #3159 |
| baseline follow | #3182 |
| multifaceted | #3184 |
| clarified | #3188 |
| distinct | #3192 |
| bronchodilator | #3194 |
| pleiotropy | #3196 |
| monitoring female | #3197 |
| genetic receptors | #3197 |
| aor 95 | #3198 |
| 037 | #3201 |
| development disease | #3206 |
| disease genotype | #3207 |
| volume 1 | #3208 |
| 069 | #3209 |
| suburban | #3211 |
| bronchial asthma | #3213 |
| surveys | #3214 |
| messages | #3216 |
| university students | #3218 |
| epidemiological | #3227 |
| housekeeping | #3227 |
| catarrhalis | #3235 |
| functional effects | #3245 |
| 050 | #3251 |
| agents child | #3252 |
| beds | #3257 |
| health surveys | #3257 |
| 08 | #3258 |
| 360 | #3259 |
| genetic epigenesis | #3260 |
| missing data | #3261 |
| systemic inflammation | #3261 |
| prospective cohort | #3264 |
| eventually | #3266 |
| enhanced expression | #3270 |
| spores | #3271 |
| automobiles | #3272 |
| 3rd | #3275 |
| nested case | #3280 |
| premature birth | #3283 |
| 4th | #3289 |
| appreciation | #3296 |
| 19th | #3300 |
| european ancestry | #3301 |
| 098 | #3306 |
| lab | #3308 |
| cells toll | #3314 |
| influential | #3317 |
| corynebacterium | #3318 |
| surveys humans | #3318 |
| weight children | #3327 |
| child | #3332 |
| idiotypic | #3338 |
| subtle | #3341 |
| logistic regression models | #3343 |
| th17 cells | #3349 |
| age children | #3352 |
| acid receptor | #3354 |
| noncommunicable diseases | #3354 |
| influencing | #3358 |
| 509 | #3361 |
| 086 | #3367 |
| ifn γ | #3371 |
| 166 | #3372 |
| manifests | #3374 |
| polymorphisms genes | #3377 |
| 566 | #3377 |
| genetic variants | #3379 |
| rooms | #3380 |
| gut microbiome | #3384 |
| genetic background | #3388 |
| differed | #3397 |
| 0004 | #3398 |
| genetic protein structure | #3408 |
| benzene | #3408 |
| turn | #3409 |
| protecting | #3409 |
| alternaria alternata | #3418 |
| tlr | #3421 |
| gg | #3421 |
| occupational asthma | #3423 |
| maternal health | #3433 |
| sociodemographics | #3436 |
| 092 | #3443 |
| air pollution | #3445 |
| factors smoking | #3445 |
| guangzhou | #3448 |
| epithelial barrier | #3461 |
| disease genetic | #3465 |
| trends prevalence | #3467 |
| 049 | #3468 |
| airflow limitation | #3468 |
| cytokine responses | #3469 |
| omega6 | #3470 |
| th2 cytokine | #3470 |
| rye | #3480 |
| humans linkage | #3484 |
| 089 | #3484 |
| 043 | #3484 |
| 18s | #3488 |
| ambient air pollution | #3494 |
| counselling | #3496 |
| skin patients | #3497 |
| aged children | #3500 |
| total population | #3501 |
| postal | #3507 |
| evidences | #3507 |
| raw | #3512 |
| heating | #3515 |
| onset symptoms | #3519 |
| 95th | #3523 |
| 032 | #3525 |
| respiratory mucosa | #3525 |
| analysing | #3529 |
| schoolaged children | #3540 |
| innate immune response | #3541 |
| older children | #3542 |
| microbiota | #3544 |
| 059 | #3548 |
| bronchial epithelial | #3550 |
| seasonal | #3551 |
| parent | #3557 |
| 5p | #3565 |
| molecular biomarkers | #3566 |
| microbiota composition | #3568 |
| 042 | #3570 |
| coevolution | #3578 |
| tract humans | #3594 |
| minor allele | #3596 |
| plausibility | #3603 |
| children parents | #3604 |
| birch | #3605 |
| parents children | #3606 |
| linkage disequilibrium | #3610 |
| cough | #3612 |
| association polymorphisms | #3618 |
| objectively | #3623 |
| genotype humans | #3626 |
| cats | #3627 |
| claimed | #3628 |
| relating | #3629 |
| environment female | #3630 |
| pollution | #3634 |
| risk alleles | #3638 |
| broad spectrum | #3641 |
| hej | #3643 |
| odds | #3644 |
| 0011 | #3652 |
| lung volume | #3654 |
| skewed | #3670 |
| contact | #3674 |
| publication child child | #3677 |
| resides | #3679 |
| complex diseases | #3680 |
| 251 | #3681 |
| 1995 | #3684 |
| genetic control | #3686 |
| disequilibrium male | #3686 |
| toxoplasma | #3686 |
| 046 | #3688 |
| monocytogenes | #3691 |
| host immune | #3691 |
| adult blood | #3691 |
| 655 | #3695 |
| gene frequency | #3697 |
| il17 | #3701 |
| biological agents | #3703 |
| 456 | #3704 |
| gloves | #3704 |
| study gwas | #3705 |
| cette | #3725 |
| mice models | #3726 |
| 577 | #3727 |
| allocate | #3730 |
| genetic gene | #3735 |
| desorption ionization | #3735 |
| hyper | #3748 |
| ovalbumin ova | #3753 |
| glutathione transferase | #3755 |
| 094 | #3755 |
| vehicle emissions | #3759 |
| helperinducer | #3763 |
| adaptive immunity | #3764 |
| coeliac | #3765 |
| regressions | #3766 |
| positive bacteria | #3766 |
| function decline | #3771 |
| 824 | #3786 |
| housing | #3795 |
| gm csf | #3797 |
| time trends | #3798 |
| sympathomimetics | #3802 |
| multicenter studies | #3807 |
| nutrition examination | #3820 |
| weight child | #3825 |
| tcells | #3832 |
| girls | #3834 |
| bethesda | #3837 |
| relation | #3838 |
| health problem | #3838 |
| receptors immunologic | #3843 |
| 076 | #3846 |
| models immunological | #3854 |
| exposure risk | #3861 |
| epistasis | #3865 |
| tremendous | #3867 |
| loci genetic | #3869 |
| immunoglobulin | #3873 |
| utero | #3873 |
| respiratory diseases | #3876 |
| berlin | #3876 |
| maternal smoking | #3881 |
| lymphoid cells | #3891 |
| parental | #3899 |
| positively | #3912 |
| 368 | #3920 |
| 319 | #3920 |
| colonisation | #3922 |
| volatile organic compounds | #3934 |
| confounding | #3940 |
| arthropod | #3942 |
| 051 | #3943 |
| maternal serum | #3946 |
| airway resistance | #3947 |
| maternal fetal | #3948 |
| denaturing | #3950 |
| human milk | #3950 |
| asthma exacerbations | #3957 |
| progeny | #3957 |
| faced | #3958 |
| genetic predisposition | #3958 |
| exacerbations | #3960 |
| epigenetic modifications | #3970 |
| culturing | #3971 |
| viable | #3982 |
| ecuador | #3991 |
| congresses | #3995 |
| health utilization | #3999 |
| ndvi | #4004 |
| 381 | #4005 |
| r5 | #4019 |
| newborn infant premature | #4023 |
| variation humans | #4026 |
| messenger reverse | #4026 |
| capita | #4029 |
| infant nutritional | #4032 |
| pellucida | #4033 |
| phase 2 | #4035 |
| ema | #4036 |
| environments | #4036 |
| single nucleotide | #4050 |
| occupational | #4052 |
| dipeptidyl | #4055 |
| genetic risk | #4060 |
| positive associations | #4061 |
| tlr9 | #4064 |
| humans polymorphism | #4069 |
| reverse | #4070 |
| prevotella | #4081 |
| dairy | #4093 |
| 493 | #4094 |
| 023 | #4107 |
| unbalanced | #4109 |
| clarification | #4112 |
| coding region | #4113 |
| chronic disease | #4118 |
| 052 | #4118 |
| ethnically | #4120 |
| effects exposure | #4120 |
| children 2 | #4126 |
| positional | #4136 |
| 087 | #4136 |
| salmeterol | #4139 |
| urban population | #4151 |
| luminex | #4154 |
| th17 | #4162 |
| researcher | #4163 |
| chronic respiratory | #4163 |
| 011 | #4170 |
| husbandry | #4180 |
| mrna expression | #4180 |
| sulfur dioxide | #4182 |
| th1 cells | #4183 |
| 424 | #4185 |
| rgs | #4187 |
| ruled | #4189 |
| respiratory infection | #4193 |
| protected | #4194 |
| zealand | #4204 |
| lifestyle | #4210 |
| risk loci | #4212 |
| finland | #4213 |
| preterm delivery | #4220 |
| populationbased sample | #4221 |
| growing body | #4222 |
| whey | #4236 |
| androstadienes | #4237 |
| inflammatory disease | #4243 |
| disease genotype humans | #4247 |
| body height | #4248 |
| adult onset | #4250 |
| increasing trend | #4252 |
| inhaled | #4253 |
| indoor environments | #4256 |
| participated | #4256 |
| neonatal mice | #4262 |
| children born | #4269 |
| healthy individuals | #4289 |
| metagenome | #4300 |
| ordinal | #4303 |
| influenced | #4314 |
| ephedrine | #4318 |
| cx3cl1 | #4318 |
| immunologic receptors | #4322 |
| activity pa | #4324 |
| 1 gene | #4337 |
| male mothers | #4339 |
| male obesity | #4345 |
| years life | #4346 |
| phytohemagglutinins | #4349 |
| nucleotide | #4353 |
| children study | #4356 |
| 093 | #4358 |
| diagnostics | #4359 |
| healthy children | #4370 |
| 410 | #4375 |
| urban area | #4379 |
| rationale | #4393 |
| poaceae | #4397 |
| protects | #4404 |
| age 12 | #4405 |
| fluticasone | #4405 |
| stratified | #4414 |
| lpa | #4417 |
| cephalometry | #4418 |
| exposure levels | #4418 |
| percentile | #4421 |
| hypopharynx | #4424 |
| 95ci | #4425 |
| female sex | #4428 |
| 15 years | #4429 |
| onset | #4434 |
| crohn disease | #4437 |
| participating | #4439 |
| pupils | #4442 |
| dr3 | #4449 |
| secondary prevention | #4449 |
| receptors protein | #4451 |
| rash | #4457 |
| chances | #4457 |
| goblet | #4459 |
| confers | #4461 |
| patients cystic fibrosis | #4466 |
| increased prevalence | #4468 |
| respiratory viruses | #4468 |
| 457 | #4474 |
| 0022 | #4496 |
| prevalence risk factors | #4499 |
| severe asthma | #4499 |
| culture techniques | #4499 |
| microorganisms | #4511 |
| genetic effects | #4516 |
| infant | #4517 |
| trajectories | #4530 |
| no2 | #4538 |
| inflammatory diseases | #4542 |
| statistical | #4545 |
| butter | #4551 |
| assisted laser | #4555 |
| gramnegative bacteria | #4558 |
| structural equation modeling | #4559 |
| receptor alpha | #4564 |
| control children | #4572 |
| 49 | #4573 |
| ahr | #4583 |
| population prevalence | #4583 |
| prevalence estimates | #4588 |
| 080 | #4591 |
| neutrophilic | #4598 |
| adaptor protein | #4600 |
| haplotypes humans | #4600 |
| airway | #4601 |
| knowledge gaps | #4603 |
| strikingly | #4630 |
| daily practice | #4632 |
| lactis | #4634 |
| detectability | #4660 |
| str | #4661 |
| random | #4676 |
| aiming | #4676 |
| pef | #4683 |
| 299 | #4688 |
| accumulating | #4695 |
| measles | #4697 |
| 1014 | #4699 |
| hscrp | #4700 |
| gstp1 | #4725 |
| current evidence | #4730 |
| tlc | #4741 |
| associations | #4745 |
| bacterial communities | #4747 |
| immune | #4749 |
| obstructive lung | #4753 |
| lactic acid bacteria | #4754 |
| genetic risk factors | #4755 |
| transcriptomics | #4768 |
| lifestyle factors | #4772 |
| pathophysiologic | #4775 |
| lung development | #4777 |
| unclear | #4782 |
| exposure air | #4785 |
| immune responses | #4795 |
| quantity | #4804 |
| pulmonary function | #4809 |
| filament proteins | #4812 |
| plateau | #4814 |
| helminth | #4821 |
| albuterol | #4823 |
| respects | #4823 |
| adult air | #4837 |
| 399 | #4838 |
| female food | #4841 |
| implicating | #4844 |
| pointed | #4848 |
| feeding | #4851 |
| new cases | #4858 |
| haplotype analysis | #4874 |
| ont | #4886 |
| hcs | #4889 |
| 624 | #4896 |
| occupations | #4896 |
| respiratory illness | #4897 |
| newborn male | #4902 |
| studies effects | #4919 |
| hyperventilation | #4927 |
| asthma chronic | #4928 |
| dans | #4930 |
| contributors | #4940 |
| postnatal development | #4944 |
| respective | #4955 |
| starts | #4964 |
| tolerance induction | #4965 |
| blood mononuclear | #4969 |
| natal | #4973 |
| 322 | #4975 |
| airway disease | #4975 |
| predisposition disease | #4986 |
| eosinophils | #4994 |
| potential effects | #5005 |
| explore | #5011 |
| adaptor | #5012 |
| laser desorption | #5018 |
| epidemiology | #5018 |
| serine protease | #5020 |
| functionality | #5023 |
| inbred c57bl models | #5024 |
| inhalation | #5049 |
| livestock | #5058 |
| 95 | #5062 |
| paediatric | #5065 |
| manifestation | #5069 |
| milk human | #5071 |
| inflammatory markers | #5072 |
| grass | #5072 |
| 219 | #5083 |
| genetic analyses | #5084 |
| covariates | #5089 |
| held | #5091 |
| hormonal | #5091 |
| alpha1 | #5092 |
| urgent | #5094 |
| habits | #5099 |
| unexposed | #5099 |
| genomewide significance | #5100 |
| 097 | #5100 |
| il3 | #5102 |
| highrisk | #5105 |
| lysate | #5106 |
| gwas | #5119 |
| latent | #5125 |
| smoke | #5126 |
| 103 | #5130 |
| crucial | #5133 |
| 12 years | #5134 |
| regional differences | #5144 |
| mononuclear | #5153 |
| decades | #5159 |
| traffic | #5159 |
| dysbiosis | #5183 |
| 383 | #5186 |
| lung epithelial | #5191 |
| fingerprinting | #5191 |
| reflect | #5193 |
| p40 | #5196 |
| butyrates | #5200 |
| 070 | #5204 |
| age onset | #5209 |
| airways | #5210 |
| window | #5232 |
| hallmarks | #5241 |
| taxa | #5242 |
| recruited | #5243 |
| isotype | #5247 |
| bronchopulmonary | #5247 |
| crp levels | #5256 |
| psychosocial factors | #5267 |
| quartile | #5274 |
| inflammatory disorders | #5279 |
| dietary supplementation | #5280 |
| gprotein | #5283 |
| international | #5289 |
| early phase | #5305 |
| 123 | #5306 |
| environmental variables | #5314 |
| cutoff | #5318 |
| coupled receptor | #5329 |
| excessive | #5333 |
| 136 | #5336 |
| comprehensively | #5339 |
| suppressive | #5348 |
| immunology | #5348 |
| gene expression | #5348 |
| meat | #5350 |
| disease susceptibility | #5359 |
| supernatants | #5369 |
| new strategies | #5380 |
| illumina | #5384 |
| serum proteins | #5392 |
| 233 | #5406 |
| substantial | #5412 |
| discussions | #5423 |
| smad3 | #5429 |
| vitamin supplementation | #5436 |
| sensitized | #5441 |
| certainty | #5443 |
| 337 | #5450 |
| geometric | #5456 |
| 224 | #5465 |
| marks | #5470 |
| hypothesis | #5473 |
| growing evidence | #5475 |
| epidemiologic | #5476 |
| challenge | #5476 |
| phenotype | #5481 |
| healthy control subjects | #5495 |
| cytokines disease | #5496 |
| 373 | #5496 |
| floor | #5496 |
| road | #5504 |
| aged asthma | #5537 |
| alter | #5539 |
| 556 | #5544 |
| term exposure | #5547 |
| 454 | #5550 |
| coexpression | #5570 |
| predisposition | #5574 |
| 512 | #5578 |
| 45 | #5580 |
| lose | #5584 |
| 321 | #5595 |
| methacholine | #5602 |
| figures | #5602 |
| 258 | #5610 |
| 2nd | #5610 |
| 062 | #5630 |
| ld | #5634 |
| 14 years | #5637 |
| airflow | #5642 |
| contribute | #5645 |
| aa | #5661 |
| bacterial species | #5667 |
| protein coupled | #5668 |
| 081 | #5668 |
| notable | #5679 |
| contraceptives | #5682 |
| hints | #5688 |
| cytokine expression | #5693 |
| prebiotics | #5694 |
| commission | #5700 |
| offspring | #5704 |
| 134 | #5704 |
| cows | #5713 |
| cytokine production | #5722 |
| tlr7 | #5725 |
| presentations | #5727 |
| stepwise | #5729 |
| fecal samples | #5753 |
| animal humans | #5764 |
| 021 | #5770 |
| house | #5777 |
| rna expression | #5788 |
| cold | #5790 |
| maternal | #5797 |
| predominance | #5812 |
| persists | #5817 |
| humans immunity | #5824 |
| comprehensive | #5824 |
| cholecalciferol | #5831 |
| snps | #5833 |
| hen | #5848 |
| commensal | #5856 |
| 384 | #5863 |
| mites | #5878 |
| 078 | #5881 |
| bangladesh | #5887 |
| study genotype | #5888 |
| drug development | #5891 |
| sleeping | #5898 |
| workplace | #5900 |
| immunoglobulin igg | #5902 |
| paf | #5910 |
| study associations | #5924 |
| adjust | #5930 |
| encourage | #5930 |
| helper | #5938 |
| differ | #5944 |
| western europe | #5945 |
| investigate association | #5947 |
| questionnaire survey | #5947 |
| male risk | #5953 |
| 0017 | #5958 |
| 216 | #5963 |
| eastern europe | #5978 |
| promoter polymorphism | #5989 |
| disease prevalence | #5991 |
| longitudinal data | #5995 |
| interleukin15 | #5996 |
| adaptive immune | #5999 |
| calling | #6002 |
| 367 | #6008 |
| patients symptoms | #6008 |
| panels | #6009 |
| doseresponse relationship | #6012 |
| box | #6020 |
| pathogen interactions | #6022 |
| immune tolerance | #6023 |
| tract infections | #6029 |
| obese children | #6032 |
| adult population | #6032 |
| diversity | #6047 |
| existing methods | #6054 |
| risk variants | #6060 |
| prevalent | #6063 |
| eastern | #6064 |
| gmcsf | #6064 |
| modifier | #6066 |
| persisted | #6067 |
| restricted | #6068 |
| comparability | #6070 |
| 122 | #6072 |
| implication | #6077 |
| ors | #6082 |
| unselected | #6082 |
| ovalbumin | #6086 |
| microflora | #6091 |
| interleukin17 | #6094 |
| time flight | #6103 |
| 099 | #6113 |
| recruiting | #6117 |
| conferred | #6117 |
| genetic polymorphisms | #6122 |
| causality | #6128 |
| repeated | #6132 |
| fev1 | #6134 |
| fecal | #6135 |
| ahead | #6140 |
| 24 years | #6146 |
| programme | #6152 |
| 16 years | #6157 |
| town | #6158 |
| intermediate filament | #6161 |
| avec | #6163 |
| welfare | #6164 |
| gathered | #6166 |
| keeping | #6173 |
| constituent | #6182 |
| toluene | #6192 |
| determining | #6193 |
| genomewide association study | #6196 |
| narcotic | #6202 |
| conferring | #6205 |
| gross | #6216 |
| populations | #6233 |
| genuine | #6233 |
| illnesses | #6241 |
| institute | #6243 |
| prematurity | #6246 |
| administration inhalation | #6246 |
| protease inhibitor | #6252 |
| odds ratio 95 | #6262 |
| parents | #6266 |
| indoor environment | #6270 |
| study groups | #6270 |
| proposal | #6285 |
| offers | #6287 |
| irr | #6291 |
| communicable diseases | #6301 |
| nested | #6303 |
| alpha 1 | #6304 |
| tests | #6307 |
| young age | #6316 |
| outdoor | #6321 |
| infrequent | #6326 |
| allele frequencies | #6326 |
| interferons | #6343 |
| peptidase | #6346 |
| immunity mucosal | #6349 |
| 067 | #6355 |
| lymphocytes helper | #6360 |
| studies association | #6370 |
| 090 | #6375 |
| adjustments | #6385 |
| bivariate | #6388 |
| protective factor | #6390 |
| iu | #6394 |
| levels serum | #6400 |
| decreased risk | #6401 |
| immunological | #6409 |
| selection bias | #6410 |
| cell subsets | #6411 |
| genetic determinants | #6417 |
| infant premature | #6418 |
| 119 | #6439 |
| questions | #6448 |
| hypothesized | #6466 |
| mmp9 | #6467 |
| lower respiratory | #6475 |
| adverse health | #6475 |
| 287 | #6486 |
| 274 | #6490 |
| premature | #6493 |
| omalizumab | #6501 |
| gst | #6507 |
| sleep disturbance | #6507 |
| 238 | #6507 |
| links | #6512 |
| murine model | #6515 |
| infant feeding | #6523 |
| adam | #6524 |
| repeated measurements | #6527 |
| increased expression | #6529 |
| fev1 fvc | #6530 |
| diseases risk | #6548 |
| implied | #6555 |
| centers | #6567 |
| 1012 | #6571 |
| statements | #6572 |
| completion | #6598 |
| disease onset | #6602 |
| 283 | #6602 |
| children adults | #6604 |
| pollutant | #6605 |
| hospital admissions | #6617 |
| promoter region | #6624 |
| consumed | #6647 |
| accessible | #6653 |
| host pathogen | #6653 |
| adjusted 95 | #6654 |
| intervention studies | #6660 |
| playing | #6672 |
| 138 | #6684 |
| candidate genes | #6684 |
| bacterium | #6709 |
| cell responses | #6711 |
| systematic search | #6715 |
| cytokines dendritic | #6716 |
| washout | #6720 |
| nod2 | #6730 |
| haplotypes | #6732 |
| impulse | #6732 |
| cells disease | #6734 |
| 0009 | #6734 |
| ova | #6739 |
| focuses | #6745 |
| 126 | #6750 |
| n10 | #6757 |
| cities | #6761 |
| quartiles | #6763 |
| height weight | #6765 |
| mumps | #6769 |
| plethysmography | #6771 |
| eosinophilic | #6783 |
| disease mechanisms | #6787 |
| 065 | #6794 |
| developing | #6798 |
| 330 | #6807 |
| remained | #6813 |
| chronic exposure | #6823 |
| microbiology | #6831 |
| growing | #6846 |
| elucidated | #6846 |
| mz | #6852 |
| microorganism | #6861 |
| 305 | #6868 |
| cream | #6874 |
| lower incidence | #6887 |
| functional studies | #6890 |
| beef | #6896 |
| incidences | #6900 |
| inert | #6911 |
| academia | #6924 |
| supplementary | #6934 |
| zona | #6939 |
| multivariate logistic | #6941 |
| tertiles | #6948 |
| specific effects | #6949 |
| 1 diabetes | #6962 |
| 044 | #6965 |
| lung | #6972 |
| pathogenic bacteria | #6972 |
| maturation | #6975 |
| specialists | #6986 |
| infections | #6991 |
| transducer | #6998 |
| obesity bmi | #6999 |
| attendance | #7012 |
| summarizes | #7024 |
| infectious diseases | #7025 |
| shaping | #7027 |
| ribosomal 16s | #7033 |
| organic compounds | #7037 |
| 231 | #7041 |
| 028 | #7042 |
| confirming | #7043 |
| evidence association | #7046 |
| explaining | #7053 |
| amelioration | #7060 |
| concert | #7095 |
| 313 | #7102 |
| 019 | #7109 |
| linoleic acid | #7111 |
| type 1 diabetes | #7111 |
| triggering | #7114 |
| serum total | #7117 |
| breath tests | #7117 |
| 164 | #7122 |
| increased incidence | #7128 |
| th1 | #7132 |
| homeobox | #7134 |
| male membrane | #7135 |
| health humans | #7136 |
| homozygote | #7150 |
| consenting | #7153 |
| compare | #7155 |
| daily life | #7165 |
| increased risks | #7167 |
| likewise | #7184 |
| agents anti | #7184 |
| spatial variation | #7197 |
| develop | #7209 |
| health nutrition | #7223 |
| irritable bowel syndrome | #7227 |
| helper cell | #7228 |
| discusses | #7228 |
| spore | #7229 |
| cohort | #7231 |
| grow | #7238 |
| 163 | #7243 |
| influences | #7244 |
| beta1 | #7244 |
| analyses | #7255 |
| 0015 | #7268 |
| standardised | #7277 |
| 058 | #7278 |
| 053 | #7283 |
| handling | #7288 |
| urbanization | #7299 |
| herpesviridae | #7299 |
| 022 | #7309 |
| internationality | #7310 |
| single nucleotide polymorphisms | #7317 |
| personalized | #7355 |
| attending | #7374 |
| air pollutants | #7376 |
| 199 | #7387 |
| rome | #7392 |
| university | #7411 |
| linoleic | #7424 |
| potential risk | #7443 |
| histories | #7457 |
| 9 months | #7467 |
| human body | #7474 |
| boiling | #7486 |
| stratification | #7488 |
| bronchi | #7493 |
| alps | #7515 |
| spp | #7515 |
| enrollment | #7519 |
| intestinal diseases | #7523 |
| pediatrics | #7535 |
| toxoplasmosis | #7551 |
| bowel diseases | #7561 |
| allele | #7582 |
| eosinophil | #7586 |
| oropharyngeal | #7591 |
| considerably | #7612 |
| overt | #7613 |
| diseases animals | #7613 |
| worked | #7643 |
| school | #7649 |
| 316 | #7658 |
| haemophilus | #7669 |
| health conditions | #7671 |
| peanut | #7684 |
| prenatal | #7684 |
| rna ribosomal | #7700 |
| 161 | #7725 |
| nox | #7726 |
| europe | #7728 |
| leukocytes | #7731 |
| population | #7736 |
| characterised | #7744 |
| vehicles | #7748 |
| 308 | #7763 |
| single | #7777 |
| flora | #7792 |
| clinical examination | #7797 |
| infant male | #7799 |
| attended | #7802 |
| sputum | #7804 |
| reader | #7805 |
| lymphocyte subsets | #7808 |
| 66 | #7809 |
| 171 | #7839 |
| pyrosequencing | #7845 |
| conjunction | #7848 |
| m3 | #7856 |
| pa | #7859 |
| participation | #7865 |
| 1996 | #7881 |
| investigators | #7882 |
| specific | #7895 |
| deficiencies | #7898 |
| asked | #7899 |
| specificities | #7907 |
| months age | #7912 |
| parasitic | #7915 |
| epigenesis genetic | #7919 |
| neisseria | #7922 |
| 160 | #7928 |
| protective role | #7929 |
| egg | #7933 |
| therapeutic intervention | #7939 |
| listeria monocytogenes | #7941 |
| pbmcs | #7944 |
| fall | #7947 |
| unresolved | #7949 |
| lockdown | #7950 |
| prevalence incidence | #7950 |
| immune function | #7953 |
| altering | #7959 |
| human subjects | #7966 |
| collecting | #7980 |
| explanatory | #7997 |
| fatty acid composition | #8002 |
| lacking | #8024 |
| 264 | #8040 |
| bordetella | #8049 |
| phorbol | #8077 |
| separately | #8084 |
| rising | #8086 |
| 304 | #8087 |
| helper inducer | #8091 |
| weight infant | #8101 |
| 088 | #8109 |
| determinants | #8119 |
| regarded | #8119 |
| multiple logistic | #8132 |
| career | #8149 |
| factor binding | #8160 |
| polymorphism genetic | #8162 |
| gene regulation | #8172 |
| etiologies | #8201 |
| omega3 | #8202 |
| mutually | #8209 |
| initiative | #8212 |
| sophisticated | #8214 |
| 140 | #8224 |
| community based | #8228 |
| epigenesis | #8236 |
| emerged | #8237 |
| 266 | #8255 |
| hypotheses | #8257 |
| cars | #8265 |
| examination | #8283 |
| modifiable | #8285 |
| adolescent | #8294 |
| 242 | #8295 |
| hc | #8303 |
| belonged | #8306 |
| humans immunization | #8308 |
| based cohort | #8312 |
| nights | #8331 |
| objectives | #8337 |
| critical roles | #8342 |
| 111 | #8348 |
| nasal mucosa | #8351 |
| genera | #8357 |
| nineteen | #8357 |
| pylori infection | #8359 |
| normal weight | #8367 |
| instillation | #8385 |
| interleukin10 | #8388 |
| relative abundance | #8412 |
| latest | #8415 |
| author | #8420 |
| spearman | #8422 |
| infant low | #8429 |
| covariate | #8435 |
| authorities | #8438 |
| aspergillosis | #8440 |
| reduce risk | #8441 |
| 16s | #8447 |
| 113 | #8460 |
| multifactorial | #8460 |
| anhydride | #8462 |
| syncytial | #8462 |
| contrasting | #8463 |
| similarities | #8478 |
| minor | #8478 |
| profound | #8479 |
| investigate | #8497 |
| asthmatic patients | #8506 |
| resembles | #8511 |
| mass body | #8521 |
| genetic factors | #8538 |
| relations | #8543 |
| cytokines | #8544 |
| so2 | #8558 |
| prospective cohort study | #8565 |
| extract | #8568 |
| 4 years | #8590 |
| inclusion | #8598 |
| genetic loci | #8618 |
| humidity | #8633 |
| facilitates | #8642 |
| strong evidence | #8645 |
| logistic | #8648 |
| animal | #8656 |
| dendritic cells dcs | #8665 |
| adaptive | #8676 |
| 101 | #8677 |
| oropharynx | #8681 |
| defines | #8685 |
| histamine | #8716 |
| responsiveness | #8726 |
| increased odds | #8730 |
| choosing | #8732 |
| prevention | #8737 |
| 193 | #8776 |
| exploring | #8780 |
| 30 years | #8799 |
| airborne | #8805 |
| vdr | #8811 |
| incidence infant | #8815 |
| integrates | #8824 |
| unknown | #8840 |
| alveoli | #8852 |
| antibody levels | #8861 |
| traditional | #8865 |
| 155 | #8867 |
| association analysis | #8868 |
| humans logistic | #8879 |
| cesarean | #8884 |
| ears | #8884 |
| burden disease | #8884 |
| utilization | #8888 |
| residence | #8903 |
| bdnf | #8911 |
| pools | #8916 |
| 273 | #8926 |
| processed | #8935 |
| reactive protein | #8944 |
| pattern recognition | #8957 |
| lipopolysaccharide lps | #8958 |
| olive | #8963 |
| phase | #8966 |
| 177 | #8983 |
| 194 | #8996 |
| 0007 | #8998 |
| underlying | #9006 |
| 172 | #9017 |
| preschool humans | #9028 |
| surveyed | #9029 |
| humans lung | #9031 |
| sequelae | #9032 |
| receptor 4 | #9040 |
| population surveillance | #9046 |
| transferase | #9049 |
| cytokine | #9057 |
| boys girls | #9070 |
| london | #9088 |
| lower risk | #9095 |
| median duration | #9096 |
| parturition | #9101 |
| flanking | #9109 |
| nutritional physiological | #9139 |
| determinant | #9154 |
| statistical methods | #9170 |
| differing | #9175 |
| study selection | #9180 |
| butyrate | #9182 |
| secretions | #9187 |
| food | #9198 |
| exert | #9209 |
| dogs | #9217 |
| fungi | #9222 |
| 186 | #9234 |
| accompanying | #9239 |
| pattern | #9248 |
| human skin | #9259 |
| multivariate analyses | #9269 |
| popularity | #9269 |
| 04 | #9278 |
| 275 | #9282 |
| counts | #9296 |
| quintile | #9297 |
| controversial | #9299 |
| tract | #9302 |
| 95 women | #9304 |
| allele frequency | #9306 |
| haplotype | #9306 |
| outcome measures | #9309 |
| 345 | #9313 |
| anova | #9328 |
| prospectively | #9334 |
| eosinophilia | #9338 |
| vocs | #9351 |
| logistic regression analysis | #9353 |
| funded | #9360 |
| olds | #9364 |
| responders | #9364 |
| proteinase | #9366 |
| urban | #9376 |
| tlr4 | #9383 |
| infantile | #9386 |
| numerous | #9388 |
| 232 | #9392 |
| maldi | #9404 |
| ages | #9407 |
| newborn | #9409 |
| incidence | #9412 |
| 286 | #9422 |
| 5000 | #9432 |
| streptococcus | #9438 |
| extrinsic | #9445 |
| sick | #9460 |
| countries | #9478 |
| 016 | #9481 |
| anthropometric | #9495 |
| worker | #9498 |
| fatty acids | #9509 |
| longitudinally | #9512 |
| comprise | #9517 |
| markers | #9532 |
| antigen presenting | #9554 |
| 256 | #9559 |
| body composition | #9561 |
| airway obstruction | #9573 |
| 165 | #9574 |
| pharyngeal | #9579 |
| global health | #9583 |
| social class | #9585 |
| ifn gamma | #9589 |
| actinobacteria | #9597 |
| nutritive | #9598 |
| replicated | #9599 |
| occurrence | #9605 |
| lessons | #9617 |
| increases risk | #9627 |
| substances | #9659 |
| mucous | #9666 |
| adult mice | #9669 |
| crude | #9672 |
| dietary supplements | #9672 |
| child child | #9678 |
| reference | #9687 |
| obesity | #9698 |
| common genetic | #9743 |
| diagnoses | #9743 |
| populationbased study | #9744 |
| 9 | #9746 |
| p004 | #9752 |
| mothers | #9753 |
| mononuclear cells | #9760 |
| il10 | #9761 |
| proinflammatory | #9761 |
| directly | #9772 |
| publications | #9772 |
| 1 protein | #9773 |
| obstruction | #9774 |
| body mass bmi | #9788 |
| reliable | #9790 |
| 158 | #9800 |
| electrophoretic | #9807 |
| therapeutic strategies | #9818 |
| prove | #9826 |
| 20th | #9843 |
| random allocation | #9844 |
| 102 | #9849 |
| cluster | #9849 |
| modifying | #9850 |
| rrna | #9873 |
| nps | #9884 |
| restrictive | #9899 |
| altogether | #9903 |
| reality | #9904 |
| receptors | #9909 |
| immunomodulatory | #9920 |
| tagging | #9925 |
| intranasal | #9929 |
| century | #9933 |
| 39 | #9935 |
| southern | #9938 |
| 1991 | #9964 |
| bacterial infections | #9964 |
| tnf α | #9973 |
| 0002 | #9995 |
| exclusively | #10002 |
| 152 | #10006 |
| presenting cells | #10012 |
| lavage fluid | #10012 |
| particulate matter | #10015 |
| mass bmi | #10020 |
| health outcomes | #10050 |
| reproducible | #10052 |
| 57 | #10065 |
| disappeared | #10087 |
| 87 | #10096 |
| elucidation | #10099 |
| parts | #10121 |
| superoxide dismutase | #10123 |
| immune cell | #10127 |
| 072 | #10143 |
| nasal | #10159 |
| exist | #10160 |
| bias | #10162 |
| expression genes | #10164 |
| ascertained | #10166 |
| sedentary behavior | #10168 |
| 4 months | #10169 |
| exclusions | #10169 |
| timing | #10174 |
| incidence prevalence | #10175 |
| discover | #10203 |
| western | #10210 |
| microbial communities | #10218 |
| fungal | #10222 |
| adaptor proteins | #10226 |
| alpha subunit | #10236 |
| weaker | #10259 |
| influenzae | #10264 |
| 212 | #10290 |
| study children | #10303 |
| ghana | #10324 |
| aim | #10332 |
| analyze | #10356 |
| factorial | #10361 |
| interleukin12 | #10361 |
| 142 | #10364 |
| concepts | #10386 |
| centrally | #10386 |
| methodologies | #10387 |
| ulcerative colitis | #10399 |
| respiratory disease | #10403 |
| 17 | #10408 |
| polyunsaturated | #10422 |
| parasites | #10430 |
| scientific | #10436 |
| modelled | #10448 |
| nose | #10465 |
| flow rate | #10471 |
| bronchiolitis | #10473 |
| exposed | #10477 |
| 07 | #10499 |
| realtime pcr | #10503 |
| c3h | #10522 |
| twothirds | #10527 |
| interquartile range | #10528 |
| adjusted | #10532 |
| acetates | #10561 |
| 94 | #10565 |
| new zealand | #10576 |
| 010 | #10595 |
| biodiversity | #10595 |
| societal | #10603 |
| france | #10605 |
| priming | #10614 |
| homeodomain | #10623 |
| time pcr | #10638 |
| boys | #10643 |
| indirectly | #10650 |
| bacteriological | #10653 |
| 206 | #10664 |
| 004 | #10665 |
| ribosomal | #10691 |
| vitamins | #10703 |
| bidirectional | #10706 |
| positivity | #10711 |
| possibilities | #10723 |
| 008 | #10728 |
| items | #10729 |
| newborn infant | #10763 |
| ancestry female | #10768 |
| nitrous | #10770 |
| swabs | #10771 |
| entered | #10774 |
| regulation humans | #10776 |
| female gastrointestinal | #10776 |
| responses | #10786 |
| skin | #10787 |
| transferases | #10789 |
| increased production | #10799 |
| national institute | #10805 |
| suppressing | #10825 |
| workshop | #10850 |
| physical activity | #10855 |
| postnatal | #10859 |
| prevent | #10862 |
| bronchoalveolar | #10864 |
| fvc | #10873 |
| km2 | #10911 |
| functional role | #10915 |
| standardization | #10926 |
| 2002 | #10934 |
| 036 | #10944 |
| carriers | #10949 |
| subclinical | #10957 |
| microbiological | #10968 |
| subsequent | #10971 |
| 16s rrna | #10983 |
| immunoglobulins | #10986 |
| lps | #10988 |
| 217 | #10992 |
| roc | #10992 |
| 191 | #10993 |
| constituents | #10993 |
| harm | #10994 |
| 197 | #10996 |
| aerosol | #11002 |
| swiss | #11006 |
| inconsistent | #11009 |
| chance | #11022 |
| poland | #11028 |
| antibody responses | #11043 |
| amniotic | #11054 |
| 6 12 | #11055 |
| serology | #11092 |
| low birth | #11092 |
| passive | #11120 |
| chromosomes human | #11127 |
| ulcerative | #11134 |
| disturbed | #11159 |
| 235 | #11177 |
| crohn | #11187 |
| community | #11188 |
| 144 | #11222 |
| gut | #11232 |
| il12 | #11233 |
| confined | #11247 |
| environmental pollutants | #11258 |
| fourth | #11270 |
| 157 | #11286 |
| rna messenger | #11289 |
| duration | #11314 |
| regulatory mechanisms | #11327 |
| highest risk | #11328 |
| intron | #11330 |
| studies diet | #11351 |
| persistent | #11353 |
| chronic diseases | #11376 |
| 040 | #11389 |
| birth weight | #11397 |
| juvenile | #11415 |
| nitrogen dioxide | #11427 |
| cell function | #11428 |
| modulate | #11435 |
| supplements | #11440 |
| 18 years | #11446 |
| discuss | #11455 |
| female | #11457 |
| 105 | #11459 |
| epigenetics | #11463 |
| gut microbiota | #11475 |
| quinolines | #11485 |
| genetic susceptibility | #11493 |
| 128 | #11502 |
| factor1 | #11515 |
| 86 | #11521 |
| haemophilus influenzae | #11522 |
| late onset | #11524 |
| helicobacter | #11533 |
| biomarker | #11536 |
| 012 | #11542 |
| cd28 | #11550 |
| interact | #11564 |
| 78 | #11583 |
| households | #11587 |
| proteases | #11587 |
| variant | #11588 |
| physiological phenomena | #11594 |
| healthy control | #11597 |
| 130 | #11601 |
| celiac | #11633 |
| risk disease | #11636 |
| dispersion | #11666 |
| narrative | #11668 |
| interquartile | #11709 |
| gene polymorphisms | #11736 |
| introduction | #11752 |
| trimester pregnancy | #11755 |
| confirmation | #11758 |
| harmful | #11806 |
| lipopolysaccharides | #11813 |
| gram negative | #11824 |
| 222 | #11824 |
| irrespective | #11831 |
| 075 | #11858 |
| subtypes | #11860 |
| episodes | #11867 |
| incident | #11881 |
| insight | #11899 |
| fetal | #11900 |
| 230 | #11904 |
| air | #11924 |
| started | #11931 |
| genetic | #11936 |
| ifn | #11939 |
| 1990 | #11944 |
| autoantigens | #11967 |
| natural | #11982 |
| lowest | #11990 |
| genetic association | #11992 |
| protein levels | #11997 |
| finding | #12007 |
| initially | #12014 |
| 151 | #12047 |
| solely | #12055 |
| quantifying | #12075 |
| pcr | #12106 |
| case control | #12121 |
| ultimately | #12124 |
| upregulation | #12127 |
| immunologic factors | #12176 |
| subsets | #12179 |
| estimating | #12184 |
| country | #12201 |
| young children | #12219 |
| 149 | #12221 |
| inflammatory response | #12238 |
| leukocyte count | #12248 |
| fish oil | #12249 |
| december | #12256 |
| sle | #12270 |
| shifted | #12297 |
| began | #12327 |
| relapsing | #12330 |
| antibiotics | #12339 |
| 006 | #12341 |
| gm | #12351 |
| completed | #12354 |
| european continental | #12371 |
| minority | #12421 |
| linkage | #12422 |
| reasons | #12444 |
| ifngamma | #12445 |
| relevance | #12447 |
| lung tissue | #12462 |
| colonization | #12463 |
| 170 | #12467 |
| european | #12469 |
| inflammatory cytokine | #12469 |
| lymphocyte activation | #12520 |
| saline | #12546 |
| 17 years | #12583 |
| scarce | #12583 |
| 117 | #12590 |
| defense | #12609 |
| length polymorphism | #12616 |
| predictors | #12620 |
| tobacco | #12634 |
| crohns disease | #12638 |
| discriminating | #12641 |
| 203 | #12655 |
| residence characteristics | #12657 |
| tested | #12664 |
| collect | #12680 |
| detectable | #12682 |
| 156 | #12683 |
| cd3 | #12684 |
| total | #12687 |
| child development | #12695 |
| cystic fibrosis | #12696 |
| contributing | #12697 |
| residential | #12708 |
| multicentre | #12731 |
| beta2 | #12735 |
| aspect | #12741 |
| swedish | #12751 |
| enhancer | #12752 |
| 204 | #12773 |
| clinical manifestations | #12796 |
| 184 | #12815 |
| lung diseases | #12819 |
| combinations | #12856 |
| 104 | #12860 |
| pregnancy | #12873 |
| aspects | #12899 |
| sedentary | #12908 |
| translated | #12918 |
| elevated levels | #12943 |
| infants | #12943 |
| united kingdom | #12946 |
| debate | #12955 |
| human genome | #12959 |
| inflammatory bowel | #12963 |
| coded | #12998 |
| 154 | #13016 |
| annually | #13056 |
| 52 | #13056 |
| 220 | #13057 |
| elusive | #13067 |
| extracellular vesicles | #13082 |
| suffer | #13086 |
| future | #13086 |
| glucocorticoids humans | #13096 |
| genetic rna | #13096 |
| intrauterine | #13097 |
| measurable | #13120 |
| delayed | #13147 |
| conversely | #13160 |
| schistosomiasis | #13161 |
| differential effects | #13191 |
| strong association | #13209 |
| glucocorticoid | #13217 |
| methodological | #13236 |
| great | #13255 |
| developing countries | #13257 |
| 127 | #13262 |
| consultation | #13264 |
| 276 | #13267 |
| 018 | #13274 |
| proportions | #13279 |
| stimulated | #13297 |
| weaning | #13299 |
| hallmark | #13313 |
| 017 | #13323 |
| manifestations | #13333 |
| gene | #13338 |
| odds ratios | #13351 |
| nucleotide risk | #13354 |
| pediatric | #13397 |
| crp | #13407 |
| initiate | #13419 |
| 11 | #13424 |
| burden | #13446 |
| bowel | #13447 |
| kingdom | #13448 |
| auc | #13449 |
| mechanisms underlying | #13450 |
| 210 | #13457 |
| 20th century | #13476 |
| younger | #13480 |
| secretion | #13500 |
| 129 | #13518 |
| considerable | #13527 |
| 045 | #13543 |
| relevant | #13545 |
| confirm | #13567 |
| beijing | #13578 |
| visits | #13581 |
| 188 | #13602 |
| statistically | #13612 |
| respiratory syncytial | #13621 |
| 1989 | #13652 |
| inheritance | #13663 |
| 181 | #13690 |
| argue | #13695 |
| 020 | #13702 |
| depending | #13723 |
| lavage | #13735 |
| 014 | #13736 |
| pneumonia | #13774 |
| study association | #13782 |
| neighboring | #13790 |
| impairment | #13810 |
| sweden | #13833 |
| schistosoma | #13835 |
| severe | #13852 |
| concerns | #13856 |
| cohorts | #13856 |
| establishing | #13859 |
| genomics humans | #13875 |
| human pair | #13893 |
| ranged | #13900 |
| multiplex | #13937 |
| loci | #13953 |
| membrane glycoproteins | #14048 |
| mental health | #14054 |
| additionally | #14064 |
| chromosomes | #14069 |
| fat mass | #14090 |
| restore | #14107 |
| tendency | #14138 |
| nucleotide polymorphism | #14141 |
| establish | #14142 |
| subgroups | #14166 |
| immigrants | #14182 |
| randomly selected | #14189 |
| examples | #14202 |
| fetal development | #14226 |
| expand | #14234 |
| 183 | #14237 |
| concomitant | #14257 |
| socioeconomic status | #14258 |
| multigene | #14259 |
| disease genome | #14278 |
| refined | #14314 |
| breast | #14318 |
| unsaturated | #14320 |
| addresses | #14337 |
| independently | #14350 |
| health organization | #14355 |
| tightly | #14399 |
| amniotic fluid | #14424 |
| severity | #14432 |
| 121 | #14439 |
| penicillium | #14441 |
| epidemiologic studies | #14443 |
| tuberculosis | #14444 |
| 1 month | #14454 |
| studying | #14492 |
| 007 | #14492 |
| derivation | #14517 |
| tolerance | #14521 |
| contributed | #14529 |
| conclude | #14532 |
| systematically | #14533 |
| elevated | #14573 |
| humans | #14580 |
| factors socioeconomic | #14586 |
| cystic | #14593 |
| stranded | #14599 |
| food intake | #14600 |
| horse | #14606 |
| animals antigens | #14624 |
| 6 | #14638 |
| differentially expressed | #14641 |
| effector cells | #14675 |
| 205 | #14693 |
| striking | #14700 |
| lymphocyte count | #14703 |
| lipopolysaccharide | #14704 |
| filament | #14706 |
| transcription | #14707 |
| representative | #14726 |
| tetradecanoylphorbol | #14755 |
| classify | #14766 |
| trimester | #14772 |
| operate | #14777 |
| represents | #14788 |
| glycoproteins | #14799 |
| maximal | #14801 |
| cells patients | #14821 |
| determines | #14831 |
| 2 years | #14850 |
| seropositivity | #14866 |
| genetic analysis | #14890 |
| mice mice | #14912 |
| 002 | #14917 |
| ancestry | #14925 |
| maternal age | #14929 |
| clostridium | #14981 |
| marker | #14999 |
| ctla4 | #15005 |
| 162 | #15012 |
| ethnic | #15032 |
| male | #15042 |
| receptor | #15068 |
| compared healthy | #15084 |
| modulates | #15087 |
| disparities | #15118 |
| 00001 | #15123 |
| stronger | #15140 |
| p00001 | #15177 |
| luciferase | #15184 |
| gram | #15200 |
| longitudinal studies | #15223 |
| immune cells | #15233 |
| 131 | #15264 |
| hong kong | #15269 |
| cumulative | #15330 |
| copd | #15346 |
| nfkappab | #15356 |
| environmental monitoring | #15362 |
| socioeconomic | #15368 |
| gestational age | #15392 |
| curve | #15407 |
| physician | #15419 |
| integrate | #15467 |
| induce | #15469 |
| assessing | #15476 |
| modulated | #15501 |
| cells dcs | #15509 |
| perinatal | #15516 |
| pregnancy risk | #15527 |
| gonadal | #15550 |
| marked | #15553 |
| 003 | #15556 |
| dysregulation | #15556 |
| feces | #15556 |
| 110 | #15569 |
| built | #15581 |
| archaea | #15621 |
| tgfβ | #15667 |
| cytometry | #15669 |
| controlling | #15688 |
| inflammatory agents | #15708 |
| dietary fats | #15739 |
| cell surface receptors | #15743 |
| igg | #15765 |
| genotype | #15766 |
| il1 | #15772 |
| imply | #15830 |
| pregnant | #15831 |
| exclusive | #15843 |
| developed countries | #15863 |
| 47 | #15874 |
| cells animals | #15894 |
| 116 | #15895 |
| socioeconomic factors | #15901 |
| sensitivity specificity | #15922 |
| reflected | #15966 |
| humans inflammation | #15992 |
| agreement | #16016 |
| varies | #16017 |
| diagnosed | #16043 |
| unrelated | #16046 |
| casecontrol study | #16049 |
| filled | #16050 |
| transient | #16060 |
| conditional | #16084 |
| interleukin1beta | #16103 |
| major | #16105 |
| 12 | #16129 |
| located | #16168 |
| homozygous | #16182 |
| effector | #16208 |
| inducer | #16232 |
| anti inflammatory | #16238 |
| transducing | #16239 |
| psychosocial | #16242 |
| 93 | #16314 |
| born | #16347 |
| dendritic cells | #16365 |
| define | #16372 |
| causing | #16382 |
| bacterial | #16387 |
| 7 | #16394 |
| genome wide | #16420 |
| varied | #16428 |
| squared | #16431 |
| volatile | #16432 |
| 082 | #16433 |
| bacteria | #16447 |
| represented | #16476 |
| height | #16488 |
| ibd | #16518 |
| established | #16536 |
| identifying | #16549 |
| participants | #16561 |
| thought | #16634 |
| triggered | #16636 |
| areas | #16662 |
| broad | #16671 |
| academic | #16675 |
| functionally | #16694 |
| microsatellite | #16697 |
| genetic polymorphism | #16725 |
| characterizing | #16726 |
| 0006 | #16756 |
| dendritic | #16762 |
| centre | #16765 |
| 084 | #16783 |
| distributed | #16795 |
| agricultural | #16798 |
| dead | #16800 |
| nitric oxide | #16855 |
| chromosome | #16895 |
| bowel disease | #16898 |
| personal | #16912 |
| 91 | #16918 |
| 09 | #16918 |
| investigating | #16978 |
| utilize | #16980 |
| opportunities | #17033 |
| promoter | #17034 |
| steroid | #17056 |
| anti bacterial | #17061 |
| dna bacterial | #17074 |
| 81 | #17089 |
| mother | #17091 |
| epigenetic | #17095 |
| continuing | #17105 |
| messenger | #17106 |
| progression | #17115 |
| monocytes | #17130 |
| genotypes | #17190 |
| confirms | #17201 |
| individual | #17225 |
| seasons | #17244 |
| 53 | #17287 |
| untranslated | #17292 |
| denmark | #17301 |
| 137 | #17321 |
| retinoic | #17351 |
| drug therapy | #17361 |
| earlier | #17361 |
| cross | #17377 |
| encountered | #17387 |
| taxonomic | #17423 |
| visible | #17455 |
| strong | #17549 |
| excluding | #17551 |
| tnfalpha | #17598 |
| heterozygote | #17605 |
| alleles | #17619 |
| avoidance | #17647 |
| bronchoalveolar lavage | #17656 |
| bacterial agents | #17666 |
| introduced | #17690 |
| cd4 cells | #17717 |
| dcs | #17724 |
| initiating | #17727 |
| comparing | #17740 |
| newborns | #17784 |
| quantified | #17787 |
| regression | #17798 |
| lesser | #17810 |
| geographical | #17857 |
| interviewed | #17866 |
| 84 | #17903 |
| covering | #17927 |
| prospective | #17949 |
| bmi | #17963 |
| animals | #17994 |
| 009 | #18003 |
| drawn | #18014 |
| disease chronic | #18024 |
| longitudinal | #18047 |
| particulate | #18073 |
| monthly | #18086 |
| 77 | #18100 |
| altered | #18146 |
| 085 | #18150 |
| publication administration | #18171 |
| children adolescents | #18178 |
| snp | #18187 |
| neurotrophic | #18224 |
| systemic lupus erythematosus | #18235 |
| samples | #18263 |
| restriction fragment | #18268 |
| negative | #18269 |
| dismutase | #18321 |
| susceptibility | #18324 |
| demographics | #18339 |
| recognize | #18347 |
| inflammatory responses | #18460 |
| inflammatory bowel disease | #18499 |
| chemokines | #18511 |
| served | #18518 |
| difference | #18526 |
| mast cell | #18536 |
| 148 | #18545 |
| replication | #18548 |
| exists | #18580 |
| immunization | #18589 |
| remain | #18590 |
| intervals | #18593 |
| secretory | #18604 |
| carried | #18634 |
| fold | #18655 |
| provided | #18675 |
| 83 | #18683 |
| 36 | #18709 |
| symptom | #18710 |
| differentially | #18718 |
| variation genome | #18742 |
| rise | #18757 |
| weight | #18797 |
| epithelial cells | #18798 |
| candidate | #18807 |
| sum | #18807 |
| additional | #18812 |
| immunophenotyping | #18818 |
| families | #18838 |
| basis | #18843 |
| 1997 | #18843 |
| 28 | #18854 |
| maintain | #18856 |
| variants | #18858 |
| 13 | #18882 |
| fragment length | #18919 |
| missing | #18966 |
| lower | #18985 |
| sampling | #19004 |
| receptors cell | #19024 |
| intake | #19030 |
| vitamin | #19034 |
| experiencing | #19122 |
| susceptible | #19133 |
| fats | #19173 |
| balb mice | #19208 |
| crosssectional study | #19250 |
| c57bl mice | #19256 |
| promoter regions | #19283 |
| polymerase | #19291 |
| locus | #19302 |
| clinical presentation | #19308 |
| 1992 | #19352 |
| contributes | #19382 |
| termed | #19414 |
| mouse model | #19415 |
| trait loci | #19415 |
| clear | #19476 |
| partially | #19504 |
| completely | #19506 |
| elucidate | #19510 |
| socio | #19512 |
| × 10 | #19521 |
| pollutants | #19552 |
| validated | #19554 |
| necrosis | #19582 |
| illustrate | #19602 |
| lasting | #19718 |
| time polymerase | #19720 |
| healthrelated quality | #19789 |
| polymerase chain | #19797 |
| inbred balb mice | #19855 |
| 1998 | #19855 |
| chronic obstructive | #19868 |
| 5 years | #19869 |
| selecting | #19937 |
| carrying | #19967 |
| context | #19977 |
| baseline | #19977 |
| negatively | #19998 |
| 95 confidence interval | #20023 |
| inbred balb | #20051 |
| interferon gamma | #20056 |
| easy | #20065 |
| acetaminophen | #20066 |
| shared | #20130 |
| 74 | #20150 |
| 64 | #20157 |
| health | #20163 |
| activates | #20164 |
| summary | #20181 |
| reporter | #20212 |
| serological | #20244 |
| adjusting | #20271 |
| 1 year | #20289 |
| interacting | #20295 |
| autoimmune diseases | #20301 |
| 61 | #20339 |
| stimulation | #20363 |
| 14 | #20418 |
| identifies | #20457 |
| demonstrating | #20473 |
| 2003 | #20528 |
| humans longitudinal | #20557 |
| returned | #20566 |
| ratio | #20593 |
| 26 | #20613 |
| inflammatory | #20615 |
| interactions | #20618 |
| behavior female | #20629 |
| nitric | #20636 |
| chain reaction | #20655 |
| upregulated | #20694 |
| highest | #20707 |
| genetically | #20746 |
| immunologic | #20771 |
| recurrent | #20779 |
| cells female | #20794 |
| interleukin | #20806 |
| wide | #20813 |
| clarify | #20844 |
| blood | #20864 |
| 51 | #20870 |
| cd4 cell | #20884 |
| rodents | #20894 |
| infectious | #20895 |
| causal | #20898 |
| create | #20974 |
| mucosal | #20983 |
| named | #20988 |
| obstructive | #20991 |
| interval | #21015 |
| suggesting | #21054 |
| 59 | #21130 |
| hereditary | #21187 |
| identical | #21192 |
| followup | #21199 |
| regulation | #21207 |
| epithelial cell | #21236 |
| essentially | #21325 |
| kappab | #21354 |
| variety | #21563 |
| mast | #21565 |
| celiac disease | #21617 |
| infection | #21622 |
| endpoint | #21718 |
| tumor necrosis | #21799 |
| reduced | #21829 |
| 10 years | #21837 |
| measures | #21851 |
| stress psychological | #21874 |
| alterations | #22024 |
| definitive | #22102 |
| assess | #22118 |
| continued | #22161 |
| correlate | #22201 |
| familial | #22235 |
| ensure | #22257 |
| frequency | #22288 |
| abolished | #22332 |
| continental ancestry | #22431 |
| reflecting | #22432 |
| unchanged | #22438 |
| validation | #22455 |
| score | #22546 |
| frequent | #22558 |
| tumor necrosis factor | #22615 |
| 95 confidence | #22620 |
| balb | #22645 |
| closely | #22684 |
| genes | #22753 |
| coupled | #22803 |
| continuously | #22829 |
| reactive | #22841 |
| indicating | #22843 |
| comparable | #22875 |
| murine | #22957 |
| 22 | #22977 |
| neonatal | #22988 |
| supported | #23008 |
| introduce | #23009 |
| type 1 | #23013 |
| report | #23048 |
| ifnγ | #23104 |
| necrosis factor | #23137 |
| predict | #23148 |
| lived | #23179 |
| increasingly | #23205 |
| rich | #23217 |
| count | #23292 |
| smoking | #23305 |
| modulating | #23348 |
| late | #23357 |
| mechanisms | #23394 |
| confidence | #23438 |
| 1 | #23526 |
| young | #23528 |
| adjustment | #23611 |
| exclude | #23665 |
| endopeptidases | #23709 |
| adolescents | #23720 |
| factors united | #23849 |
| defined | #23927 |
| extensive | #23929 |
| body | #24002 |
| dietary | #24027 |
| intracellular | #24110 |
| 5 | #24167 |
| 3 | #24232 |
| lymphocytes | #24242 |
| aimed | #24342 |
| increasing | #24355 |
| symptomatic | #24455 |
| depend | #24530 |
| reduces | #24548 |
| interaction | #24609 |
| collected | #24626 |
| adults | #24658 |
| remains | #24734 |
| needed | #24798 |
| responsible | #24851 |
| rsv | #24888 |
| 15 | #24969 |
| putative | #25032 |
| identification | #25068 |
| enrolled | #25223 |
| representing | #25239 |
| yielded | #25263 |
| determine | #25273 |
| extracellular | #25281 |
| analysis performed | #25297 |
| sex factors | #25359 |
| documented | #25522 |
| anti | #25535 |
| describing | #25574 |
| comprised | #25660 |
| matter | #25795 |
| transcriptase polymerase | #25871 |
| continue | #25896 |
| lymphocyte | #25994 |
| decreased | #26047 |
| enabling | #26157 |
| diminished | #26261 |
| previous | #26271 |
| healthy | #26310 |
| 16 | #26319 |
| profiling gene | #26374 |
| implicated | #26377 |
| dioxide | #26380 |
| inflammation | #26386 |
| tended | #26519 |
| applied | #26644 |
| contained | #26780 |
| describes | #26787 |
| generally | #26891 |
| multivariate | #26969 |
| capable | #27003 |
| unaffected | #27064 |
| presenting | #27110 |
| moderate | #27144 |
| 18 | #27195 |
| heterozygous | #27203 |
| acquired | #27213 |
| oligonucleotide | #27226 |
| concluded | #27331 |
| undergone | #27359 |
| topic | #27376 |
| proteins signal | #27393 |
| reached | #27432 |
| large | #27637 |
| recognized | #27654 |
| positive lymphocytes | #27691 |
| 001 | #27802 |
| linked | #27832 |
| preschool female | #27932 |
| models genetic | #27987 |
| predicted | #28046 |
| 0005 | #28071 |
| subsequently | #28087 |
| quantitative | #28099 |
| respect | #28131 |
| represent | #28157 |
| impaired | #28234 |
| reverse transcriptase | #28434 |
| continental | #28581 |
| plays | #28633 |
| positive | #28648 |
| immunoenzyme | #28655 |
| occurring | #28707 |
| screened | #28708 |
| square distribution | #28750 |
| transcriptase | #29017 |
| quantitative trait | #29137 |
| versus | #29158 |
| allowed | #29194 |
| comparison | #29267 |
| affect | #29339 |
| administered | #29469 |
| easily | #29520 |
| human | #29690 |
| weak | #29736 |
| possess | #29786 |
| physical | #29792 |
| pair | #29885 |
| correlated | #29909 |
| chain | #29911 |
| characterize | #29984 |
| gastrointestinal | #30316 |
| providing | #30537 |
| 005 | #30590 |
| aims | #30608 |
| factual | #30658 |
| 2 | #30659 |
| confirmed | #30719 |
| markedly | #30761 |
| 4 | #30907 |
| eligible | #31311 |
| fatty | #31332 |
| upper | #31437 |
| frequently | #32564 |
| mice knockout | #32696 |
| predictive tests | #32836 |
| peripheral | #32944 |
| humanized | #33092 |
| expression | #33163 |
| registered | #33261 |
| functional | #33617 |
| dominated | #33759 |
| selected | #33999 |
| mediated | #34372 |
| independent | #34407 |
| activate | #34542 |
| acids | #34703 |
| occur | #34769 |
| mediate | #35225 |
| conducted | #35568 |
| national | #35610 |
| evaluate | #35821 |
| 0001 | #35859 |
| developed | #36145 |
| characterized | #36394 |
| measurements | #36573 |
| express | #37054 |
| measured | #37778 |
| follow studies | #37967 |
| appears | #37978 |
| biological | #38141 |
| examined | #38373 |
| include | #39853 |
| adult | #39859 |
| clinically | #40140 |
| united | #42200 |
| mice inbred | #42559 |
| consistent | #42590 |
| excluded | #42832 |
| expression regulation | #43143 |
| inbred | #45657 |
Jalankan laporan | |
Prominent publications by Erika RM von Mutius
KOL-Index: 23349
BACKGROUND: Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma.
METHODS: As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, ...
| Dikenal sebagai Risk Asthma | 7 Years | Year Life | Children Aged | Rhinoconjunctivitis Eczema |
KOL-Index: 18397
BACKGROUND: Phase III of the International Study of Asthma and Allergies in Childhood measured the global prevalence of symptoms of asthma, rhinoconjunctivitis, and eczema in children.
OBJECTIVE: To investigate the associations between the use of antibiotics in the first year of life and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old.
METHODS: Parents or guardians of children 6 and 7 years old completed written questionnaires on current symptoms and ...
| Dikenal sebagai International Study | Rhinoconjunctivitis Eczema | Year Life | Symptoms Asthma | 95 Risk Factors |
Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood
[ PUBLICATION ]
Importance: Atopic dermatitis is an inflammatory, pruritic skin disease that often occurs in early infancy with a chronic course. However, a specific description of subtypes of atopic dermatitis depending on the timing of onset and progression of the disease in childhood is lacking.
Objective: To identify different phenotypes of atopic dermatitis using a definition based on symptoms before age 6 years and to determine whether some subtypes are more at risk for developing other allergic ...
| Dikenal sebagai Atopic Dermatitis | 6 Years | Age Children | Allergic Diseases | Food Allergy |
KOL-Index: 17686
BACKGROUND: Associations between exposure to cats and dogs and respiratory and allergic outcomes in children have been reported in affluent countries, but little is known about such associations in less-affluent countries.
METHODS: The International Study of Asthma and Allergies in Childhood, phase 3 was carried out in children aged 6-7 years and adolescents aged 13-14 years across the world. Questions about cats and dogs in the home were included in an additional questionnaire. Using ...
| Dikenal sebagai Cats Dogs | Asthma Rhinoconjunctivitis | Affluent Countries | Children Adolescents | International Study |
KOL-Index: 15451
BACKGROUND: There is increasing evidence that environmental exposures determining childhood illnesses operate early in life. Prenatal exposure to a farming environment through the mother might also play an important role.
OBJECTIVE: We sought to investigate the role of maternal exposures to environments rich in microbial compounds for the development of atopic sensitization, asthma, and corresponding alterations in the innate immune system in offspring.
METHODS: In the children of the ...
| Dikenal sebagai Atopic Sensitization | Innate Immunity | Farm Exposure | Microbial Compounds | Expression Receptors |
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study
[ PUBLICATION ]
BACKGROUND: Reduced lung function is a feature of chronic asthma, which becomes apparent at school age. Unknown factors between birth and school age determine the progressive loss of pulmonary function in children with persistent asthma. We investigated the role of allergic sensitisation and allergen exposure early in life.
METHODS: The German Multicentre Allergy Study followed 1314 children from birth to 13 years of age. We regularly interviewed parents about their child's asthma and ...
| Dikenal sebagai Chronic Asthma | School Age | Life Children | Birth Cohort | Allergen Exposure |
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison.
[ PUBLICATION ]
OBJECTIVES: To compare the prevalence of asthma and allergic disorders among children in Munich, western Germany, and Leipzig, eastern Germany, where environmental exposure, particularly air concentrations of sulphur dioxide and particulate matter, and living conditions have differed over the past 45 years.
DESIGN: Prevalence surveys among school-children aged 9-11 years in Leipzig and Munich. Self completion of written questionnaire by the children's parents and lung function ...
| Dikenal sebagai Allergic Disorders | Munich Leipzig | Prevalence Asthma | Seasonal Surveys | Living Conditions |
KOL-Index: 14833
BACKGROUND: Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown.
METHODS: We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an ...
| Dikenal sebagai European Ancestry | Association Asthma | Single Nucleotide Receptors | Tumor Necrosis Factor | Human Pair |
Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study
[ PUBLICATION ]
BACKGROUND: Associations between early life exposure to farm animals and respiratory symptoms and allergy in children have been reported in developed countries, but little is known about such associations in developing countries.
OBJECTIVE: To study the association between early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema in a worldwide study.
METHODS: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) was carried ...
| Dikenal sebagai Farm Animals | Asthma Rhinoconjunctivitis | Isaac Phase | Early Life | Affluent Countries |
KOL-Index: 14598
The German reunification offers a unique opportunity to study the impact of environmental factors on the development of childhood respiratory and allergic disorders in ethnically similar populations. We investigated the prevalence of asthma, hay fever, atopy, and bronchial hyperresponsiveness (BHR) in 9- to 11-year old children in West Germany (n = 5,030) and East Germany (n = 2,623). A self-administered questionnaire was distributed to the parents. Children underwent cold air challenge ...
| Dikenal sebagai East Germany | Asthma Fever | Prevalence Bhr | Environmental Factors | Atopic Sensitization |
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods
[ PUBLICATION ]
International comparative studies, investigating whether disease incidence or prevalence rates differ between populations and, if so, which factors explain the observed differences, have made important contributions to the understanding of disease aetiology in many areas. In Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence rates of symptoms of asthma, allergic rhinitis and atopic eczema in 13-14-yr-olds, assessed by standardised ...
| Dikenal sebagai International Study | Asthma Allergies | Prevalence Rates | Atopic Eczema | Childhood Isaac |
KOL-Index: 13844
BACKGROUND: Mutations in the filaggrin gene (FLG) have been shown to play a significant role in ichthyosis vulgaris and eczema, 2 common chronic skin diseases. However, their role in the development of other atopic diseases such as asthma and rhinitis has not yet been clarified in large population-based studies.
OBJECTIVES: To study the effect of FLG mutations at the population level and their effect on other atopic phenotypes.
METHODS: Association analysis of the 2 common FLG-null ...
| Dikenal sebagai Filaggrin Mutations | Atopic Eczema | Allergic Rhinitis Asthma | Role Development | Disease Genotype Humans |
Increased food diversity in the first year of life is inversely associated with allergic diseases
[ PUBLICATION ]
BACKGROUND: The role of dietary factors in the development of allergies is a topic of debate, especially the potential associations between infant feeding practices and allergic diseases. Previously, we reported that increased food diversity introduced during the first year of life reduced the risk of atopic dermatitis.
OBJECTIVE: In this study we investigated the association between the introduction of food during the first year of life and the development of asthma, allergic rhinitis, ...
| Dikenal sebagai Food Diversity | Allergic Diseases | Year Life | Development Asthma | Atopic Sensitization |
Orang -orang kunci untuk Atopic Dermatitis
Top Kols di dunia
Pilih frasa pencarian atopic dermatitis , atopic dermatitis patients , atopic dermatitis psoriasis , atopic dermatitis children , atopic dermatitis asthma
Erika RM von Mutius:Dampak ahli
Konsep yang manaErika RM von Mutiusmemiliki pengaruh langsung:Atopic dermatitis, Childhood asthma, Allergic diseases, Atopic sensitization, Allergic rhinitis, International study, Farm milk, East germany.
Erika RM von Mutius:Dampak Kol
Konsep yang terkait dengan karya penulis lain yang manafor which Erika RM von Mutius memiliki pengaruh:Atopic dermatitis, Allergic rhinitis, Childhood asthma, Food allergy, Lung function, Air pollution, Early life.
Tools
Apakah ini profil Anda? Klaim profil Anda Salin URL Sematkan tautan ke profil Anda |